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ABSTRACT
The use of biodegradable polymers makes the surgical
removal of the depleted device unnecessary. Furthermore
the degradation of carrier can be utilized to control the
rate of drug release. The biodegradable polymers receiving
the most attention at this time are these prepared from
lactic and glycolic acids, mainly because of the
established biocompatibility.
The synthesis of poly(lactide-co-glycolide) polymers by the
ring opening polymerization of lactide and glycolide was
investigated from a pharmaceutical viewpoint. The effects
of changing the polymerization conditions on the properties
of the resulting polymer and on the yield of the
polymerization were discussed with respect to a co-ordinate
mechanism of polymerization. The factors investigated were
the catalyst type and concentration, co-catalyst
concentration and time and temperature of polymerization.
The polymerization conditions affected the properties of
the resulting polymers through their effect on polymer mw
and composition. There was significant interdependence
between the preparative variables. It appears possible to
control the properties of the polymer formed by modifying
the polymerization conditions.
A spray dried technique was adopted to prepare polymer
powders. The main problem encountered in the spray drying
was the production of threads, instead of particles, when
relatively high molecular weight (MW) polymers were
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sprayed, unless very dilute solutions were used. The spray
dried powders were soft and ductile having yield pressure
ranging from 28 to 33 MPa. The degradation of spray dried
powders proceeded through a non autocatalytic mechanism in
phosphate buffer, pH = 7.4. The rate of hydrolysis, and
consequently the rate of mass loss from the polymer
increased with an increase in glycolide content or a
decrease in the polymer MW.
The contact angle of spray dried polymers with water ranged
from 72° to 78°, indicating a moderate polymer
hydrophobicity. The percent water uptake, water uptake
rate and swelling of the polymers increased with increasing
glycolide content or decreasing polymer MW.
The rate of phenobarbitone (model drug) release from
polylactide co-glycolide) heterogeneous matrices was
affected by both technological factors and polymer
properties. A composite release mechanism was considered
to operate involving diffusion of the drug through water
filled capillaries and pores of the matrix and drug
diffusion through the swollen polymer. The release of
phenobarbitone was significantly sustained, indicating the
suitability of using poly(lactide-co-glycolide) matrix
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1.1	 Biodegradable Polymers in Controlled Drug Delivery
1 • 1 1	 Introduction
The use of biodegradable polymers in the formulation of
controlled drug release systems makes the surgical removal
of the depleted device unnecessary. In addition, the
degradation process can be utilized to control the rate of
drug release.
Terminology for this process has tended to be unprecise
with biodegradation bioerosion and bioabsorption used to
describe in vivo degradation phenomena. The term
bioabsorbable has been used to characterize surgical
sutures which are 'absorbed' by the body, i.e. the solid
material eventually disappears from the site of
application.
No clear definitions have been made between the terms
biodegradation and bioerosion. Graham and Wood (1982) and
Heller (1985) used 'biodegradable" and "bioerodible"
respectively to describe polymers completely solubilizing
as a consequence of a degradation process and ultimately
disappearing from the site of implantation. However,
Holland et al. (1986) took the term biodegradation to refer
to the hydrolytic, enzymatic or bacteriological degradation
processes occurring in a polymer, which do not necessarily
proceed to a stage where the physical form of the polymer
is affected. Bioerosion, on the other hand, necessitates
physical loss from the polymer matrix and this may be
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brought about by a variety of physical or chemical
processes which are not always specified.
1.1.2	 Biodegradation Mechanisms
Polymer degradation can be classified by three basic
mechanisms (fig 1). Type I degradation refers to the
polymers soluble in water, which have been made insoluble
by covalent cross-links and which solubilize as the cross-
links (type IA) or the backbone (type IB) undergo
hydrolytic cleavage. In type II degradation, polymers that
are initially water-insoluble are solubilized by
hydrolysis, ionization, or protonation of a pendant group.
In type III degradation, hydrophobic polymers are converted
to small water-soluble molecules by backbone cleavage.
These types represent extreme cases and actual degradation
may take place by a combination of all three types.
(Heller, 1985).
1.1.3 Drug Release From Biodegradable Delivery Systems
The rate of drug release from biodegradable reservoir
devices can be constant and predictable, provided the rate
controlling membrane does not degrade until drug delivery
has been completed. In this case the kinetic models for
the release from non-biodegradable reservoir devices (Baker
and Lonsdale, 1974) are applicable. The rate of release
can be controlled only by changing the shape and dimensions
of the device, or by changing the nature or thickness of
the membrane; degradation simply removes the expended
-12-
device. If the rate controlling membrane undergoes
significant degradation during drug delivery, changes in
membrane thickness or physical properties would change the
rate of drug release.
Drug release from biodegradable monolithic devices may
predominantly occur by diffusion, degradation of the
polymer, or by a combination of these two mechanisms. If
the matrix degrades much slower than the drug diffuses, the
release kinetics can be described by the Higuchi's model
(Higuchi, 1963). If the drug release due to diffusion is
minimal, whilst degradation is relatively rapid, then the
rate of drug release can be controlled by degradation.
There are two types of hydrolytic degradation of a solid
polymer.	 In one, homogeneous (usually referred to as
"bulk") degradation the hydrolysis occurs throughout the
z
matrix. In the other, heterogenous (usually referfecl to as
"surface") degradation, the hydrolysis is confined to the
surface of the device (Holland et al., 1986).
The detailed understanding of drug release from a matrix
undergoing homogeneous degradation is complex, because it
combines diffusion and degradation. Because the homogenous
degradation changes the matrix the permeability of the
polymer to the drug will increase with time and the release
rate will not normally be predictable. Theoretically,
heterogeneously degraded matrices should not produce zero-
order release kinetics. However, many do; probably because
of some degree of tissue encapsulation, which occurs with
-13-
all dosage forms and leads to the formation of a water
boundary layer capable of controlling release rates
(Benagiano and Gabelnik, 1979).
The drug release from matrices undergoing heterogeneous
degradation can be zero-order provided diffusional release
is minimal and the overall surface area of the device
remains constant. In addition, the deterioration of the
mechanical properties, which can result in the
disintegration of devices undergoing homogenous
degradation, is avoided by utilizing devices which undergo
surface degradation. (Heller, 1985).
Where the surface degradation follows zero-order kinetics
the drug release can be determined by equation 1, proposed
by(Hophenberg, /1976):
= 1- r K0tV	 Equation 1
Where Mt/M 1. is the fraction of drug released at time t, K
is the zero-order degradation rate constant, and C 0 is the
initial drug content. The values n and a depend on the
geometry of the device. For the infinite slab, n=l and a
is half the thickness; for the cylinder n=2 and a is the
radius; for the sphere, n=3 and a is the radius. It is
evident that a constant rate of release is only obtained
-14-
from the infinite slab and that delivery rates from
cylinders and spheres decrease with time.




Delivery Systems Based on Polymers Undergoing
Type I Degradation
In these systems water-soluble macromolecules are converted
to an insoluble three dimensional network by means of
covalent cross-links. When these networks are placed in an
aqueous environment they can swell only to the extent
allowed by the cross-link density. Such systems are
completely permeated by water and the aqueous solubility of
the incorporated drug becomes a very import consideration.
Biodegradable hydrogels could be useful for extended
delivery either of drugs with low solubility in water, or
macromolecules physically entangled in the cross-linked
hydrogel matrix. The latter cannot diffuse out of the
matrix even though it is freely soluble in water.
Type I degradation can be subdivided into two subtypes, 1A
and lB.
In type 1A degradation the hydrogel dissolves when the
cross-links, which connect the water-soluble polymer
chains, cleave. The degradation products are high
molecular weight (MW) polymers soluble in water and, if
such systems are to be implanted, these polymers must
degrade further to small water soluble molecules which can
be readily eliminated from the implantation site.
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A widely investigated system undergoing type IA degradation
is that prepared by copolyiiierizing vinyl pyrrolidine or
acylamide with N,N' methylene-bisacrylamide. The rate of
degradation is very slow and the hydrogel completely
solubilizes with a useful time span at cross-linker
concentration of less than 1% (Heller 1985).
Hydrogels from polyacrylamide or poly(vinyl pyrrolidine)
cross-linked with N,N' methylene bisacrylide have been
investigated for the controlled release of macromolecules,
such as bovine serum albumin, rabbit immunoglobulin, bovine
pancreatic insulin, and rat luteinizing hormone. The
results obtained show that these hydrogels release the
macromolecules at satisfactory rates only at the high
cross-link density necessary to immobilize the
macromolecules which prevents solubilization of the matrix
(Heller and Baker, 1980).
Another system of interest is gelatin cross-linked with
formaldehyde. The hydrolytic instability of gelatin
resides both in the cross-linkages and the poly(amino acid)
backbone, so that it is suitable for both topical and
systemic applications. Gelatin cross-linked with
formaldehyde has been used as a matrix for the controlled
release of hydrocortisone acetate and a useful prolonged
release of the drug was achieved. The first order kinetics
indicated that matrix erosion contributed little or nothing
to the release of the drug and depletion occurred before
significant matrix degradation (Heller, 1980).
-16-
In subtype lB degradation the hydrogel dissolves by
cleavage of the water-soluble polymer chains resulting in
low MW degradation products. Thus, provided all
degradation products are toxicologically innocuous, such
systems can be considered for implantation applications.
Subtype lB degradation is undergone by the polymer prepared
by copolymerizing dextran, previously reacted with acrylic
acid glycidyl ester, and N,N'-methylene bisacrylamide.
Macromolecules such as carbonic anhydrase, human serum
albumin, immunoglobulin, and catalase have been
incorporated with microspheres from this material with no
loss of activity in vivo degradation of these inicrospheres
depended on enzymatic activity. Release of proteins from
the polyacrylodextran particles was greater than from
polyacrylamide particles (Edman et al., 1980).
Hydrogels were prepared by copolymerizing fuinaric acid and
poly(ethylene glycol) and were cross-linked with various
amounts of N-vinyl pyrrolidine. The release of bovine
serum albumin from microspheres of this hydrogel was
controlled by the degradation of the matrix and could be
regulated by the amount of vinyl co-monomer used. The rate
of degradation, and consequently the rate of drug release,
could be increased by partial substitution of fumaric acid
by a diacid containing and electron withdrawing group
(Heller et al., 1983).
-17-
1.2.2	 Delivery Systems Based on Polymers Undergoing
Type II Degradation
Two classes of devices using type II, or a combination of
type II and III degradation, have been developed. In one
the drug is dispersed within, or is surrounded by the
polymer matrix being released as solubilization takes
place. The other class contains the active agent
covalently bonded to the polymer chain by a hydrolytically
labile bond, so that the active agent is released to the
surrounding medium as this bond cleaves (pendant chain
systems).
Polymers of the first class are partially esterified
copolymers of methyl vinyl ether and maleic anhydride, or
partially esterified copolymers of ethylene and maleic
anhydride ( Heller et al., 1978). They solubilize by
ionization of carboxylic acid groups. In a constant pH
environment they undergo a controlled dissolution process
and matrices release the incorporated drug at a rate
controlled by the surface degradation process. Disks from
this material inserted in the lower fornical cul-de-sac of
rabbits have been shown to release hydrocortisone at a
constant rate (Heller and Baker, 1980).
The partial ester copolymer has also been used as a model
for a self-regulated drug delivery system in which the drug
release is mediated by the amount of a specific external
molecule. Hydrocortisone loaded disks were coated with
hydrogel containing urease. Hydrolysis of urease causes an
increase in the pH, due to the release of aminonium ions,
-18-
which in turn increases both the degradation and
hydrocortisone release rate (Heller and Trescony, 1979).
Both water soluble and water-insoluble biodegradable
pendant chain systems have been investigated.
A significant feature of the soluble pendant chain systems
is the ability to target drugs to specific body sites.
Poly(l-glutamic acid), in which the homing group
immunoglobulin and the anticancer agent p-phenylene diamine
mustard have been covalently bonded, have been used to
target lytuphoma mice cells. The homing group enhances the
effectiveness of the anticancer agent, presumably by
concentrating the polymer at the lyinphoma cells. The
macromelecular drug was shown to be more effective than the
individual component, or mixtures of the individual
components (Rowland et al., 1975).
In the water insoluble pendant chain systems, polymers
initially soluble in water have been rendered insoluble by
the covalent attachment of a hydrophobic drug. One such
system has been prepared by coupling norethindrone to
poly(N5-hydroxypropyl-l-glutamine) via carbonate linkages.
Upon implantation in rats, slowly declining release
kinetics over 144 days were obtained. Only minor tissue
reaction and no immunologic response was observed
(Pet^ersen et al., 1980).
The release of drugs from insoluble pendant chain systems
is considered to proceed via aqueous diffusion into the
-19-
polymer, hydrolysis of the polymer-drug linkages and
diffusion of the drug from the matrix. The release rate is
determined by a combination of the rate of hydrolysis and
rate of water permeation into the polymer (Heller, 1985).
1.2.3	 Delivery Bystems Based on Polymers Undergoing
Type III Degradation
In these systems, high molecular weight water insoluble
macromolecules are converted to small, water-soluble
molecules by hydrolytic cleavage of labile bonds in the
polymer backbone. Because these polymers are converted to
small, water-soluble molecules, their principal application
is for the systemic administration of therapeutic agents
from subcutaneous, intramuscular or intraperitoneal
implantation sites.
Polymeric systems containing hydrolytic instability in the
polymer backbone are: aliphatic polyesters, polyamides,




Poly(e-caprolactone) is a semicrystalline polyester having
glass transition temperature, Tg=650C and melting point 63°C
(Pitt et al. 1980). It is prepared by the ring opening
polymerization of the €-caprolactone which can be effected
by at least four different mechanisms categorized as
-20-
anionic, cationic, co-ordination and radical. Each method
provides different degrees of control of the MW and
molecular weight distribution (MWD), the end group
composition, and the chemical structure and sequence
distribution of the poly(e-caprolactone) copolymers. Each
of these characteristics, in turn, affects the permeability
and biodegradability of the polymer (Pitt, 1990a).
Poly(€-caprolactone) biodegrades through an homogeneous
biphasical process. 	 Degradation begins with random
hydrolytic scission of the ester bonds. This chain
scission has been shown to be autocatalyzed by the
generation of carboxylic acid end groups. There is no
weight loss during this first stage of degradation. Second
phase degradation is characterized by a decrease in the
rate of chain scission and the onset of weight loss.
Weight loss from the polymer was attributed to the
diffusion out of the small chain segments produced by the
break up of the polymer mass. The final products of
poly (€-caprolactone) metabolism are c-hydroxycaproic acid
and water (Pitt, 1990a).
Complete elimination from the body of the poly(€-
caprolactone) with an initial number average molecular
weight, M, of 50,000 requires three years (Holland et al.,
1986). However, degradation can be accelerated to more
useful rates by employing copolymers, or blends of poly(c-
caprolactone) with other biodegradable polymers (Pitt et
al., 1981b; Pitt et al. 1987).
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Poly(€-caprolactone) and its copolymers have been
considered for the controlled delivery of drugs such as
steroids, narcotic antagonists and macromolecules (Pitt and
Schindler, 1984; Pitt et al., 1987; Tice et al, 1987).
Release of lipophilic drugs from monolithic poly (€-
caprolactone) devices is very rapid and diffusion
controlled, but can be slowed by employing copolymers of
poly(e-caprolactone) instead of the homopolymer. Thus, 1-
methadone was microencapsulated with poly(6-caprolactone-
co-l-lactide) using a solvent evaporation technique.
Increasing the proportion of lactic acid slowed the rate of
in vitro drug release whilst the release mechanism changed
from diffusion to degradation controlled (Cha and Pitt,
1988).
Levonorgestrel when suspended in a suitable oil, such as
ethyl oleate, and incorporated into poly (c-caprolactone)
capsules released the steroid at a constant rate for up to
one year, when implanted in rabbits. The oil apparently
served to enhance the contact and dissolution of the drug
into the capsule wall (Pitt and Schindler, 1984).
Whereas poly (€-caprolactone) is very permeable to low MW
drugs, Fickian diffusion of macromolecules through poly
(e-caprolactone) membranes is too slow to have any
practical application. This deficiency was recently
overcome by preparing poly (c-caprolactone) capsules with
controlled porosity by a leaching procedure.
	 Thus, a
constant release rate of a luteinizing hormone releasing
-22-
hormone (LHRH) analogue was maintained for more than 60
days using this technique (Schindler, 1987).
The microencapsulation and controlled release of nucleic
acids to stimulate the production of interferon has been
patented (Tice et al., 1987).
1.2.3.1.2. Poly(3-hydroxy butyric acid)
Poly(d(-) - 3 - hydroxybutyric acid) (PHB) has been
obtained from strains of bacteria, such as Azobacter
beijeinckii, Bacillus megatenium, Rhodosririllurn rubrum and
Bacillus cereus (Gilding, 1981; Korsatko et al.,1983a).
Grassie et al. (1984) have described the synthetic
preparation of low MW PHB.
The degradation of PHB appears to be a simple hydrolysis in
vitro, but there are indications of enzymatic involvement
in vivo (Holmes, 1985). The biodegradation rate of PHB and
its valerate copolymers (PHB-PHV) has been shown to depend
on the polymer MW, the porosity of the matrix, and the
valerate content of the copolymer (Holland et al., 1987).
The polymers are regarded as non-toxic and the monomer is
a normal constituent of human blood (Gould et al., 1987),
Pouton et al. (1988), found that after intramuscular
injection in rats of PHB and PHB-PHV mild inflammation was
detected, but this was associated to the injection vehicle
or the trauma caused by the penetration of the needle
rather than with the polymers or monomers. They also
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reported that the polymers caused no inhibition in the
growth of CHO-Ki cells in culture (these cells are a useful
model of mammalian cells), but the cells were proven to be
sensitive to the presence of monomers above concentrations
of 10 mg.m1 1 , suggesting that high concentrations of monomer
may be expected to have a deleterious effect on the
metabolism of the surrounding tissue. However, it is not
likely that such concentrations would be present in vivo,
because degradation of the polymer is slow and free monomer
would be expected to be rapidly cleared from the site of
polymer implantation.
Gilding (1981) showed that the thermal processing caused
PHB degradation. However, its copolymers with poly(3-
hydroxy valerate) (PHV) have good melt stability and can
therefore be easily processed to matrices for controlled
drug delivery (Holland et al., 1986).
The release of hydroxyethyltheophylline from PHB matrices
has been reported to be diffusion controlled with high drug
loadings, but both diffusion and degradation controlled
with low loadings (Korsatko et al., 1983 a,b). Drug
release from PHB-PHV compressed matrices has been shown to
depend on the MW of the drug, the copolymer composition,
the drug loading, and the porosity of the matrix (Gould et
al., 1987).
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1.2.3.1.3 Polydioxanones and polyoxylates
Polydioxanone and polyoxylates have been primarily
synthesized for use as bioabsorbable surgical sutures
(Holland et al., 1986) The commercial suture Maxon is a
copolymer of 1,3 dioxane-2-one (32.5%) and glycolide, and
has been reported to have better handling properties than
the equivalent polyglycolide suture Dexon (Katz et al.,
1985).
Copolymers of polydioxanones and polyoxylates with the
structurally similar poly(lactide) and poly(glycolide) have
been suggested for the preparation of controlled drug
delivery systems (Shalaby and Jamiolkowski, 1978; Guerrero
et al., 1980). However, further research is needed to
evaluate in detail their biodegradation and
biocompatibility (Holland et al., 1986).
1.2.3.1.4	 Polyamides
Nylons are not considered biodegradable materials even
though some of them are hydrophillic and hydrolysable,
undergoing slow biodegradation. Moiseev (1979) and
Gumargalieve (1980) demonstrated hydrolytic and enzyme
catalyzed surface degradation of nylon 6.6 implants both in
vitro and in vivo. The implants lost 80% of their initial
tensile strength during three years implantation in dogs.
Poly(amino acids) have been shown to degrade enzymatically
both in vitro and in vivo (Williams, 1982). The hydrolytic
instability of the amide bond has been used in the
-25-
preparation of polymers designed to give controlled
biodegradation via the introduction of segments susceptible
to the affects of specific enzymes (Kopecek, 1981).
Copolymers of glutamic acid and p-ethyl-i-glutamate have
been used as biodegradable membranes in the release of the
narcotic antagonist naltrexone and as monolithic devices
for the delivery of contraceptive steroids (Sidman et al.,
1979 and 1980). The same copolymers have been used to
prepare hydrogel membranes, permeable to proteins with a mw
range of 12 x to 69 x l0 (Sidman et al., 1983).
Poiy(amino acids) have also been utilized as chemical
carriers of active agents (paragraph 1.2.2).
1.2.3.1.5	 Poly(cyano acrylates)
Aikyl cyanoacrylates can undergo a very rapid
polymerization and adhere firmly to moist tissue. They
have evoked considerable interest as surgical adhesives
(Leonard et al.,l967).
Poly(cyano acrylates) have been shown to undergo hydrolytic
degradation by a reverse knoevenagel reaction (Leonard et
al. ) 1966, Vazin and Florence,1980). The rate of
degradation depends on the length of monomer alkyl chain,
and on NW and MWD of the polymer. It is also affected by
the size and specific surface area of the polymer and by
the pH of the dissolution medium (Vezin and Florence,1980).
Poly(methyl cyanoacrylate) is histotoxic due to the rapid
degradation and accumulation of degradation products.
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Poly(butyl cyanoacrylate) is better tolerated (Lehman et
al., 1966; Mungiu et al., 1979).	 The toxicity of
poly(alkyl cyanoacrylate)	 nanoparticles,	 free	 and
doxorubicin loaded, has been investigated. It was
demonstrated that the nanoparticles induced cellular damage
only at concentration of 1% or greater in the culture
medium, and therefore can be safely utilized as drug
carriers (Kante et al., 1982; Couvreur et al., 1982).
Biodegradable microcapsules (Florence et al., 1976;
Florence et al., 1979) and magnetic particles for drug
targeting (Ibrahim et al., 1983) have also been prepared
using poly(alkyl cyanoacrylates).
1.2.3.1.6	 Polyanhydrides
Polyanhydrides undergo a controlled heterogeneous
degradation which can be used to regulate the rate of drug
release from polyanhydride formulations (Chasm et al.,
1990).
Polyanhydrides of high MW can be prepared by melt
polycondensation. The factors affecting the MW are monomer
purity, time, temperature of polymerization and the type of
catalyst. Significantly higher molecular weights were
achieved using shorter polymerization periods with
catalysts, such as cadmium acetate, earth metal oxides and
diethyl zinc-water (Domb and Langer,1987). Polyanhydrides
homopolymers such as poly(carboxy phenoxy acetic acid)
(PCPA) and copolymers, such as the copolymer of bis
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carboxyphenoxypropane and sebacic acid, P(CPP-SA) have been
synthesized.
The degradation of polyanhydrides involves hydrolysis of
the anhydride linkage, which proceeds in an essentially
constant rate. The degradation rate depends on the length
of the aliphatic chain in the polymer backbone decreasing
with an increase in chain lengthening. The relative ratio
of the two monomers has a marked effect on the degradation
rate of polyanhydride copolymers. By altering the
carboxyphenoxypropane - sebasic acid ratio in the P (CPP-
SA) copolymer, nearly any degradation time between 1 day
and 3 years can be achieved (Leong et al., 1985).
Release studies for anticancer agents (Chasm et al., 1988;
Grossman et al., 1988), steroids (Leong et al., 1986a) and
proteins (Mathiowitz et al., 1985; Mathiowitz and
Langer,l987;) incorporated in polyanhydride matrices, or
microcapsules, showed that these polymers are capable of
delivering a wide range of drugs for prolonged periods of
time. Biocompatibility tests for polyanhydrides gave
satisfactory results (Leoriet al., 1986b; Brem et al.,
1988a,b). P (CPP-SA) loaded with the cancer
chemotherapeutic agent carmustine is currently studied in
man, for the local treatment of brain cancer. The safety




Poly(ortho esters) have been developed for the preparation
of delivery systems where drug release would be
predominantly controlled by a surface degradation process
(Heller et al., 1990).
Poly(ortho esters) useful in the fabrication of controlled
release devices have been synthesized by the addition of
polyols to diketene acetals (Heller et al., 1980). The
reaction proceeds spontaneously but when catalyzed by small
amount of acids, high MW polymers are formed virtually
instantaneously. The MW can be regulated by appropriate
skewing of the stoichiometry of the monomers' mixture. The
mechanical properties of poly(ortho esters) can be varied
within wide limits by careful selection of the diol or the
I 34
mixture of diols (Heller et al., 1.9.&3; Heller et al.,
1•
198fi).
The initial degradation products of these poly(ortho
esters) are the diol and the pentaerythritol ester. The
pentaerythritol ester hydrolyzes at a slower rate to
pentaerythritol and the corresponding aliphatic acid. The
rate of degradation decreases with an increase in the
polymer MW (Sparer et al., 1984).
Because orthoester linkages are acid sensitive, but stable
in basic media, the degradation can be controlled by
incorporating acidic or basic excipients in the formulation
(Heller,1985). Acidic excipients have been used to prepare
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surface degrading devices having a relatively short
duration of drug release (Sparer et al., 1984).
Another method of accelerating the degradation, without
employing excipients, is the introduction of pendant
carboxylic acid groups in the polymer backbone, which upon
ionization in the water catalyze the hydrolysis of the
polymer (Heller et al., 1984).
The degradation rate and consequently the rate of drug
release can be decreased by incorporating basic excipients
into the matrix. Thus the release of levonorgestrel from
rods containing 71% mol magnesium hydroxide implanted
subcutaneously in rabbits occurred concomitantly with the
degradation of the polymer for at least 20 weeks (Heller et
al., 1985). A plausible mechanism for the degradation of
devices containing magnesium hydroxide is that the base
stabilizes the interior of the device and degradation then
only occurs in the surface layers where the base has been
eluted or neutralized (Heller,1986).
1.2.3.1.8	 Polyphosphazenes
Polyphosphazenes are a new class of polymers which can be
either biodegradable or non-biodegradable by changing the
side groups attached to an unconventional macromlecular
backbone (Allcock,1990). A wide range of polyphosphazene
molecular structures can be obtained by either substitution
reactions involving the macrom1ecular intermediate
poly(dichlorophosphazene) or polymerization of a cyclic
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trinter whose chioro side groups have been previously
replaced by organic groups (Ailcock et al., 1966; Ailcock
et al., 1978; Alicock and Moore,1975). The properties of
the polymer, such as crystallinity and hydrophilicity,
depend on the type and disposition of different groups
(Ailcock, 1990).
Water-insoluble biodegradable polyphosphazenes have been
used for the preparation of matrix controlled drug release
systems. The sustained release of progesterone and bovine
serum albumin from matrices based on imidazole-
methyiphenoxy polyphosphazene copolymers has been
demonstrated. A lag period of 80 hours, followed by a
period of almost constant release for 900 hours, was
observed with progesterone discs implanted subcutaneously
in rats. The release of bovine serum albumin exhibited an
initial burst of 25% which could be eliminated by coating
the matrices with polymer (Laurencin et al., 1987).
Insoluble biodegradable polyphosphazenes have also been
used as chemical carriers for the chemically controlled
release	 of	 steroids	 (Ailcock	 and	 Fuller,1980),
antibacterial agents (Alicock and Austin,1981), local
anaesthetics (Ailcock et al., 1982 k) and polypeptides
(Alicock et al., 1982b).
Water-soluble macromllecular drugs could be more effective
in some forms of therapy than their small molecular
counterparts because of their restricted ability to escape
through biological membranes. Furthermore, targeting
groups can also be linked to the macromolecule to increase
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the effectiveness of the drug (Allcock,1990). The
properties of macromelecular drugs have been exploited to
reduce the side effects of the antitumour agent (NH3 ) 2 PtC12.
Kidney damage, caused by the readily excreted drug, can be
reduced by its reaction with poly(bis-methylamino-
phosphazene), in which a non-excretable co-ordination
complex is formed (Allen et al., 1977).
1.3	 Poly(lactide-co-glycolide) Polymers
1.3,1	 Introduction
Glycolic acid and lactic acid are the common names of the




Glycolic Acid	 Lactic Acid
Lactic acid contains an asymmetric carbon atom and








When condensed the direction of rotation of sodium D line
is reversed, so that L (+) lactic acid gives L(-) lactide
and L(-) polylactic acid and D(-) lactic acid give D(+)
lactide and D(+) polylactic acid (Wise et al., 1979k).
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Six membered cyclic dimers of lactic or glycolic acid-
lactide (LE) and glycolide (GE) respectively (Fig. 2) - can
be synthesized by removing the free water and much of the
bound water from an aqueous solution of the appropriate
acid by vacuum distillation. The cyclization occurs in the
vapour phase (Wise et al., 1979k).
They are white, crystalline, very hygroscopic materials
which are readily hydrolysed in the presence of moisture.
Lactide contains two asymmetric carbon atoms and exists as
four different diastereonieric compounds, the L,L and D,D
antipodes (L(-) and D(+) lactides respectively), the D,L
diastereomer or meso-lactide, and the D,D and L,L racemic
combination of L(-) and D(+) lactides (racemic lactide),
depending on the L and D configuration of the lactic
moieties forming the cyclic molecules (Fig 3). Racemic
lactide consists largely of a mixture of D and L lactide,
not the mesoform. The melting point of this mixture is
higher than that of the individual components (Chabot et
al., 1983).
isomer:	 1-lactide D-lactide D,L-lactide Meso-lactide
Melting:	 95-36	 95-36	 124-126	 41-42
Point. (°C)
Glycolide (melting point 82°C) exists in two isomeric
configurations resulting in two crystal forms designated a
and (Fig. 4). The a crystal is thermodynamically
preferred if crystallization occurs above 42°C, the $
crystal form below that temperature.
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The a form has been found to be more stable hydrolytically
and is therefore preferred for use in preparing high MW
polymers. It is slowly but unpredictably converted to the
i3 isomer on standing at ambient temperature (Frazza and
Schmitt, 1971).
1.3.2 Synthesis of poly(lactide-co-glycolide) polymers
Low molecular weight polymers can be prepared by the direct
polyesterification of lactic and/or glycolic acids.
Condensation of a-hydroxycarboxylic acids can be effected
by the removal of water by boiling it from the reaction
mixture, or by azeotropic distillation with an aromatic
hydrocarbon solvent (Fig. 5) (Filachione and Fischer,1944).
At reaction temperatures below 120°C an acid, such as
toluene suiphonic acid or sulphuric acid, beneficially
increases the reaction rate, but above this temperature the
rate-limiting step is generally water removal, so that
little benefit is gained by employing a catalyst. An upper
limit for number overage molecular weight of approximately
10000 exists for polymers produced using the step growth
condensation reaction (Fig. 5) (Wise et al., 1979k).
In order to prepare higher MW polymers it is necessary to
proceed by ring opening of the cyclic diesters, lactide and
glycolide. This ring opening polymerization has been shown
to proceed through pair addition of lactic or glycolic acid
units yielding polydimers (Fig. 6). As many of the
catalysts for the ring opening polymerization do not alter
the lactide configuration, this pair addition mechanism of
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chain growth provides a means to synthesize polymers with
various configurational structures, or tacticity, from
suitable mixtures of lactide diastereoisomers. The
resulting stereocopolymers have been shown to contain the
monomeric units in the same proportion as that of the
monomer mixture, which implies that the reactivities of the
optically active and racemic monomers are the same (Chabot
et al., 1983). Because glycolide has been found to be more
reactive than lactide (Gilding and Reed,1979) it is
probable that copolymers containing blocks of glycolic acid
repeating units will be produced rather than copolyiners of
a random structure.
Ring opening polymerization can be effected in solution or
in a melt. Solution polymerization proceeds in a suitable
organic solvent such as chloroform, tolue± or dioxane. As
low temperatures are employed (25 to 80°C) long reaction
periods (12 hours to a few days) are necessary to obtain
high molecular weights and satisfactory conversion.
Solution polymerization involves relatively mild
conditions, allowing better control of the reaction, and it
was therefore, preferred to melt polymerization when
studies on the mechanism, or kinetics, of polymerization
were carried out. A co-ordinate polymerization mechanism
has been proposed for the solution polymerization of
lactide (Dittrich and Schulfz197l).
For biomedical application poly ( lactide-co-glycolide)
polymers have been prepared by melt polymerization, which
is more rapid and convenient than solution polymerization.
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Monomers of high purity and low acidity are required in
order for high MW polymers to be obtained (Lowe,1954). The
exclusion of moisture is also essential because it may
cause termination of the chain growth reactions, or
hydrolysis of the monomers to acidic products. Schindler
et al. (1977) reported that high MW polymers were obtained
only with the use of silanized glass vessels.
Jacobson (1970) argued that the amount and type of catalyst
used would determine the particular temperature and time
required to produce the polymer. He suggested that, as a
rule, the lower the amount of catalyst, the longer the time
required to produce polymer of a given MW and conversely
the higher the catalyst concentration the shorter the time.
Melt polymerization is usually conducted over a period of
2-6 hours at about 160-220°C. With crystalline polymers,
such as poly(glycolide), it has been reported as preferable
that the polymerization is initiated at a temperature below
the melting point of the polymer, and when solidification
of the polymer produced commences the temperature is raised
above the melting point to prevent solidification and to
complete polymerization (Lowe,l954; Chujo et al., 1967).
Lactones can be polymerized by both cationic or anionic
mechanisms (Cherdron, 1962), therefore, a variety of
catalysts have been employed to polymerize lactide and/or
glycolide.
For intermediate molecular weights (10000 - 40000) protic
acid catalyzed polymerizations are convenient and
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effective. If the concentration of reactive impurities is
less than the catalyst concentration, then the mw is
determined by the catalyst concentration (Wise et al.,
1979k). Thus, lactide and glycolide were bulk polymerized
at 130°C with p-toluenesulphonic acid as a catalyst for 7-10
days and the resulting material was a solid golden mass
(Kitchell and Wise,1985). Glycolide was polymerized using
sulphuric acid or phosphoric acid and a brittle and highly
coloured polymer resulted (Chujo et al., 1967).
Tertiary amines, such as triethylamine, trimethyl amine and
-Vt-
diethyl-,ithutylamine, have been used for the anionic
solution polymerization of glycolide (Klootwijk,1966; Braun
and Kohl,197'6).
Oxides of zinc, magnesium, cadmium, lead and antimony have
been reported as suitable catalysts for the melt
polymerization of lactide and/or lactide (Kulkarni et al.,
1966; Jacobson,1970). Powdered zinc has also been used
successfully in the preparation of poly(lactide)
stereocopolymers (Chabot et al., 1983).
Polymers with high molecular weights can be synthesized
using Lewis acids, such as zinc chloride, aluminium
chloride, tin tetrachioride, and antimony trifluoride, or
organometallic compounds and salts, such as dialkyl zinc,
trialkyl aluminium, tetralkyl tin complexes, and stannous
octoate, as catalysts (Tsuruta et al., 1964; Chujo et al.,
1967; Gilding and Reed,1979). It is presumed that the
polymerization mechanism with organometallic catalysts
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involves nucleophilic attack of a carbonyl on one of the
lactide or glycolide carbonyls. The effect of catalyst
concentration on polymer molecular weight is not as clear
in the case of organometallic catalysts as it is in the
case of acid catalysts (Wise et al., 1979a).
1 • 3 • 3	 Poly (lactide-co-glycolide) Properties
One important advantage of poly(lactide-co-glycolide)
polymers - and the one that characterizes this family of
polymers - is the variability in polymer properties. A
broad spectrum of performance characteristics can be
obtained by careful manipulation of three key variables:
composition (lactide:glycolide ratio), monomer
stereochemistry, and molecular weight
1.3.3.1 Physical	 Properties	 of	 Poly(lactide-co-
glycolide)
1.3.3.1.1 Bolubility
Solubility of the polymers in common organic solvents is an
important factor with regard to fabrication of drug
delivery dosage forms. Poly(dl-lactide) and poly(dl-
lactide-co-glycolide) with less than 50 mol % in glycolic
acid units content are soluble in acetone, ethylacetate,
tetrahydrofuran, dioxan, benzene and halogenated
hydrocarbons (e.g. chloroform, methylene chloride).
Poly(l-lactide) is soluble only in chlorinated solvents at
ambient temperature, but is soluble in benzene at an
elevated temperature (Kulkarni et al., 1971; Schindler and
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Harper,1979; Deasy et al., 1989). Poly(glycolide) and
glycolide-rich copolymers are quite insoluble materials.
Exotic solvents such as hexafluorisopropanol (HFIP), are
often used in analytical procedures as solvents for these
polymers (Gilding and Reed,1979).
Recently, the solubility parameters (6) of certain
biodegradable polymers were determined (Sieinann, 1985).
The 6 values for poly(l-lactide), poly(dl-lactide) and a
58:42 (LE:GE % mol) polymer were, surprisingly, very
similar [ranging from 16.4 to 16.8 X 10 3 (JM 3 )° 5 ] and
reflected the hydrophobic character of these polymers. The
6 values for tetrahydrofuran and chloroform, which are good
solvents for these polymers, were of the same magnitude in
accordance with the solubility parameter concept [6 for
chloroform 13.0 X
	 and for tetrahydrofuran 18.6 X 103(JW
3)0.5)
1.3.3.1.2	 Crystallinity
The crystallinity, the glass transition temperature (Tg)
and the melting point of poly(lactide-co-glycolide)
polymers depend on their composition and the enantiomeric
composition of lactide units in the polymer (Gilding and
Reed,1979; Vert et al., 1981).
Typical crystallinities for poly(glycolide) sutures are 46-
52% whilst for poly(l-lactide) the crystallinity is 37%.
Poly(dl-lactide) and poly(dl-lactide-co-glycolide) with 0-
70 mol % glycolic acid units content are amorphous.
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Poly(l-lactide-co-glycolide) having 25-70 Mol% glycolic
acid units is also amorphous (Gilding and Reed,1979). The
melting points of poly(l-lactide) and poly(glycolide) are
in the range 170-180°C and 220-230°C respectively
(Lewis,1990). Although poly(dl-lactide) is amorphous, it
undergoes a solid-melt transition in the region of 130-135°C
(Holland et al., 1986). Glass transition temperatures
range from 36°C for poly(glycolide) to 65°C for poly(l-
lactide) (Lewis,1990).
1.3.3.1.3	 Thermal Behaviour
Poly (lactide-co-glycolide) polymers are thermoplastic
materials, stable enough to be heat processed, providing
moisture is absent, for the fabrication of prosthetic or
drug delivery implants and surgical sutures. After
prolonged heating above 200°C, under nitrogen or vacuum, the
polymers degrade to lactide and/or glycolide (Gilding and
Reed, 1979). At lower temperatures thermal degradation is
a time/temperature function and is considerably accelerated
by impurities, residual monomers and humidity (Boehringer
Ingeiheim, personal communication, 1989).
1.3.3.1.4	 Water Uptake
Composition and monomer stereochemistry affect the water
uptake and hydration rate of poly(lactide-co-glycolide)
polymers.
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Gilding an Reed (1979), working with poly(1-lactide-co-
glycolide) films, showed that equilibrium water content (%
water absorbed until constant weight, normally after 3-4
days of immersion in phosphate buffer, pH = 7.4) increases
with the increase in glycolide content and reaches a
maximum of -30% at 70 mol% glycolide, decreasing thereafter
as the crystallinity of the polymers increases. However,
Dunn et al. (1988), working with poly(dl-lactide-co-
glycolide) films reported that the polymers continued to
absorb water steadily, even after 25 days immersion in
milli-Q water, to reach much higher water contents than
those reported by Gilding and Reed (1979). Pitt and Gu
(1987) reported very low water uptake values of 0.84 and
0.57 % for a 70:30 (LE:GE % mole) polymer and poly(l-
lactide) respectively, without any reference on the method
of measurement.
1.3.3.2 Molecular Weight of Poly(lactide-co-glycolide)
The most important feature distinguishing polymers from low
molecular weight species is the existence of a distribution
of chain lengths.	 Because of the existence of this
distribution in any finite sample of polymer, the
experimental measurement of molecular weight can give only
an average value (Billmeyer,1984).
Some methods of mw measurement are based on counting the
number of molecules in a known mass of material (e.g.,
methods based on colligative properties of polymer
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solution), leading to the number-average molecular weight
1-1
Equation 2
where N, is the number of molecules in the sample having
molecular weight M
In other methods the parameter measured is proportional to
the mass of the molecule (e.g., methods based on light
scattering from solutions of polymers). With these methods





From the above equations it is obvious that M, is always
bigger than M. The ratio N/M defines the polydispersity
of a polymer and is a measure of the breadth of the
molecular weight distribution curve. The molecular weight
distribution (MWD) of a polymer sample can be determined by
size exclusion chromatography (Billmeyer,1984).
The viscosity of a polymer solution is a measure of the
size or extension in space of polymer molecules and is





In equation (4) (n] is the intrinsic viscosity of the
polymer and K, a constants characteristic for a particular
polymer-solvent system at a given temperature. For many
systems a lies between 0.6 and 0.8. Typical values of K
range between 0.5 X	 and 5 X	 (Billmeyer,1984).
The intrinsic viscosity (or limiting viscosity number) is
the reduced viscosity or the inherent viscosity
extrapolated to infinite dilution:
[n] =limn1=lim-iC	 Equation 5
En] =limn1=lim_lnnreiC Equation 6
It can thus be determined by extrapolating to zero
concentration plots of reduced or inherent viscosity versus
concentration. Alternatively it can be calculated by the




Intrinsic viscosity measurement leads to the viscosity-
average Molecular weight, Mu:
'' NM'M=Ld11_
N1M1 	 Equation 8
For many polymers Mu is 10-20% below M. If the MWD of the
samples is known in sufficient detail to calculate from a
molecular weight average that has been measured, the
constants in the equation:
[n] =K.M
Equation 9
can be calculated. A less precise relation:
[n]K.M	 Equation 10
is sometimes used to relate weight average molecular weight
directly to intrinsic viscosity for a limited series of
samples (Billmeyer,1984).
The molecular characterization of polymers using the Mark-
Houwink equation is the most frequently applied method
because of the simplicity, speed and accuracy of viscometry
(Quackenbos,1980). Schindler and Harper (1979), Rak et al.
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(1985) and Deasy et al. (1989) determined Mark-Houwink
constants for poly(lactide). Wise et al. (1979a) and Pitt
and Gu (1987) reported Mark-Houwink constants for
poly(lactide-co-glycolide) polymers. These are tabulated
in Table 1.
The polydispersity of poly(lactide-co-glycolide) polymers
is usually around 2 indicating a fairly uniform polymer
4
chain length (Gresser et al., 198,1; Rak et al., 1985).
1.3.3.3	 Mechanical Properties
The strength of poly(lactide-co-glycolide) depends on
composition, monomer stereochemistry, mw and processing.
The strength of crystalline poly(l-lactide) and
poly(glycolide) is considerably higher than that of the
less crystalline poly(dl-lactide) and poly(lactide-co-
glycolide) (Gilding and Reed,1979; Vert et al., 1981). Rak
et al. (1985) found a linear relationship between mw and
Young's Modulus of elasticity (E) and the energy required
to break poly(dl-lactide) films. Also, the tensile
strengths (T) of the films increased with an increase in
polymer mw, ranging from 2.6 to 6.9 MPa.
Vert et al. (1981) showed that the strength (E,T) of PLA
implants decreases with the increase in D units in the
polymer. Tensile strength ranged from 64 MPa for poly(l-
lactide) to 42 MPa for poly(dl-lactide). Poly(l-lactide)
matrix reinforced with poly(glycolide) fibres has the
necessary strength to be used as a completely absorbable
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composite material for the osteosynthesis of human
fractures (Vert et al., 1984).
1.3.3.4 Biodegradation of Poly(lactide-co-glycolide)
Poly ( lactide-co-glycolide) polymers are hydrolytically
biodegraded into lactic and glycolic acid and eliminated
from the body through the krebs cycle, primarily as carbon
dioxide and in urine. There appears to be no differences
in the rate of poly(lactide-co-glycolide) degradation in
different body tissues (Kulkarni et al., 1966; Brady et
al., 1973; Miller et al., 1977).
The mechanism of poly(lactide) biodegradation has been
SI6
proposed to be a two stage process (Pitt et al., 4.9.8+; Pitt
and Gu,1987). During the first stage random hydrolytic
cleavage of ester bonds occurs, which is believed to be
autocatalyzed by the carboxylic acid groups generated. The
chain scission process appears to follow first order
kinetics. There is no enzymatic involvement at this stage
as indicated by observation of the same degradation
kinetics in vitro. The second stage is characterized by
the onset of mass loss from the polymer matrix and an
increase in the rate of chain scission. The mass loss
begins when the polymer has been degraded to a molecular
weight level below that required for coherence and chain
fragments small enough to dissolve in the degradation




io far, enzymatic involvement in the biodegradation of
poly(lactide-co-glycolide) polymers has not been
ascertained, although it has been shown that some enzymes
accelerate the degradation in vitro of poly(glycolide)
sutures and poly(lactide) powders (dilliams, 1981;
Williams and Mort, 1977). Differences between the in vitro
and the in vivo degradation profiles have been also
reported (Williams,1982). However, the aforementioned
cannot be considered adequate proof of the role of enzymes
in the biodegradation of poly(lactide-co-glycolide) since
enzymes are not the only species in the physiological
environment. Thus, Williams (1982) reported that lipids
affect significantly the degradation in vitro of
poly(glycolide) sutures. Also, tissue encapsulation of the
polymer matrix in vivo may inhibit the removal of
degradation products from the matrix resulting in poor
correlation between in vitro and in vivo degradation data.
Holland et al. (1986), suggested that for polymers in the
glassy state little enzymatic involvement could be expected
in the early stages of degradation. This may become more
marked in the later stages, however, as erosion and
physical fragmentation of the polymer occurs.
An increase in the molecular weight caused an increase in
the biodegradation time of poly(dl-lactide) polymers
(Chawla and Chang,1986; Ogawa et al., 1988), whilst an
increase in glycolide content initially increased and then
decreased the biodegradation rate of poly(lactide-co-
glycolide) polymers (Miller et al., 1977;	 Reed and
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Gilding,198l). The turning point in poly(lactide-co-
glycolide) biodegradability appears to be a matter of
controversy. Miller et al.,(1977) found that the 50:50
(LE:GE %mol) composition had the lowest biodegradation half
life (approx. 1 week), whilst Reed and Gilding (1981)
reported that the most hydrated composition, i.e. the 30:70
(LE:GE % mol) was also the fastest degraded in vitro. The
30:70 copolymer began to fragment at 12 days, and underwent
100% mass loss within 4 weeks in vitro. By changing the
composition polymers with a degradation time from a few
weeks to more than one year can be obtained (Lewis, 1990).
Pitt and Gu (1987) reported that the degradation rate in
vitro of a 70:30 (l-LE:GE %mol) was 17 times greater than
that of poly(l-lactide). This was attributed to the
greater susceptibility of glycolate ester to hydrolysis,
coupled with some plasticization of the copolymer by the
absorbed water. However, Fredericks et al. (1984) reported
that there was no preferential attack on either the lactide
or glycolide units of a random 8:92 (l-LE:GE %mol) polymer
despite the difference in their hydrophilicity.
For the crystalline poly(lactide-co-glycolide) polymers
used as surgical sutures (Dexon, Vicryl) an almost complete
loss of strength is observed before any mass loss takes
place (Craig et al., 1975; Chu,1985). Because the
amorphous regions of the polymer hydrolysed first, it
becomes apparent that the strength of the suture relies on
molecules in these regions. These may be tie molecules
connecting the crystallites (Fredericks et al., 1984).
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Vert et al. (1981,1984) showed that increasing the content
in D units in poly(lactide) stereo copolymers increased the
biodegradation rate. Poly(l-lactide) appears to be the
more biostable member in the poly(lactide-co-glycolide)
family.
Beck et al. (1983) reported that the biodegradation rate of
poly (lactide-co-glycolide)	 microspheres	 containing
norethisterone increased with an increase in the size of
the injected microspheres, which was attributed to the
increased surface area of the smaller microspheres.
Processing and annealing could affect the biodegradation
rate of poly(lactide-co-glycolide) polymers (Vert et al.,
1981). Gilding and Reed (1979) showed that 'y radiation
causes degradation of poly(lactide-co-glycolide). The
formation of low molecular weight compounds during the
sterilization of the ready for implantation end-products by
means of y radiation may significantly accelerate the
biodegradation rate of poiy (lactide-co-glycolide) polymers
(Vert et al., 1984).
Dunn et al. (1988) argued that the microstructure of
poly(lactide-co-glycolide) polymers can affect their
degradation rate, and differences in the solubility and
degradation of two different samples of a copolymer, with
the same monomer ratio were attributed to differences in
the sequence of monomer units in the copolymer chains.
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1.3.3.5	 Biocompatibility and Tissue Reactions
The bioconipatibility and non toxicity of poly(lactide-co-
glycolide) polymers was first demonstrated in the process
of developing biodegradable sutures. Sutures from
poly(glycolide) and 10:90 (l-LE:GE %mol) polymer have been
found to be non toxic, inert, non antigenic and non
pyrogenic (Merrittet al., 1974).
In experiments with animals, involving poly(lactide-co-
glycolide) implants in bone and soft tissues, none or only
mild inflammatory response, which diminishes with time, has
been found in most studies (Kulkarni et al., 1966; Brady et
al., 1973; Getter et al., 1972; Cutright et al., 1974; Vert
et al., 1984). The lack of inflammatory response indicates
inertness and tissue receptivity. No implant migration or
rejection, nor allergic responses have been reported (Wise
et al., 1979a).
However, poor biocompatibility of poly(lactide) implants
has also been reported. Thus, poly(dl-lactide)
microparticles (1-10k) were found to cause inflammation
after intra-articular injection into the knee joints of
rabbits (Ratcliffe et al., 1984). The same microparticles
were found to stimulate the release of lysosomal enzyme
from cultured macrophages, which may explain their
inflammatory action in vivo. By contrast a none
inflammatory response was observed when the inicroparticles
were compressed into small tablets and implanted
subcutaneously in rats (Smith and Hunneyball, 1986).
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The tolerance of tissues to implanted articles is not only
determined by the pure material properties. The site,
surface characteristics and shape of the implant may also
have an influence on tissue response (Graham and
Wood, 1984)
The reactions of soft tissues to poly(lactide-co-glycolide)
implants involve accumulation of foreign body giant cells
and marked fibroblastic activity. The implants are
gradually surrounded and invaded by tissue fibres until
finally absorbed and replaced by connective tissue
3
(Kulkarni et al., 1966; Brady et al., 197,).
Similar responses have been observed when poly(lactide-co-
glycolide) particles were implanted intra-osteally. Upon
implantation mild foreign body reaction is elicited with an
accumulation of histocytes and mast cells in close vicinity
to the implant which is gradually encapsulated by bone and
connective tissue. Polymer degradation is accompanied by
a fibrous invasion of the cracks which develop. This
contains giant cells and mononuc].eated cells. The implant
is finally replaced by bone or marrow tissue (Vert et al.,
1984; Tun)?et al., 1985).
There exist few reports in the literature concerning the
application of poly(lactide-co-glycolide) implants in human
subjects. Little polymer particles were used for the
fixation of fractures of the skull and jaw. According to
preliminary clinical results all fractures healed in a
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normal way. No acute or chronic tissue reactions were
observed (Vert et al., 1984).
Brekke et al. (1983) applied poly(lactide) mesh as a
surgical dressing in the healing of dental extraction
wounds. The poly(lactide) dressing was well tolerated by
the tissue and showed no adverse effects on normal healing.
The incidence of localized osteitis following mandibular
third molar extractions was significantly reduced by the
application of the poly(lactide) dressings. Rokkanen et
al. (1985) found no difference in the outcome between two
groups of patients with displaced fractures of the ankle
treated with conventional metallic implants and
poly (lactide-co-glycolide) implants, respectively.
1.3.3.6	 Fabrication Techniques
Poly(lactide-co-glycolide) polymers are generally low
melting thermoplastic materials with good solubility in
common organic solvents, glycolide-rich polymers being the
exceptions. These properties allow considerable flexibility
in the fabrication of drug delivery systems. Three types
of delivery systems based on poly(lactide-co-glycolide)
polymers have been investigated : Microparticles, implants
and fibres.
Microspheres and microcapsules of poly(lactide-co-
glycolide) polymers can be prepared using standard
microencapsulation techniques (Maulding,1987). A solvent
evaporation procedure particularly useful for entrapment of
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water insoluble drugs has been developed (Beck et al.,
1979; Tice and Lewis,1983). The reproducibility and scale-
up of this procedure was demonstrated with a contraceptive
formulation having a lifetime of 90 days (Lewis et al.,
1988). Organic phase separation techniques are suitable
for incorporation of water soluble peptides and
macromolecules into microspheres, on either a relatively
large or a small batch size (Fong,1979; Kent et al., 1984).
Processes based on spray-drying or fluidized bed coating
have also been developed (Wise et al., 1976; Nuwayser and
Deroo, 1987; Bodmeier and Chen,1988).
Standard methods of processing thermoplastic polymers can
be employed to fabricate implantable articles from
poly(lactide-co-glycolide) polymers. In these methods high
temperature and pressure are usually involved, and care
should be therefore exercised to keep moisture levels in
the materials and humidity in the working areas as low as
possible to avoid polymer degradation. Considerations of
importance when selecting fabrication methods are heat
stability of polymer and active agent, the polymer
softening temperature, and the size and shape of the end
product (Billmeyer,1984).
Poly(lactide-co-glycolide) films can be prepared by casting
a solution of the polymer in a volatile solvent containing
the drug or by compression moulding of polymer and drug
mixtures (Jackanicz et al., 1973; Hutchinson,1982).
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Implants in the form of beads have been prepared by
transfer moulding of film pieces (Schwope et al., 1975) and
in the form of small cylinders by extrusion of film pieces
or freeze dried powders (Schwope et al., 1975; Gresser et
al., 1978; Hutchinson,1982; Kitchell and Wise 1985).
Reservoir 'oly(lactide-co-glycolide) implants in the form
of coated pellets or capsules have also been studied
(Boswell and Scribner,1973; Pitt et al., 1979; Marcotte et
al., 1990). A technique for the preparation of porous
capsules, suitable for controlled delivery of
macromolecules, has been developed by Schindler (1987).
Monolithic fibres can be prepared by melt extrusion of
polymer and drug mixtures, and reservoir fibres have been
prepared either by a melt spinning technique or by a wet
phase inversion process (Dunbiet al., 1981; Eenink et al.,
1987). In the latter method the drug is incorporated in
the hollow fibre, after the fibres are produced and offers
the possibility of utilizing drugs which are unstable under
spinning conditions (Eenink et al., 1987).
1.3.3.7	 Sterilization Techniques
Gases, such as ethylene oxide, and 
'y radiation can be
utilized for sterilization of poly(lactide-co-glycolide)
drug delivery systems. However, ethylene oxide has been
found to cause softening or plasticising of some
poly(lactide) compositions (Lewis,1990). Residual vapour
is also a problem since it has been shown to be inutagenic
(Kitchell and Wise,1985).
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The recommended sterilization method for poly(lactide-co-
glycolide) products is y radiation (Kitchell and Wise, 1985)
even though Gilding and Reed (1979) showed that radiation
caused dose dependent degradation of poly(glycolide)
sutures, probably through an unzipping mechanism. Also,
Tice et al. (1982) reported that y radiation decreased the
inherent viscosity and increased the biodegradation rate of
poly(lactide-co-glycolide) copolymers. In most cases doses
of 'y radiation ranging from 2.5 to 3.0 ihrad can be utilized
without serious degradation of the polymer (Lewis,1990).
Filter sterilization of drug-polymer solutions and aseptic
preparation procedures are the alternative when
sterilization of the final dosage form is not possible.
Aseptic processing can be particularly useful with
microencapsulated products which almost always involve
solutions of the polymer in organic solvents.
1.3.4 Drug Poly(lactide-co-glycolide) Delivery Systems
A wide range of drugs have been incorporated in
poly (lactide-co-glycolide) polymers including, steroids,
narcotic antagonists, antimalarial drugs, anticancer
agents, antiinflammatory drugs, local anaesthetics,
antibiotics and bioactive macromolecules (polypeptides,
proteins, and synthetic nucleic acids).
A growing number of polypeptides and proteins have recently
been produced by recombinant DNA processes. Although they
are highly potent and specific in their physiological
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functions, most of them are difficult to administer
clinically. They are generally not therapeutically active
by oral administration and they have an extremely short
biological half life when administered parenterally, and
daily multiple injections are required. This therapeutic
regimen is highly risky to administer without close medical
supervision and also often difficult for most patients to
accept. The development of sustained release formulations
could be a significant improvement in the administration of
such drugs (Banga and Chien,1988). However, bioactive
macromolecules are usually characterized by complex three-
dimensional structures, critical for their bioactivity.
These molecules can easily be inactivated by both physical
and chemical mechanisms, such as fragmentation,
deamination, covalent dimerization, oxidation, unfolding,
aggregation, and adsorption, therefore their incorporation
in sustained release formulations is still a problem.
1.3.4.1	 Contraceptive Steroid Systems
The controlled delivery of contraceptive steroids was one
of the first applications of poly(lactide-co-glycolide)
polymers. Implants (films, beads, rods) and granular
particles were fabricated with progesterone, levonorgestrel
and norethisterone (Jackanicz et al., 1973; Anderson et
al., 1976; Yolles,1975; Wise et al., l978). None of these
early systems have had significant clinical success,
probably due to the polymers and fabrication methods used
to prepare them (Lewis,l990).
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Nevertheless, these early studies demonstrated the
feasibility of extended controlled delivery of steroids
using poly(lactide-co-glycolide) polymers and revealed the
factors controlling the rate of release from such matrix
systems. Thus, the release rate was found to depend on
polymer composition, drug loading, and polymer molecular
weight (Wise et al., 1980).
Beck and co workers developed steroid load poly(dl-lactide-
co-glycolide) inicrospheres using a patented solvent-
evaporation technique (Beck et al., 1979; Tice and
Lewis,1983). The mechanism of steroid release from such
inicrospheres was a combination of initial leaching and
diffusion followed by biodegradation of the matrix (Tice
and Cowsar,1984). The rate and duration of release was
affected by the polymer composition, drug loading, size
distribution and quality of the microspheres (Lewis and
Tice 1983).
Often, biphasic release patterns have been observed with
microspheres (Beck et al., 193-Sa,b). The early elevated
drug levels in blood are probably due to leaching and
diffusion of the drug form the surface of the particles.
The blood levels show a decline and when substantial
degradation of the matrix occurs a second elevated drug
level in blood is observed (Beck et al., 1983a).
In practice these two regions have been made to merge by
careful adjustment of the polymer properties and
characteristics of the inicrospheres. Thus, by using an
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85:15 poly(dl-lactide-co-glycolide) polymer a more constant
rate of norethisterone release over the desired lifetime of
the formulation (90 days) was obtained (Beck and
Tice,1983). This formulation has recently undergone
successful phase I and phase II clinical trials (Lewis et
al., 1988).
Poly(l-lactide) hollow fibres were prepared using a dry-wet
phase inversion spinning process and filled with a 25%
weight dispersion of micronized levonorgestrel in castor
oil. Preliminary release experiments in rabbits showed
that constant levonorgestrel blood plasma levels could be
obtained over a 210 days period (Eenink et al., 1987).
1.3.4.2	 Narcotic Antagonist Systems
The first disclosure of the use of a synthetic
biodegradable polymer for the systemic delivery of
therapeutic agents was probably that made by Yolles et al.
(1970), who described the release of cyclazosine from
poly(lactide) films. The release was characterized by a
large initial burst which was eliminated by encasing the
film in a drug-free poly(lactide) film, thus, in effect
converting a monolithic system to a diffusiona]. one
(Woodland et al., 1973).
The release of the narcotic antagonists cyclazosine,
naloxone, and naltrexone from poly(l-lactide) composites in
particulate form has been investigated (Yolles, 1975). For
cyclazosine and naltrexone in vitro release rates were
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found to be faster than the in vivo release rates, whereas
for naloxone they were similar. Particles with 100, 200
and 35O average size released the drug at similar rates,
but particles of 6OO released drug at considerably lower
rate (Yolles,l975).
The release of naltrexone from spheres and rods has also
been investigated (Schwope et al., 1975). Naltrexone was
found to dissolve readily in poly(dl-lactide) and in some
poly(l-lactide) copolyiners so that matrix systems with very
high drug content (e.g. 80% by weight) could be prepared.
The drug release in vitro was affected by drug content,
copolymer composition, solubility of the drug in water, and
geometry of the delivery system. Coating the beads with
pure polymer also reduced the rate of naltrexone release
(Schwope et al., 1975). A good correlation between in
vitro and in vivo (mice and monkeys) release data was
obtained with these formulations (Wise et al., 1979k).
Naltrexone was also encapsulated in poly(lactide-co-
caprolactone) (10:90) copolyiners using a microfluidized
bed coating process (Nuwayser et al., 1988). Uncoated
poly(l-lactide-co-glycolide) microcapsules released 80% of
their drug content in phosphate buffer within 2 days.
Coating the microcapsules with additional polymer slowed
the release rate, and at 9% coating level microcapsules
releasing naltrexone for 50 days at a constant rate were
obtained.
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Cha and Pitt (1988) prepared microspheres and microcapsules
of L-methadone using poly(l-lactide-co-glycolide) and
poly(lactide-co-caprolactone) polymers. The desired
lifetime (1 week) could be better approached using blends
of different types of inicrospheres rather than blends of
the polymers.
1.3.4.3	 Antimalarial Systems
Wise et al. (1976'1978b and 1979b) investigated the release
of antimalarial drugs [sulfathiazine, 2,4-diamino-6-(20-
napthylsulphonyl) quinazoline and mixtures of them] from
poly (lactide-co-glycolide) microcapsules and matrices.
Although encouraging results were obtained from experiments
in mice, these early formulations failed to reach a
significant status (Lewis,1990).
Recently, Tsakala et al. (1988) formulated pyrimethamine
microspheres and implants based on several poly(lactide-co-
glycolide) polymers. Experiments in vitro and in vivo
(mice) showed that the microspheres did not produce an
adequate duration of drug delivery for practical
application. However, promising results were obtained with
the implants, as more than 3 months protection against
Plasmodium berghei was observed in animals.
1.3.4.4	 Anticancer Systems
Drug toxicity is a serious problem in cancer chemotherapy.
Relatively few poly ( lactide-co-glycolide) formulations
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containing anticancer agents have been investigated for
their potential in reducing drug toxicity.
The first to study poly(lactide-co-glycolide) anticancer
systems were Yolles and coworkers (Yolles,1975; Yolles et
al., 1978). Cytoxan, cyclophosphamide, cis
dichiorodiammine platinum and doxorubicin were combined
with poly(l-lactide) to produce films and particulate
systems. Although the release was not fully characterized
increased effectiveness and lower toxicity for these
systems, as compared to single dose administration, was
reported.
Small poly(lactide) and PHB microspheres containing the
antineoplastic drug cyclohexyl chloroethyl nitrosourea were
prepared by a solvent evaporation process (Bissery,1984).
The possibility of targeting such microspheres to specific
organs, on the basis of particle size, was investigated.
When these microspheres were injected intravenously in mice
a 100-fold decrease in leukaemia cell survival was observed
in both spleen and liver, compared to untreated controls.
The 2-4k diameter microspheres were effective against Lewis
lung carcinoma in mice, being preferentially targeted to
the lungs (Bissery et al., 1985).
Poly(lactide) microspheres containing doxorubicin were
evaluated in vitro and in vivo (Juni et al., 1985). The
rate of release in vitro after the initial burst was small,
so prolonged release was obtained. Plasma levels of the
drug following intra-arterial administration of the
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microspheres into the liver of dogs were considerably lower
than those following administration of the drug solution in
saline. Microangiography revealed embolization due to the
presence of microspheres in peripheral arteries in the
liver. Intra-arterial chemoembolization is an effective
method for treatment of solid tumours in organs (Juni et
al., 1985).
Studies have also been conducted with cis platin in the
field of chemoembolization. Microspheres prepared by a
solvent evaporation procedure were characterized in vitro
and critical factors with regard to drug release kinetics
were identified. it was concluded that factors affecting
the distribution of drug crystals in the microspheres are
more important in drug release than the incorporation of
glycolic units in the polymer backbone (Spenlel^uer et al.,
1986 and 1988).
A w/o emulsion method developed for the incorporation of
mitomycin C into poly(lactide) microspheres. The
microspheres showed a dose-dependent drug release pattern
with microspheres of higher drug loading having a faster
release rate than those of lower drug loading. An enhanced
antiproliferative activity against the growth of the K562
human erythroleukokemia cells was observed with the
microspheres as compared with the non-formulated drug (Tsai
et al., 1986).
The release of cisplatin from cylindrical implants based on
poly(lactide) (75% in 1-lactide) and poly(dl-lactide-co-
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glycolide) polymers has been investigated. The
formulations were inserted in the renal parenchyma of mice.
Release from the poly(lactide) implants was inadequate, but
a continuous release of platinum for at least 3 weeks was
observed with the poly(lactide-co-glycolide) 	 (75:25)
implants. The implantation resulted in high platinum
concentrations in the kidney tissues and low plasma
concentrations, compared to systemic injection (Hecquet et
al., 1986).
Strobel et al. (1987) investigated anticancer drug delivery
devices which would be combined with radiation therapy or
hyperthermia. The devices consisted of orthodontic wire or
sutures dip-coated with drug (misonidazole or andriamycin)
and poly(lactide-co-glycolide) polymers and they were
designed to be inserted directly into a brain tumour. Drug
release in vitro followed the expected first-order
kinetics.
1.3.4.5	 Antibiotic Systems
Antibiotic poly (lactide-co-glycolide) formulations have
been investigated for the topical treatment of open wounds
and periodontal disease (Dunn et al., 1987; Tice et al.,
1984 and 1986).
Copolymers degrading relatively fast were used to prepare
microspheres which would release their content within one
to two weeks period. A range of antibiotic compounds, such
as ampicillin anhydrate, tetracycline and chloramphenicol,
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were incorporated in these microspheres using solvent
evaporation or phase separation techniques (Lewis et al.,
1980). The microspheres were shown to release the drug
according to a desired first-order fashion in vitro. An
initial burst of release providing for the immediate
perfusion of the tissues with drug was observed followed by
a prolonged release which maintained a low therapeutic
level of antibiotic in the tissues for the intended period.
Stability and batch to batch reproducibility data for these
microspheres were reported (Tice et al., 1984 and 1986).
Monolithic fibres, prepared by melt-extruding blends of the
drug with poly(e-caprolactone) and poly(€-caprolactone-co-
lactide) polymers, were used to deliver tetracycline to the
periodontal pocket. These fibres gave first order release
over a period of 6 days, but when coated with pure polymer
the release rates were essentially constant and the
duration of release was significantly extended. Many of
the fibres were soft and flexible and could be placed
easily in the periodontal pocket to control bacterial
growth. The copolymer fibres were tacky, a characteristic
which should help retain the fibres in periodontal pocket
(Dunn et al., 1987).
A composite material prepared from hydroxyapatite and
poly(dl-lactide), containing dideoxykanamycin B to prevent
bacterial growth, has been tested as a substitute or a
filler in the repair of bone defects. Release studies in
rats showed that the concentration of the antibiotic was
effectively maintained and prevented infection at the
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implantation site. The rate and duration of release could
be regulated by the mw of the polymer (Ikada et al., 1986).
1.3.4.6	 Antiinflammatory Systems
Poly(dl-lactide-co-glycolide) (85:15) microspheres
containing methyiprednisolone were prepared for intra-
articulate administration. Experiments in rabbits with
induced arthritis showed that prolonged (up to 5 months)
antiinflammatory response was achieved following a single
injection of microspheres (Tice et al., 1985).
Poly(dl-lactide) films loaded with hydrocortisone acetate
were prepared and the effects on the inflammatory and
healing responses were investigated in rats using a cage
implant technique. The results showed that the films
inhibited all aspects of inflammation throughout the 21-
days implantation period. The white cell concentration in
the exudates withdrawn from cages containing hydrocortisone
films were at all times lower than the white cell
concentrations in the controls (empty and poly(lactide)
film containing cages) (Spilizewski et al., 1986).
A solvent evaporation process was used to prepare
hydrocortisone loaded microspheres from poly(lactide-co-
glycolide) polymers. The rate of drug release in vitro
increased as the initial payload carried by the
microspheres increased, Changing the polymer from
poly(lactide) to poly(lactide-co-glycolide (65:35), whilst
fixing the steroid content at 12-13%, caused a decrease in
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release rate. The release data did not fit any of the
common kinetics models (Cavalier et al., 1986).
1.3.4.7	 Other Applications
Local anaesthetic drugs, such as lidocaine, etidocaine, and
bupivacaine, have been microencapsulated with poly(l-
lactide) using an air suspension coating technique. The
microencapsulated local anaesthetic formulations
demonstrated sustained release, lower local and systemic
toxicity, and longer duration of action compared to pure
drug (Williams et al., 1984).
In an attempt to improve patient compliance disulfiram, a
drug prescribed to discourage alcoholics from drinking
alcohol, has been formulated into implantable rods using
poly (1-lactide-co-glycolide) polymers. The formulations,
when implanted subcutaneously in rats were shown to release
the drug continuously for 3 months.	 At necropsy, no
encapsulation of the residual rods was found (Phillips and
Gresser,1984).
Suzuki and Price (1985) studied the release of
chlorpromazine from poly(lactide) microspheres. They
concluded that the release characteristics of these
microspheres can be optimized for various requirements by
at least three methods: (a) by employing polymers of
different molecular weight, (b) by changing the particle
size of the microspheres, and (C) by changing the drug
loading.
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Mason et al. (1988) investigated the possibility of
controlled delivery of neurotransmitter molecules directly
to the central nervous system. Dopamine microencapsulated
in poly(dl-lactide-co-glycolide) polymer was injected in
the lateral striatum of rats. The animals exhibited
contralateral rotations for prolonged period, whilst
control animals injected with placebo microcapsules did not
show any consistent rotational behaviour.
Immunocytochemical studies confirmed the presence of
significant amounts of dopamine containing inicrocapsules up
to 4 weeks after implantation. Neither invasion of
microcapsules from macrophages nor tissue inflammation, was
observed.
1.3.4.8 Systems for the Delivery of Macromolecules
1.3.4.8.1 Delivery Systems for Polypeptides
Polypeptides of relatively low mw (less than 5000) are
stable in the presence of poly(lactide-co-glycolide)
excipients and their biodegradation products. They have
been successfully combined with poly(lactide-co-glycolide)
polymers to prepare controlled release formulations (Tice
and Cowsar, 1984; Maulding et a'., 1987).
Hutchinson (1982) first described the release of acid-
stable polypeptides from poly (lactide-co-glycolide)
matrices. Release from these systems is accomplished by
two distinct mechanisms. The first involves leaching of
the drug from polypeptide domains at or near the surface of
the implant. The second degradation of the polymer. The
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erosion of the matrix generates aqueous pores or channels
through which the drug in the interior of the implant can
be liberated. Because of these two mechanisms the release
of polypeptides from these systems is normally biphasic.
However, these two phases can be made to overlap by
appropriate choice of polymer properties and polypeptide
content. Thus, Hutchinson and Furr (1985) reported the
continuous release of Zoladex (a Luteinizing hormone
releasing hormone (LH-RH) analogue) from a poly(lactide-co-
glycolide) subdermal depot over a period of 28 days both in
vitro and in vivo.
Sanders et al. (1984) studied the release of nafarelin
acetate (a LH-RH analogue) from poly(dl-lactide-co-
glycolide) implants and microspheres. They reported
similar release profiles to those reported by Hutchinson
(1982), but which were described as "triphasic". The
release was characterized by a "secondary" phase during
which very little or no peptide was released, preceded and
followed by phases of higher release rate. The duration of
the "secondary" phase was found to be proportional to the
mw of the copolymer and both the duration of the
"secondary" phase and the total duration of release were
found to be proportional to the monomer ratio (Sanders et
al., 1986).
Recently one intramuscular injection of biodegradable
controlled release nafarelin microspheres in human males,
was shown to effectively suppress the testosterone plasma
levels for more than one month. Fine adjustment of the
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release kinetics could be achieved by modification of
loading level, from 1% up to 8%, which was presumed to
influence the extent of channelling caused by loss of
compound, known to be a major influence in controlling
S
diffusional release (Sanders et al., 198/).
Low mw poly(dl-lactide) and compression moulding were
employed to prepare needles containing a LH-RH agonist.
The advantage of this formulation is that it can be easily
injected under the skin and renewed conveniently. Tests in
human with prostate cancer showed that the therapeutic
effects could be maintained over long periods with the
periodic renewal of the needles (Kaetsu et al., 1987).
Ogawa et al. (1988a,b) described a method for the efficient
entrapment of leuprolide acetate (a LH-RH analogue) in
poly (dl-lactide-co-glycolide) mnicrospheres. The release
was found to be affected by the polymer composition and
less by the polymer molecular weight. They aimed to
produce a delivery system capable of releasing the peptide
at an approximately constant rate for one month and this
was best achieved by utilizing a poly(lactide-co-glycolide)
(75:25) copolymer of 14000 mw.
Kwo,jet al. (1986) studied the delivery of insulin using
poly(l-lactide) microspheres and pellets. They proposed
that release occurred via pores in the polymer matrix.
Significant initial release (burst effect) was observed
with microspheres both in vitro and in vivo (rats).
Pellets showed a relatively small burst effect in vitro and
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no burst release was observed in vivo. The effectiveness
of these insulin preparations in vivo was found to be dose-
dependant.
1.3.4.8.2	 Delivery Systems for Proteins
The preparation of controlled delivery systems for proteins
cannot be accomplished using conventional formulation
techniques. Proteins are high MW hydrophillic molecules
which would not diffuse through the hydrophobic polymer
wall of a reservoir system at a useful rate. In addition
proteins can be easily deactivated during the formulation
procedure (Pitt, 1990b)• Incorporation of proteins in
poly(lactide-co-glycolide) systems has the additional
problem of protein instability in the presence of acidic
degradation products from the polymers. Nevertheless,
reports of the successful combination of poly(lactide-co-
glycolide) polymers with proteins have appeared in the
literature.
Human serum albumin was incorporated into microcapsules,
made from a 52:48 (LE:GE % mol) polymer, and could be
released intact in various buffers. The rate of release
was affected by the pH and ionic strength of the buffer
solution and increased with an increase in the drug loading
(Singh et al., 1988).
The release kinetics of bovine albumin diffusion from a
poly(dl-lactide) reservoir system was investigated with the
long term aim of developing a multi dose pulsatile delivery
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system. The albumin release profile was approximated by
zero order kinetics and the rate of release was affected by
the molecular weight of the polymer, the thickness and the
density of the membrane. The initiation of albumin release
could be delayed from a few hours to more than one month by
increasing the M of the poly(lactide) from 6.2 X 1O 3 to 140
X 1O and raising the concentration of the polymer coating
solution from 50 to 100 mg.ml'. The diversity in delayed-
release effect and the variations in membrane
permeabilities were attributed to changes in membrane
porosity and polymer morphology (Marcotte et al., 1990).
Poly(lactide-co-glycolide) (75:25) microspheres containing
fluorescein isothiocyanate-labelled bovine serum albumin
(FITC-BSA) and fluorescein isothiocyanate-labelled
horseradish peroxidase (FITC-HRP) were prepared by a
modified solvent evaporation method using a double
emulsion. The preparation method was gentle and maintained
the enzyme activity and the protein solubility. The
incorporation of the FITC-HRP into the poly(lactide-co-
glycolide) microspheres was found to increase its
stability. Different release profiles and rates could be
achieved by changing the mw of the polymer or modifying
factors in the preparation procedure (Cohen et al., 1991).
1.4.4.8.3	 Delivery Systems for Vaccines
Most vaccines require two or three primary immunizations,
followed by a booster for optimum immune response. A one
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time vaccination would eliminate patient compliance
problems, and it would reach a greater percentage of the
target population (Singh et al., 1991).
A method for delivering antibodies or antigens to the
female reproductive tract has been described. Because
systemic antibodies are not secreted by the internal
reproductive organs, the immunization levels of these
organs cannot be increased by systemic administration of
either antibodies or antigens, but rather must be increased
by local administration of antibodies or antigens to the
female reproductive organs. Monolithic or reservoir
poly(lactide-co-glycolide) microparticles 12O-6Oj size,
containing antigens, such as Neisseria gonorrhoea and
Herpes virus, or antibodies are deposited in the vagina
allowing the natural transport mechanism of the internal
organs to convey the microparticles into the uterus.
Furthermore, microparticles containing menstrual cycle
regulating hormones (estradiol or progesterone) could be
administered together with those containing antigens or
antibodies, so that the hormones would induce the necessary
secretory changes in the endometrium of the cervix and
would promote the contractile activity of the cervix
necessary for microparticles transport. Tests with rabbits
showed that the intravaginal installation of these
microparticles caused immunization against the various
antigens administered (Beck et al., 1988).
Gilley et al. (1988) developed poly(lactide-co-glycolide)
inicrospheres	 that	 target	 the	 Peyer's	 patches
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(lymphrentricular follicles on the gastrointestinal tract
of man) and release antigens at controlled rates. It was
noticed that microspheres less than 5,. in diameter traverse
the Peyer's patches and enter the circulation, whilst
microspheres 5 to 1O in diameter remain inside the Peyer's
patches for extended periods (months). When administered
orally in mice, microspheres less than 5 containing
staphylococcal enterotoxin B (SEB) or pneuinococcal
polysaccharide were shown to induce significant systemic
immunity. The SEB containing microspheres of 5 to 10.& size
caused a substantial mucosal anti toxin response in the
saliva, gut, and lung secretions.
Diphtheria toxoid has been microencapsulated using poly(dl-
lactide) without loss of its immunogenicity. The
microcapsules when injected subdermally to mice elicited
antibody titers comparable to those obtained with the
conventional three-dose injection of diphtheria toxoid,
over 75 days (Singh et al., 1991).
1.4	 Purpose of the Work
The advantages of employing biodegradable polymers in the
fabrication of sustained drug release systems have been
discussed in the preceding introduction. The most
successful biodegradable polymers at this time appear to be
the poly ( lactide-co-glycolide) polymers.
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Commercially poly(lactide-co-glycolide) polymers are not
available at the present in an adequate range, or with
adequate characterization. This is mainly because the
preparation process affects their chemical, physical and
mechanical properties in a way that is not well understood
and prevents the preparation of products with consistent
properties. Also there appear to be no reports in the
literature regarding their application in the preparation
of heterogeneous compressed matrices, which is one of the
most common practical techniques to achieve sustained drug
delivery.
The present work has been structured, under the following
headings, to investigate the suitability of poly(lactide-
co-glycolide) polymers in the preparation of controlled
release matrix tablets:
1. Investigation of preparative variables affecting the
properties of poly(lactide-co-glycolide) polymers as
matrix forming material.
2. Preparation and characterization of poly(lactide-co-
glycolide) powders for tableting.
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FIGURE 1. Schematic representation of degradation mechanisms.
Clycolide: R—H
Lactide: R—CH3
Fig.2 Chemical structure of glycolide and lactide
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Fig.4 Configurations of glycolide.
U-(O-CU-C)-0H + H0-CH-COOH - H-(0-CH-00)0H
0	 +H20






Fig.6 Ring opening polymerization of toctide/glycolide (R is H for
glycolide and CH3 for bc tide).
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A systematic study of the synthesis of poly(lactide-co-
glycolide) polymers appears to be lacking in the literature
Most preparative variables affecting the properties of the
produced polymer have been identified and their effects
have been analyzed in a rather empirical manner. Little,
if any, effort has been made to correlate the effects of
changing the polymerization conditions with the mechanism
of polymerization, probably because the mechanism of
polymerization has not as yet been fully elucidated. This
may account for the contradictory findings for the effect
of changing the polymerization conditions on the properties
of the synthesized polymer. Thus, an increase in the
amount of organometallic catalysts in the polymerization
mixture has been reported to cause an increase in the
molecular weight of the produced polymer (Chawla and Chang,
198/), a decrease in the molecular weight (Jacobson, 1970;
Deasy et al., 1989), or to have no significant effect (Rak
et al., 1985). Furthermore, it appears that, so far, no
attempt has been made to correlate the polymerization
conditions to the composition and microstructure of the
resulting polymer, despite the significance of these
characteristics on the polymer properties.
In this chapter a detailed study of the synthesis of
poly(lactide-co-glycolide) polymers, from a pharmaceutical
viewpoint, has been undertaken. The effect of several
preparative variables on the properties of the polymer,
such as molecular weight and composition, and on the yield
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of polymerization has been investigated. The
microstructure (sequence of monomers in the copolymer
chains) of the resulting polymers has also been considered
2.2 Investigated Variables of Polymer Synthesis
The effect of the following preparative variables on the
properties of the resulting polymers was investigated:
I. type of catalyst:	 two catalysts were used,
stannous octoate and antimony trifluoride.
II. concentration of catalyst: a lower catalyst-
0. oç
level series, i.e. o.-e 0.02, 0.03, 0.05, and
0.1% w/w of the monomers mixture was employed at
high polymerization temperatures, whilst higher
catalyst-level series, i.e. 0.02, 0.05, 0.1, 0.2,
and 0.5% were employed at low polymerization
temperatures.
III. concentration of co-catalyst: lauryl alcohol at
0.01 and 0.05%- w/w of the monomers mixture was
used.
IV. temperature of polymerization: two reaction
temperatures were applied, a low (130°C) and a
high (190°C).
V. time of polymerization: four polymerization
periods were compared, i.e., 1, 2, 4 and 8 hours
both at low and high polymerization temperatures,
using optimum catalyst levels.
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2.3	 Materials and Methods
2.3.1.	 Materials
di-Lactic acid (technical, 80% solution in water) and
glycolic acid (analar) were purchased from Aldrich.
Reagents and solvents used in the preparation and
characterization of polymers are listed in Table 2.
2.3.2	 Methods
2.3.2.1 Synthesis of polymers
The synthesis of poly(lactide-co-glycolide) polymers was
based on the method described by Gilding and Reed (1979).
2.3.2.1.1 Preparation of dl-lactide and glycolide
Lactide synthesis involves the condensation of lactic acid
to low molecular weight poly(lactic acid) which is then
depolymerized to the cyclic dimer (reactions 1, 2 in Fig.
7).
600 g of 80% dl-lactic acid solution in water and 1.44 g of
antimony trioxide were heated at 140° and magnetically
stirred in a 1000 ml round bottom flask, fitted with a
distillation head and condenser. When the rate of water
elimination fell a water aspirator was connected and the
temperature increased gradually to 1800 C. When no further
water was evolved an air condenser was substituted for the
water type and an oil pump for the water aspirator. A
clean receiver cooled in liquid nitrogen was attached. The
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temperature was then raised to 2500 C and the vacuum
increased to 0.1-0.5 mm Hg. Lactide sublimed and distilled
over as a pale yellow waxy solid. The yellow colour was
removed by washing with chloroform and, after two
recrystallizations from ethyl acetate and one from acetone,
a shiny white crystalline material was obtained with a
melting point of 124° C (measured using a Gallenkamp,
England, melting point apparatus). Glycolide was
synthesized using the same procedure as with lactide. The
purified shiny white crystalline material had a melting
point of 82° C.
Both lactide and glycolide were stored in evacuated
desiccators over silica gel until used.
2.3.2.1.2 Polymerization of lactide and glycolide
Poly(lactide-co-glycolide), 	 in 5 g batches,	 were
synthesized via the ring opening polymerization of lactide
and glycolide (reaction 3 in Fig. 7).
The polymerization mixtures consisting of monomers (lactide
and glycolide) at predetermined weight ratios, catalyst,
and co-catalyst (if used) were put into thick-walled glass
tubes which had previously been rinsed with acetone and
dried overnight. Stannous octoate is a viscous liquid and
the small quantities required could not be accurately
measured. Therefore, it was dissolved in hexane to form
stock solutions of known concentration and the appropriate
volume of these solutions was each time transferred into
-82-
the polymerization tubes. The tubes, after flushing with
nitrogen, were evacuated, sealed, and heated in an oven for
specified periods of time.
The resulting glassy, colourless to pale green solids were
dissolved in tetrahydrofuran to give approximately 20% w/w
solutions. These solutions were precipitated in excess
distilled water and the polymers collected as white cocoons
on glass rods. The purified polymers were dried in a vacuum
oven at 40° C until constant weight.
2.3.2.2	 Characterization of polymers.
2 • 3.2.2 • 1	 Molecular weight determination
The molecular weight of the samples was determined by
viscometry. The flow time of 1% w/v solutions of the
samples in chloroform was measured using our Ubbeihode
suspended level viscometer (size A). The temperature was
maintained at 25° C using a Bridge Control Series II water
bath (Townson and Mercer Ltd., England). The inherent
viscosity (iv) was calculated from the formulae:
ln rel = in t12/tl	 Equation 11
C	 C
where n is the relative viscosity, t12 is the flow time of
the polymer solution, ti is the flow time of the solvent,
and C is the concentration of the polymer solution.
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2.3.2.2.2	 Identity and Purity of Polymers
The identity and purity of the polymers was investigated by
IR and 'H-NHR spectroscopy. The 13C-NMR spectra, recorded
primarily for the investigation of the polymer
microstructure, could provide further evidence for the
purity and identity of the synthesized polymers.
The IR spectra were determined in an SP-800
spectrophotometer over the range 4000-600 cm'. KBr discs,
containing approximately 1% w/w of the compound being
examined were used, with air as reference.
The 1H-NNR spectra were recorded with a Perkin Elmer R32
spectrometer (England) operating at 90 MHz. The samples
were dissolved in CDC13 and tetramethyl silane (TMS) was
used as internal standard.
2.3.2.2.3 Determination of Polymer Composition
The composition of the samples was determined by comparing
the integrals of the surface of the peaks assigned to the
lactic unit backbone proton, >CH*_CH3, and to the glycolic
unit protons _0_CH2*_CO_ (Fig. 8).
2.3.2.2.4 Investigation of Polymer Microstructure
The microstructure of certain samples, prepared under
different polymerization conditions, was investigated using
high field (62.8 MHz approximately), ' 3C-NNR spectra,
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decoupled from protons, recorded in a Bruker WM 250
spectrometer. The polymers to be examined were dissolved
in CDC13
 and deuterated dimethyl sulfoxide (DMSO), and TMS
deuterated was used as internal standard. Expansion of the
spectra was used to obtain information for the fine
structure of the carbon resonance.
2.3.2.2.5 Investigation of Polymer Morphology
Differential scanning calorimetry (DSC) was used to study
the effect of the preparative variables on the morphology
of the polymers. The thermograms were obtained with a Du
Pont 910 instrument coupled to a Du Pont 9000 analyzer at
a heating rate of 100 C/mm. Two runs were made with each
sample, the first serving as a technique to provide a
standard thermal history for all samples. 	 The DSC
instrument was calibrated using indium (melting point
156.4°C).
2.4	 Results and discussion
2.4.1	 Preparation and characterization of polymers
During preliminary experiments the recrystallization of
lactide/glycolide was found to significantly affect the
polymerization. When crystallization was induced by an
ice-water bath, small crystals of lactide and glycolide
were obtained. These crystals did not give reproducible
polymerization behaviour and resulted in low molecular
weight polymers. However, when crystallization was allowed
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to occur slowly at ambient temperature, large crystals of
lactide and glycolide were obtained which gave reproducible
polymerization and resulted in high molecular weights
polymers. This phenomenon could be attributed to the
difference in specific surface area between large and small
crystals. These cyclic diesters are sensitive to traces of
atmospheric moisture, being converted during storage to
acidic oligomers which cause erratic polymerization
behaviour. The small crystals, having larger specific
surface area, were more labile to moisture. Moreover, when
the crystallization of glycolide proceeds at a low
temperature, the form which is more sensitive to moisture
is produced (Frazza and Schmitt, 1971).
Preliminary polymer syntheses also indicated that
polymerization temperatures in excess of 2000 C caused
polymer decomposition, when a 4 hours polymerization time
was used, giving a brown colour to the products.
The identity and purity of the synthesized polymers was
investigated with 1H-NNR and IR spectroscopy.
A typical 'H-NMR spectrum is shown in Fig. 8. The multiplet
at 1.55 ppm was assigned to the methyl protons of the
lactic acid units >CH_CH3*, the doublet at 4.80 ppm was
assigned to the protons of glycolic acid units - CH 2* - and
the multiplet at 5.20 ppm was assigned to the backbone
protons of the lactic acid units >CH*-CH 3 . Overlapping of
the signals from the 1- and d- configurations of lactic
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acid units in the P-dl-LGA copolymers results in the
multiplets at 1.55 and 5.20 ppm. If only one lactic acid
antipode had been used to prepare the copolymers the
multiplets at 1.55 and 5.20 ppm would be a doublet and a
quartet respectively.
A typical IR spectrum of the copolymers prepared in this
work is shown in Fig. 9. The major peaks assigned to the
structure of poly(lactide-co-glycolide) copolymers are:
3500 cm' (0-H stretching), 2950 and 3000 cm' (C-H
stretching), 1750 cm' (ester c=0 stretching), 2450 cm' (C-H
bending) and 1100 cm' (C-0 stretching). The IR and 'H-NMR
spectra showed that the copolymers produced were pure and
genuine.
The polymerization of lactide and glycolide has been shown
to be a chain reaction (Dittrich and Schulz, 1971). This
type of polymerization often proceeds at a very high rate
which increases the difficulty of obtaining reproducible
results (Billmeyer, 1984). The reproducibility of
polymerization in the present work has been checked by
producing two batches of 90:10 (initial lactide:glycolide
weight ratio) copolyiner under identical conditions (0.03%
w/w stannous octoate, 290° C for 1 hour). The results
obtained (iv, = 0.459, yield 1 = 56.0% and iv2 = 0.500, yield2
= 46.3%) were regarded	 as showing a satisfactory
reproducibility.
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2.4.2	 Mechanism of Polymerization
The polymerization of lactones is a chain reaction which
can be effected by both anionic and cationic catalysts.
Cherdron et al. (1962) proposed that in both anionic and
cationic polymerization chain growth occurs via alkyl-
oxygen cleavage of the lactone, i.e. by cleavage of the
bond between the carbonyl carbon and the heterocyclic
oxygen (Fig. 10 reactions 1 and 2). However, recent
research has provided evidence that polymerization
initiated by cationic catalysts proceeds via cleavage of
the alkyl-oxygen bond (Fig. 10 reaction 3) (Kricheldorf et
al., 1986). Thus, polymerization of lactide/ glycolide
using antimony trifluoride as catalyst will be cationic,
proceeding either by alkyl or alkyl oxygen cleavage (Fig.
10).
A co-ordinate mechanism for the polymerization of lactide
with organometallic catalysts, such as diethyl zinc or
triethyl aluminium, has been proposed (Dittrich and
Schul/z, 1971). A similar mechanism may operate when the
polymerization is initiated with stannous octoate, and a
possible reaction scheme is given in figure 11. The
initiation involves attack by a lone pair of electrons on
the heterocyclic lactide (glycolide) oxygen on the vacant
d orbitals of tin, and a nucleophilic addition to the
lactide carbonyl group (analogous to the nucleophilic
attack of hydroxylions during alkaline ester hydrolysis).
The lactide ring is then cleaved to give an open product
which reacts with another lactide (glycolide) molecule to
form the active species A. Propagation proceeds via the
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co-ordination of lactide (glycolide) molecules at both
sides of the tin atom (since the active intermediate
possess two co-ordination sites) in a similar manner to the
initiation step. Since the termination step usually
involves transfer to some species not essential to the
reaction, polymerization with carefully purified reagents
may lead to systems in which termination is lacking, called
"living polymers" (Billmeyer, 1984). The co-ordinate
solution polymerization of lactide using diethyl zinc has
been reported to result in a living polymerization system
(Dittrich and Schuz, 1971). The anionic solution
polymerization of glycolide has recently been shown to
follow a living polymerization mechanism (Brafrl and Kohl,
1986). Nevertheless, traces of lactoyllactic acid formed
by the hydrolysis of lactide, or traces of moisture, may
function as chain transfer agents causing termination of
the polymerization.
2.4.3	 Effect of Catalyst Type
Lewis acids and organometallic compounds are two types of
catalyst that have been reported as particularly effective
in the ring opening polymerization of lactide and
glycolide. Antinomy trifluoride is a widely used
representative of the first category and stannous octoate
of the second (Lowe, 1954; Chujo et al., 1967; Schindler et
al., 1977; Gilding and Reed, 1979; Deasy et al., 1989).
The results obtained when using these catalysts are given
in table 3. Under both polymerization conditions stannous
octoate was far more effective, resulting in polymers which
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had from 3 to 9 times, depending on the polymerization
conditions, greater molecular weight (iv) than the polymers
synthesized using antinomy trifluoride (table 3). It would
appear that organometallic type catalysts are more
effective than Lewis acids in polymerizing lactide and
glycolide. Polymers produced using antimony trifluoride
were yellowish, brittle, granular materials, whereas
polymers synthesized using stannous octoate were white,
tough, fibrous masses.
The 70:30 (initial LE:GE w/w ratio) polymers synthesized
using antimony trifluoride had higher molecular weights
than the 90:10 synthesized using the same catalyst (table
3). It appears, therefore, that antimony trifluoride is a
more effective catalyst for the polymerization of monomer
mixtures rich in glycolide. Chujo et al. (1967) reported
that Lewis acids were effective catalysts for the
polymerization of poly(glycolide) and poly(lactide-co-
glycolide) with high glycolide contents and the results
obtained here appears to confirm their report. Since
stannous octoate was found to be more effective, this
catalyst was chosen for the remainder of the work.
2.4.4	 Effect of Catalyst Level
The effect of catalyst amount (% w/w) of the polymerization
mixture) on the polymer molecular weight under two reaction
temperatures is shown in Figs. 12 and 13. At both
temperatures there was an initial sharp increase in
molecular weight at the low catalyst levels, but this
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passed through a maximum before falling at higher levels of
catalyst. The results also show that the effective
catalyst concentrations depend on the temperatures at which
the polymerization proceeds.
The effect of catalyst concentration on the percentage
yield of the reaction is shown in Table 4. The yield was
affected less by the polymerization temperature than by the
catalyst level. The change in yield with respect to
catalyst level followed the same pattern as the change in
molecular weight. There was a sharp initial increase in
the yield, but this reached a maximum at the effective
catalyst level before falling at higher catalyst levels.
High conversions were generally obtained, especially at
optimum catalyst concentrations (where optimum means the
catalyst levels resulting in polymers of the highest MW at
a given polymerization time and temperature). It appears
that the amount of catalyst required for polymers with
high molecular weights coincides with the amount of
catalyst resulting in a high yield. The optimum catalyst
levels were 0.03 and 0.1% w/w at 190°C and 130°C
respectively (Figs. 12 and 13, Table 4).
Dittrich and Schulz (1971) reported that the rate of
polymerization of lactide is proportional to the monomer
and catalyst (active species A in Fig 11) concentration.
Consequently, at very low catalyst levels the reaction rate
will be very small, leading to low MW polymers and a
correspondingly low yield. At higher catalyst levels the
reaction rate increases and high MW and percentage yield
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are obtained. This corresponds to the ascending part of
the curves in Figs.12 and 13. A further increase in
catalyst levels causes a too rapid reaction rate, resulting
in a sudden MW build up followed immediately by a MW
decline indicating that depolyinerization has taken place.
A special case of transesterification reaction called "back
biting") has been reported to occur during the cationic
polymerizations of lactones, causing degradation of the
polymer being produced (Kricheldorf et al., 1986).
Transesterification reactions have been shown to occur
during the polymerization of lactide (Dittrich and Schulz,
1971; Chabot et al., 1983), and it is, therefore, probable
that "back biting" depolymerization reactions occur during
the polymerization of lactide and glycolide. A possible
mechanism for the back biting reactions is given in figure
14. This involves the attack by a lone pair of electrons
from a carbonyl oxygen on the vacant orbital of a tin atom
in the same polymer molecule and a nucleophilic attack on
the same carbonyl group leading to cleavage of the chain
into two segments. An increase in the catalyst to monomer
ratio would increase the polymer molecules to monomer ratio
and lead to an increased probability of "back biting"
reactions taking place; especially towards the closing
stages of polymerization, when the proportion of monomers
in the polymerization mixture has greatly been decreased.
This probably accounts for the decrease in polymer
molecular weight observed when the catalyst levels
increased beyond the optimum for a given set of
polymerization conditions. (Figs 12 and 13).
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C
and Chang (198,1) used tetraphenyl tin as catalyst
and found that, for 5 hours polymerization at 170°C, and
increase in catalyst level in the range of 0.01% to 0.046%
caused an increase in poly(lactide) molecular weight.
Deasy et al. (1989) used stannous octoate and found that
for 6 hours polymerization at 160°C, and increase in the
catalyst levels from 0.19 to 0.95% caused a decrease in
poly(lactide) MW.	 It would appear that the results
6
reported by Chawla and Chang (198%) correspond to the
initial portion of the kinetics behaviour observed in this
study (ascending part of the curves in Fig. 13) whilst the
range of catalyst levels used by Deasy et al. (1989) were
in excess of the optimum level and correspond to the
descending part of the curves in Fig. 12.
Higher mw polymers were obtained at the lower temperature
level of 130°C (Figs. 12 and 13). This may be attributed
to the increased rotational and folding mobility of the
linear polymer molecules at the higher temperature, which
increasing the probability of "back biting"
depolymerization reactions resulted in a decline of the
polymer molecular weight.
Polymers with an inherent viscosity in chloroform of 0.2 or
less, which were prepared using very low catalyst levels,
are yellowish, granular, brittle materials that could
readily be powdered by grinding. Polymers with higher iv
are fibrous and tough and could not be powdered by
grinding. The shorter the chains of a linear polymer the
higher the probability that these chains would assume
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ordered ("crystalline like") structures and conversely the
longer chains of a linear polymer could be aligned parallel
to each other forming a fibrous structure and this might
explain the differences in the texture between low and high
NW polymers.
2.4.5	 Effect of Co-Catalyst
Small amounts of alcohols, such as lauryl alcohol, have
been reported to act as accelerators for the reaction at
the onset and as mw controllers, preventing
depolymerization, in the later stages of polymerization
(Schmitt et al., 1969). However, the inclusion of lauryl
alcohol in the polymerization mixture has recently been
reported to have no evident effect (Rak et al., 1985).
When lauryl alcohol was incorporated in the polymerization
mixture, increasing the co-catalyst level caused both a
lowering of molecular weight and percent conversion (Table
5). Thus, the incorporation of 0.05% w/w lauryl alcohol
resulted in a -30% decrease in the molecular weight of the
resulting polymer and a 10% decrease in the conversion.
This result shows that the molecular weight can be
regulated to lower values by the incorporation of small
amounts of lauryl alcohol in the polymerization mixture.
Frazza and Schmitt (1971) proposed that the mechanism of
glycolide polymerization by tin catalysts in the presence
of alcohol is cationic. The rate determining step is
considered to involve the ring opening addition of an
hydroxyl group from either the alcohol, or the growing
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chain, to the protonated glycolide molecule. This gives an
open chain adduct which is protonated on the penultimate
ester group. The adduct then undergoes a rapid proton
exchange with uncharged monomer and the process is repeated
to build up the chain. Protons can be generated by
decomposition of the catalyst, or through its reaction with
the alcohol (Fig. 15).
The decrease in polymer molecular weight with an increase
in lauryl alcohol content of the polymerization mixture
(Table 5) may be attributed to the increased probability of
alcohol molecules interfering with the proton exchange
(Fig. 15) by competing with the glycolide (lactide)
molecules for the protons of the growing polymer chains.
The alcohol involvement in the proton exchange, which
becomes more significant as the polymerization proceeds and
the glycolide (lactide) is depleted, inhibits further chain
growth resulting in lower molecular weight polymers.
2.4.6.	 Effect of Polymerization Time
The effect of polymerization time was studied at both 130°C
and 190°C using the optimum catalyst concentrations (Figs.
16 and 17). The molecular weight continued to increase
throughout the reaction (up to 4 hours) indicating that the
polymerization was not a chain reaction in the kinetic
sense.	 This becomes more obvious when the inherent
viscosity is plotted against percentage yield.
	 The
molecular weight continued to increase at conversions
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higher than 90%, regardless of the polymerization
temperature (Fig. 18).
At optimum catalyst levels the conversion remained
essentially constant or decreased slightly after 4 hours
polymerization. At optimum catalyst levels high % yields
were obtained after 4 hours polymerization (Table 4 and
Fig. 17), indicating that the polymerization had
essentially been completed within the 4 hours period and,
therefore, only "back biting" depolyiuerization reactions
could probably occur after that period, causing the
observed decrease in the molecular weight of the resulting
polymers (Fig. 16). When a lower than optimum level of
catalyst was employed the molecular weight and % yield were
still increasing after the 4 hours period (Figs. 16 and
17).
The polymerization has been reported to be a first order
reaction with respect to monomer. By fitting the data of
Fig. 17 to first order equations the polymerization rate
constants were calculated from the slope of the regression
lines. For polymers prepared using optimum catalyst
conditions the data up to 4 hours, and for polymers
synthesized using sub-optimum catalyst levels, the data up
to 8 hours, were used in the determination of the rate
constants. These constants indicate that the rate of
polymerization increased significantly with an increase in
the polymerization temperature or the proportion of
catalyst (Table 6).
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The time of polymerization may be expected to affect the
composition of the resulting copolymer because glycolide,
being more reactive, will be preferentially polymerized in
the initial stages, whilst lactide will be incorporated to
an ever increasing extent as the glycolide is depleted.
The composition of copolymers produced using different
reaction times is given in Table 7. The proportion of
glycolic acid units in the copolymer falls as the time of
polymerization increases. However, the composition of the
copolymers remains essentially constant at polymerization
times longer than 4 hours.
It appears that for a given polymerization temperature when
efficient amounts of catalyst are used, the optimum
polymerization time is 4 hours since the polymer molecular
weight falls at longer polymerization periods whilst the
conversion does not increase (Figs. 16 and 17). It is of
equal importance that the composition of the copolymers
appears to stabilize after 4 hours polymerization, so that
polymers with consistent properties can be prepared
employing a 4 hours polymerization period (Table 7). When
sub-efficient catalyst levels are used longer
polymerization times are required (Figs. 16 and 17). With
higher than optimum conditions of catalyst the reaction
proceeds too rapidly and shorter polymerization times have
to be employed to produce the same degree of
polymerization.
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2.4.7	 Effect of Preparative Variables on the Micro-
structure and Morphology of the Polymers
The difference in reactivity between the two monomers could
have a significant effect on the microstructure of the
copolymer. It has been estimated that the reactivity of
glycolide is 2.8 whereas the reactivity of lactide is 0.2
at 200°C, which implies that a chain with a growing
glycolide end has a 3:1 preference for adding another
glycolide, whereas an equivalent chain with a growing
lactide end has a 5:1 preference for glycolide (Gilding and
Reed, 1979). It is to be expected, therefore, that
copolymers containing blocks of glycolic acid units will be
produced rather than copolymers of a random structure. The
microstructure of a copolymer can affect its solubility in
organic solvents, its rate of hydration and its rate of
biodegradation. Thus, Dunn et al. (1988) reported that a
50:50 (LE:GE%mol) copolymer with a random structure had a
better solubility in organic solvents and a higher
degradation rate in vitro than a 50:50 block copolymer.
The monomer sequence in the copolymers prepared in this
study was investigated using high field ' 3C-NNR spectra. A
typical 13C-NNR spectrum, from a 90:10 (LE:GE initial w/w
ratio), is shown in Fig. 19 and it can be interpreted as
follows: the peak at (approximately) 16.7 ppm corresponded
to the lactic acid's methyl carbon atom, >CH-'CH 3 , the peak
at 60.7-60.9 ppm corresponded to the glycolic acid's
methylene carbon, -O-CH 2-CO-, the peak at 69.0-69.2 ppm was
assigned to the lactic acid's methine carbon, >CH-CH 3 , the
peak at 166.4 ppm was assigned to the glycolic acid's
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carbonyl carbon, -O-00-CH2-, and the peak at 169.4-169.6
ppm corresponded to the lactic acid's carbonyl carbon,
-O-00-CH-CH3 . The signals at 0 and 77 ppm approximately
were assigned to the internal standard (TMS) and the
solvent (CDCL3 ) respectively. The solvent resonance showed
up as three lines due to the spin-coupling of carbon atom
to deuterium.
Since racemic lactide was used to prepare the polymers, the
fine structure of the spectrum results from both
compositional and configurational effects. The glycolic
acid's carbonyl carbon signal showed up as a singlet, but
expansion of the spectrum revealed the existence of
shoulders on the peak, implying that there might be
glycolic acid's carbonyl carbons with slightly different
chemical shift (Fig. 20). When DMSO, which is more polar
than CDC13 , was used as solvent this signal appeared as two
singlets at 166.5 and 166.5 ppm indicating that two
slightly different molecular environments for the glycolic
acid's carbonyl carbon occurred (Fig. 21).
In Fig. 22 the spectrum in DMSO of a 70:30 (initial LE:GE
w/w ratio) is shown. The glycolic carbonyl signal was again
two singlets but the intensity of the signal was higher
because of the higher proportion of glycolide units in the
polymer. In all samples examined the glycolic carbonyl
resonance had the form shown in Figs. 21 and 22
irrespective of composition, temperature and time of
polymerization.
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In poly(lactide-co-glycolide) copolymers the possible
molecular environment for the glycolic acid's carbonyl
carbon are G'GG, GGL and LGG (G = glycolic acid unit,
L = lactic acid unit) and, consequently, in the spectrum of
a random copolymer the resonance of this carbon should
appear as three lines. However, because glycolide is more
reactive, blocks of glycolide separated by single lactide
units were probably formulated during copolymerization, so
that the concentration of GGL and LGG sequences was low
and their signals indistinguishable. 	 Consequently the
glycolic acid's carbonyl signal appeared as two peaks
instead of three (Figs. 21 and 22). Hutchinson (1982)
reported that the signal of this carbon atom appeared as
two singlets in the spectrum of heterogeneous copolymers
(polymers having molecules rich or poor in glycolide
prepared, for example, by mixing polymers with different
lactide/glycolide content) in DMSO.
The lactic acid's carbonyl carbon signal (Fig. 20) was very
similar to the signal of the same carbon atom in the
spectrum of poly(dl-lactide) in CDC1 3 , recorded by Chabot et
al. (1983).
In the spectrum of a random copolymer the resonance of the
lactic carbonyl would be expected to differ significantly
from the resonance of the same carbon in the spectrum of a
honiopolymer due to the different molecular environments
this carbon can exist in the copolymer molecules.
-100-
Thus, from the form of the glycolic and lactic carbonyl
signals it could be deduced that block poly(lactide-co-
glycolide) polymers have been prepared in this work. This
result also indicates that the transesterification
reactions - which have been shown to occur during lactide
polymerization - did not result in detectable
redistribution of glycolide units in the copolymer
molecules.
Morphology is an important characteristic of poly(lactide-
co-glycolide) polymers affecting their biodegradation rate
and mechanical strength (Vert et al., 1981 and 1984).
Amorphous polymers might be preferable in drug delivery
since they can form monophasic matrices with homogeneous
dispersion of the active ingredient.
The morphology of the polymers prepared in this study was
investigated by DSC. Because racemic lactide was used to
synthesize the polymers, a random arrangement of the
asymmetric centres which prevents the polymer chains to
assume ordered structures result, and all polymers were
found to be amorphous, showing only glass transition
temperature, Tg (Fig. 23). An increase in the molecular
weight of the polymer increased the Tg probably because of
the increased entanglement between the polymer molecules
imposing restrictions to chain mobility as the mw of the
polymer increases. An increase in the lactide content also
caused an increase in the polymer Tg which may be
attributed to the increased difficulty for chain rotation
and translation caused by the increased number of methyl
side groups in the polymer chains (Table 8).
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The free volume, chain mobility and permeability of
polymers dramatically increases at temperatures above their
Tg and a decrease of poly(lactide-co-glycolide) Tg to
values close to body temperature would affect its
biodegradation rate, since the polymer would be more
permeable to water and would be able to accommodate larger
quantities of water. For the same reasons the rate of drug
release from a polymer will be different depending on if
the polymer is above or below its Tg in the physiological
environment. Tg values as low as 37°C were observed with
low mw polymers (Table 1). Moreover, Omelczuk et al.
(1990) observed that very low mw poly(lactide) samples had
Tg values below 30°C. These data imply that low mw
poly ( lactide-co-glycolide) polymers, particularly those
with high glycolide contents (Table 8) can be close to or
above their Tg in the physiological environment and would
exhibit different biodegradation and drug release
properties than high MW polymers. Furthermore, big
differences in Tg could bring about differences in the
compaction behaviour of the polymers since polymers with
low Tg will exhibit increased consolidation during
compression due to increased plastic flow at the points of
contact between the particles. This mechanism could be
considered similar to the asperity melting found by York
and Pilpel (1973) on low melting point fatty acids.
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TABLE 2: List of Reagents and Solvents used in the




antimony trifluoride 	 Aldrich	 analar
antimony trioxide	 Aldrich	 analar
chloroform	 FSA	 analar
ethyl acetate	 FSA	 analar
hexane	 FSA	 HPLC
lauryl alcohol	 BDH	 GPR
stannous octoate	 Sigma	 analar
tetrahydrofuran	 FSA	 SLR
TABLE 3 Effect of type of Catalyst on the Inherent
Viscosity (dug) of the Copolymers






	 0.698	 0.593	 0.185 0.191
0.1% catalyst, 130°C	 0.805	 0.640	 0.090 0.141
'=4h polymerization
b lnjtial lactide:glycolide w/w ratio.
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TABLE 4: Effect of Catalyst Concentration on Percentage
Yield of Polymerization
% Stannous Octoate	 90:10'	 70:30






	 0.005	 8.0	 32.0
0.02	 93.1	 81.2
0.03	 98.0	 92.4
0 • 05	 90.3	 73 • 5
0.1	 84.0	 70.0
'Lactide:glycolide initial w/w ratio
TABLE 5: Effect of Co-catalyst Concentration on the
Molecular Weight (iv) of the Copolymer and on
the percentage yield of the polymerization.





Polymerization conditions: 0.03% stannous octoate, 4h,
190°C, 90:10 initial lactide:glycolide ratio (w/w)
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TABLE 6: Polymerization Rate of a 30:10 (Initial
Lactide: Glycolide Weight Ratio) Polymer




0.03	 130	 8	 0.415	 0. 9831
	
0.03	 190	 4	 2.418	 0. 9892
	
0.10	 130	 4	 1.658	 0.9910
The catalyst was stannous octoate. The rate constants
were calculated by fitting the % amount of monomer vs
time data to first order equations (r = correlation
coefficient)
TABLE 7: Effect of Polymerization Time on the Copolymer
Composition
Time (h)	 % Glycolic acid units




4	 13 . 9	 17.7
8	 13.9	 16.9
Starting composition 90:10 w/w lactide:glycolide (12.1%
in glycolide mol.)
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TABLE 8: Effect of Molecular Weight (iv) and composition
of the copolymer on the glass transition
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Fig.7 Synthesis of poly(loctide—co—glycolide) polymers (R is H for glycolide
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Fig. 10 Mechanism of akyl (reactions 1 and 2) and olkyl (reaction 3)






















Fig.1 I Co—ordinate polymerization mechanism of loctide/qlycolide using











initial LE: GE ratio(w/w)
______ 90:10
4	 70:30
0.1	 0.2	 0.3	 0.4	 0.5
% tannous octots
FIg. 12 Effect of catalyst level on polymer










initial LE: GE ratlo(w/w)
90:10
4	 70:30
0.02	 0.04	 0.06	 0.08	 0.10	 0.12
% stannous octoats
Fig. 13 Effect of catalyst level on polymer
mw (polymerization at 130 C for 4 h)
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(0 ,Sn - 0-CR - C 0- CR - C-R'
0	 0	 0 ____________
II	 II	 II	 .	 I	 1R-C-CU-O-Sn-0-CR-C-0-CH-C-R + C-CH-0-C-CH-0-C-CH-0
II	 II	 II
0	 0	 0
Fig.l4 Proposed mechanism of back biting depolymerization reaction
















_____ R 0 C CR 2 0 C CR 2 OH +
I	 II	 II	 0
RO	 0
0
Fig. 15 Proposed mechanism for the cotionic melt polymerization
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Fig. 18 MW of 90:10 (inItial LE:GE w/w ratio)
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Fig.3 DSC scan of 50:50 poly(Iactide-co-glycolide) copo-
lymer (iv — 0.5 dI/g).
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Of all the types of dryer, there are few that accept
pumpable fluids as the feed material at the dryer inlet and
discharge a dry particulate at the outlet. Of these few,
spray drying is unique in being able to produce powders of
specific particle size and moisture content irrespective of
dryer capacity and product heat sensitivity. Spray drying
involves atomization of the feed into a spray and contact
between spray and drying medium, usually heated air,
resulting in moisture evaporation. The drying of the spray
proceeds until the desired moisture content in the dried
particles is obtained, and the product is then recovered
from the air (Masters, 1985).
Spray drying finds great utility in the pharmaceutical
industry because of the rapidity with which drying is
achieved and the unique form of the final product. There
are three major uses for the spray drying process: (1)
drying of heat sensitive materials, (2) changing the
physical form of materials for use in tablet or capsule
manufacture, and (3) encapsulation of solid and liquid
substances.	 The final product can be in the form of
powders, granules or agglomerates. The spherical
particles produced usually flow better than the same
product dried by other conventional procedures, because the
particles are more uniform in size and shape with less
sharp edges. The spherical shape has the least possible
surface area, thus minimizing air entrapment between
particles. This improvement in flow and reduction in air
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entrapment makes spray dried materials suitable for use in
the manufacture of tablets and capsules (Rankell and
Lieberman, 1976).
In the present work poly(lactide-co-glycolide) powders were
produced by spray drying chloroform solutions of the
polymers. The in vitro degradation, hydrophobicity, and
compaction behaviour of these powders, which would affect
drug release from poly(lactide-co-glycolide) matrix tablets
were investigated.
Wettability and water uptake experiments were carried out
to assess the hydrophobicity and compaction pressure -
compact density (Heckel plots) were used to investigate the
compaction characteristics of the poly(lactide-co-
glycolide) spray dried powders. The effects of polymer
composition and mw on those properties were also
considered. Scanning election microscopy (SEN) was
employed to examine the morphology of the spray dried
particles and the change in appearance of polymer matrices
due to degradation.
3.2	 Materials and Methods
3.2.1	 Materials
Commercial dl-lactide (melting point 125°C) and glycolide
(melting point 82°C) both purchased from Boehringer
Ingeiheim were used to prepare the polymers. The phosphate
buffer pH = 7.4 was prepared from l.19g of potassium
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dihydrogen orthophosphate (BDH, GPR), 2.38 g disodium
hydrogen orthophosphate (BDH, analar) and 8.0 g of sodium
chloride (BDH, GPR) in 11 of distilled water. Chloroform
(FSA, analar), methanol (BDH, GPR), dichioromethane (FSA,
analar) tetrahydrofuran (FSA, SLR), glacial acetic acid
(FSA, SLR), and magnesium stearate (BDH, GPR) were also
used.
3.2.2	 Methods
3.2.2.1 Synthesis of Larger Polymer Batches
20 g batches of polymers were synthesized as described in
paragraph 2.3.2.1.2. These were purified by precipitation
from chloroform, using excess methanol, and dried under
vacuum at 40°C until of constant weight. The purification
of 50:50 (LE:GE%mol) polymers was difficult due to their
low solubility. Ref luxing for 48 hours in chloroform was
used to dissolve the polymers, but some material would not
dissolve, probably those polymer molecules containing a
high proportion of glycolide blocks, and was removed by
filtration. Poly(glycolide) synthesized here could not be
purified and characterized due to its insolubility in
common organic solvents. It was a brown very hard mass and
all attempts to powder it by ball milling failed.
Eventually, it was broken down into pieces using the Dartec
hydraulic press and used as such in the degradation study.
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3.2.2.2	 Spray Drying of Polymers
The polymers were dissolved in chloroform to form 2-5% w/v
solutions and spray dried using a Buchi mini spray dryer
(model 190) to prepare powders. The polymer solutions were
sprayed through an atomizer nozzle into a cylindrical (10.5
x 42.5 cm approximately) drying chamber. Atomization was
effected by impacting the liquid with high velocity
compressor generated air. Drying of the sprayed solutions
was effected by a co-current of hot air in the direction of
spraying flow.
The process parameters were: inlet temperature, 60°C; outlet
temperature, approximately 45°C; aspirator setting, 10; pump
setting, 7-10 ml.min'; spray flow, 400 ml.hour'. A 0.5 mm
nozzle was used throughout the experiments. Material
deposited on the walls of the drying chamber was retrieved
by dissolving in chloroform and the process repeated.
Three spray drying cycles per polymer batch were used. The
spray dried polymers were ground to break down the
agglomerates using a Moulinette type 320 grinder (Moulinex,
France) and sieved to produce powders of known particle-
size range. The morphology of the powders was examined
using a Phillips EM5O1B scanning electron microscope (SEM).
The spray dried polymers were stored in desiccators over
silica gel.
3.2.2.3 Degradation In Vitro of Spray Dried Polymers
500 mg of each sample were placed in glass vials containing
approximately 25 ml of phosphate buffer, pH = 7.4, and
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shaken in a water bath at 37°C. The degradation medium was
renewed at 2-week intervals. For sampling, the contents of
the vials were poured into sintered glass filters (size 4)
and the degradation liquid removed using a water aspirator.
The particles were washed with distilled water, filtered
and dried in a vacuum oven at 40°C to constant weight. The
weight and the inherent viscosity of the dried samples was
then measured. Duplicate measurements were carried out over
a 12-14 week period. Polymer powders of 420-84l were
used, except with the 50 (0.443) sample for which a higher
particle size range, 841-2OOO was used.
3.2.2.4. Compaction Properties of Polymers
The compaction behaviour of spray dried polymer powders was
investigated (Heckel, 1961 b). The powders were compressed
using a 10.55 mm diameter flat faced punch and die system
(prelubricated with a 1% suspension of magnesium stearate
in chloroform) using a Dartec 100 KN M2501 universal
testing machine (Dartec, Ltd.). A maximum force of 10 KN
was applied at a rate of 0.5 KN.s' and the force and
displacement of the upper punch continuously recorded with
a digital storage oscilloscope (Nicolet 3091). The data
were analyzed using an Apple lie computer to produce Heckel
plots.
The particle density of powder was measured with a Beckman
air comparison pycnometer (Beckman Instruments, model 930).
The liquid content (due to residual spray drying solvent or
moisture absorbed during storage) of the powders, which
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might affect their compaction behaviour, was also
determined before the compaction experiments using a
Sartorius infrared dryer (Model YDUOIL, Germany). The
liquid content of powders was low ranging from 0.2 to 0.6%
w/w.
3.2.2.5 Wettability of Polymers
Contact angle measurements were conducted to assess the
wettability of spray dried polymer powders. The contact
angles were determined by applying the h-e method (Lerk et
al., 1976).
The powders (63-l50) were compressed in a 20 mm diameter
flat-faced punch and die set using a RIIC (England)
hydraulic press. A load of 1 ton was applied. The
dimensions and weight of each disc were measured allowing
the calculation of its porosity (6). The disc was placed
on a platform which could be adjusted to ensure the disc
surface was horizontal. Deionized distilled water was
applied to the disc surface via an Agla microsyringe and
readings of the drop height were taken with a cathetometer
(Graticules Ltd., England) until additional drops caused no
increase in height. The contact angle was calculated from
the formula (Lerk et al., 1976):




where h is the height of the drop and B = pL•g/2yLv where PL
is the density of water (1.0 kgl', g is the acceleration due
to gravity (9.81 ms 2) and 'YLV is the water-vapour
interfacial tension (0.072 Nm-'). All measurements were
carried out at least in duplicate.
3.2.2.6 Water Uptake by Polymers
Tablets were prepared by compressing spray dried polymer
powders (63-150&) in a 10.55 mm diameter flat punch and die
system using the Dartec hydraulic press. A 10 KN force was
applied at a rate of 1 KN.s' with a dwell time of 15s.
The tablets, after measuring their dimensions and weights,
were placed in glass vials containing phosphate buffer, pH
= 7.4, and shaken in a water bath at 37°C. The weight
change of the tablets, with time, was recorded over a 25
day period. The dimensions of the tablets at the end of
this period were also measured. SEM photographs before and
after water uptake were taken using a Phillips EM 501B SEM.
3.3	 Results and Discussion
3.3.1	 synthesis of larger Polymer Batches for Spray
Drying
Polymers having compositions ranging from 100% lactide to
100% glycolide were synthesized by polymerizing the monomer
mixtures shown in Table 9. Examination of the values in
Table 9 show that the proportion of lactide units in the
resulting polymer is smaller than that in the initial
polymerization mixture, probably because of the greater
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reactivity of glycolide during polymerization. The mw of
the samples synthesized was regulated by modifying the
polymerization conditions according to the results obtained
in the study of poly(lactide-co-glycolide) synthesis
(Chapter 2). Thus, polymers having iv in the range 0.3-0.4
were synthesized using 0.013-0.016% w/w stannous octoate at
190°C for 5 hours, and polymers having iv in the range of
0.7-0.9 were made using 0.028-0.032% catalyst under the
same polymerization conditions. Relatively high mw
polymers, iv>l, were synthesized using 0.1-0.12% catalyst
at 130°C for 5 hours. A small increase in polymerization
time from 4 to 5 hours was introduced because during the
polymerization of the first batches unreacted monomer was
observed after 4 hours polymerization. The mw of polymers
produced under the same polymerization conditions appeared
to decrease as the glycolide content of the mixture
increased (Figs. 12 and 13), indicating that compositions
rich in glycolide require more severe polymerization
conditions that compositions rich in lactide. Therefore,
slightly higher catalyst levels were normally used for the
polymerization of monomer mixtures with a high glycolide
content. For convenience, the polymers will be referred to
in the following discussion by the designation %LE(iv),
i.e. an 85(1.278) polymer is a polymer containing 85% mol




spray Drying Characteristics of Poly(lactide-co
- glycolide)
Preliminary spray drying experiments were carried out with
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a 85(0.719) polymer but it was found that solutions of this
polymer in chloroform having concentration higher than 2%
w/v could not effectively be atomized, producing polymer
threads instead of particles, irrespective of the spray
dryer operating conditions. Similar results were obtained
using solvents such as methylene chloride, 2:1, 1:1 and 1:2
v/v mixtures of methylene chloride with chloroform,
tetrahydrofuran and glacial acetic acid. A lower mw 85:15
polymer, 85 (0.358), could successfully be "spray-powdered"
at concentrations as high as 10% in chloroform. The
relative viscosity of a 3% solution of 85 (0.719) polymer
(which would give threads) is 5.452, whilst the relative
viscosity of a 10% solution of 85 (0.358) is 11.840, i.e.
much higher, indicating that the viscosity of the solution
was not crucial for the successful spray drying of
poly(lactide-co-glycolide) polymers. Bodmeier and Chen
(1988) have reported that the successful dispersion of
liquid filaments into polymer droplets depended strongly on
the type of polymer used and only to a lesser degree on the
viscosity of the spray solution.
Even more dilute solutions were required for the effective
spray drying of polymers with higher molecular weights,
i.e. 1.5% solutions for a 85 (1.278) polymer. It appears
that the important factor is the polymer mw but this must
be considered in conjunction with the polymer concentration
in the sprayed solution. With linear polymers without
bulky side groups, such as poly(lactide-co-glycolide), the
higher the mw the stronger the intermolecular interactions,
i.e. intermolecular attractive forces (Van der Waals
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forces), physical entanglement of polymer chains, and this
probably accounts for the increased difficulty in breaking
up the polymer solution into individual droplets during
spray drying as the polymer mw increases. The parallel
alignment of the long linear polymer molecules in the
liquid filaments leaving the atomizer probably accounts for
the production of threads when high mw polymers were
sprayed. Diluting the polymer solutions reduces the
intermolecular interactions, by increasing the separation
of the polymer chains and by allowing a more effective
solvating action from the solvent which probably explains
the successful "spray-powdering" of high mw polymers using
dilute solutions. The spray dried material was deposited
in the form of aggregates on the walls of the tube
connecting the drying chamber with the cyclone and on the
walls of the cyclone. Small quantities of individual
particles were collected from the receiving vessel at the
bottom of the cyclone. The aggregates were broken down
into individual particles by grinding.
There was a significant deposition of partially dried
material on the drying chamber wall due to the combined
effects of the polymer's nature and the characteristics of
the spray dryer used. The high velocity air required to
break up the polymer solution into spray droplets projects
the spray forward and down the drying chamber at high
velocities. Since the drying chamber is small there is
not sufficient time for the droplets, especially the
coarser ones, to acquire a dry surface, resulting in the
deposition of damp particles on the wall. A layer of
-129-
sticky material is gradually developed, because of the
tacky nature of poly(lactide-co-glycolide) polymers at the
drying temperature. Furthermore, the atomizing air that
surrounds the spray droplets on leaving the nozzle prevents
intimate contact between the hot drying air and the spray
resulting in lower evaporation rates, which also contribute
to the deposition of semi-wet polymer on the drying chamber
wall.
Nevertheless, these deposits could be retrieved and
resprayed. The yield after recycling the deposits twice
was in the range of 70-80%. The remainder of the material
was lost mainly through the discharge of fine particles
with the exhaust.
The texture of the spray dried polymer particles was
investigated using SEN. The particles, irrespective of
their size, appeared to be porous, almost spherical
agglomerates of tiny spheres. The agglomerates probably
formed through droplets coalescing in the proximity of the
atomizer and drying in this state, or alternatively through
partially dried droplets adhering to each other in the
lower regions of the drying chamber, due to their sticky
surfaces. The particle surface was porous and rough but
without sharp edges (Fig. 24). Pictures of the interior of
the particles showed that the interior had a similar
texture to the surface consisting of a large number of very
small spheres attached to each other or fused together to
form a porous irregular structure (Figs. 25 and 26).
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3.3.3	 Degradation of Spray dried poly(lactide-co-
glycolide) Polymers
Both mass loss and molecular weight reduction, as expressed
by the reduction in the inherent viscosity of polymer
solutions in chloroform, of a series of poly(lactide-co-
glycolide) polymers during incubation in phosphate buffer
pH 7.4, 37°C was followed for a 12-week period.
Curves of the percent inherent viscosity (iv) remaining
with time for polymers of relatively low molecular weight,
initial iv 0.3-0.4, are shown in Fig. 27. An increase in
glycolide content of the polymer caused an increase in
molecular weight reduction rate, indicating that the
hydrolysis of ester bonds proceeded at a higher rate as the
glycolide content increased. This can be attributed to the
greater susceptibility of the glycolate ester linkage to
hydrolysis, as well as to the decrease in the glass
transition temperature of the polymers as their glycolide
content increases (Table 8). The glycolate ester linkage
has a greater susceptibility to hydrolysis than the lactate
ester linkage because the lactate ester linkage is subject
to steric hindrance, due to the presence of the methyl side
group. Glass transition temperature is a measure of the
flexibility of the polymer chains and lower Tg values
indicate higher chain flexibility and the increased ease
with which the transition state for ester linkage
hydrolysis may be achieved. Also, the closer the
temperature of the incubation medium to Tg, the higher the
permeability of the polymer to water and, therefore, an
increase in glycolide content could increase the water
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penetration rate into the polymer matrix resulting in
faster polymer hydrolysis.
The mass loss with time curves for polymers with initial
inherent viscosities of 0.3-0.4 are shown in Fig. 28. An
increase in the glycolide content of the polymer caused a
significant increase in the rate of polymer mass loss.
Thus, only 4.5% of the initial weight of a 50:50 (LE:GE%
inol) polymer remained after 12 weeks of incubation as
compared to approximately 79% of the initial weight of a
100:0 (LE:GE %mol) polymer after the same period. Mass
loss occurs when oligoiners small enough to dissolve and
diffuse out from the matrix have been produced as a result
of chain scission. The observed increase in mass loss rate
when the glycolide content of the polymer increased is
attributable to an increase in the rate of polymer
hydrolysis as the glycolide content increases.
Molecular weight reduction with time data could not be
obtained for the insoluble poly(glycolide). The mass
degradation data for this polymer are shown in Fig. 28.
The absence of hydrophobic methyl side groups in
poly(glycolide) molecules makes poly(glycolide) the most
hydrophillic member in the poly(lactide-co-glycolide)
family. However, mass loss from the poly(glycolide)
synthesized here proceeded at a rate lower than that
anticipated from its hydrophilicity. In fact, only poly(dl-
lactide) exhibited a lower mass loss rate than
poly(glycolide). Also, a lag period of approximately 2
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weeks was apparent in the mass degradation profile of
poly(glycolide) (Fig. 28).
Poly(glycolide) has been shown to be a crystalline material
(Gilding and Reed, 1979), whilst the remaining polymers
synthesized in this work have been found to be amorphous
(paragraph 2.4.7). Crystallinity decreases the water
penetration rate into the polymer matrix because
crystalline regions are more densely packed than amorphous.
Chu (1985) reported that the amorphous regions of
poly(glycolide) and poly(lactide-co-glycolide) sutures were
almost completely degraded in vitro, before any degradation
in the crystalline regions took place. Also, chain
flexibility is reduced in crystalline regions resulting in
a decrease in the ease with which the transition state for
hydrolysis of the ester bond may be achieved. Therefore,
crystalline polyesters would degrade at a lower rate than
the amorphous counterparts and this probably explains the
relatively low mass loss rate and the presence of the 2-
week lag period observed with the crystalline
poly(glycolide) (Fig. 28).
The effect of polymer composition has also been
investigated using higher molecular weight polymers, i.e.
polymers having an initial iv-O.9. An increase in the
glycolide content of the polymer caused a decrease in both
the chain scission rate and mass loss rate (Fig. 29). Only
9.5% of the initial weight of the 85 (0.901) polymer
dissolved over a 12-week period as compared with
approximately 62% of the 75 (0.848) polymer during the same
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period. An important difference from the low molecular
weight polymers was that the mass degradation curves of the
high mw polymers exhibited a clear and significant period
during which very little mass loss occurred from the
polymer, i.e. a lag period (Figs. 28 and 29).
Lag periods prior to weight loss have also been observed
with high molecular weight poly(lactide) polymers (Pitt et
al., '981bI Ogawa et al., 1988) and are associated with the
time required for the formation of soluble chain fragments
during polymer degradation. The lag period appears to
decrease with an increase in the glycolide content of the
polymer, probably because increasing the glycolide content
results in a higher hydrolysis rate. Chain fragments rich
in glycolic acid units would be more hydrophillic than
chain fragments rich in lactic acid units, therefore, an
increase in the glycolide content of the polymer could
decrease the extent to which chain fragments have to be
reduced before becoming soluble, thus decreasing the lag
period.
The degradation data for 50:50 (LE:GE %mol) polymers having
different molecular weights are shown in Figs. 30 and 31.
All polymers hydrolyzed very rapidly and the molecular
weight of many of them was reduced to less than half its
original value over a 2-week period. The mw reduction rate
appeared to increase slightly as the mw of the polymer
decreased (Fig. 30). Thus, the mw degradation half life,
t(051w) determined from the iv versus time plots, increased
from 1.6 to 2.1 weeks when the iv of the polymer increased
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from 0.307 to 0.728. An increase in polymer mw caused a
reduction in the density (mol per unit mass of polymer) of
hydrophillic chain end groups and resulted in a more
hydrophobic polymer, which absorbs water at a lower rate
and swells less (paragraph 3.3.6). The glass transition
temperature increases with an increase in polymer mw (Table
8), increasing the difficulty with which the transition
state for ester bond hydrolysis could be achieved. These
factors probably explain the observed decrease in the rate
of polymer hydrolysis with an increase in polymer niw (Fig.
30)
Rapid hydrolysis resulted in a rapid mass loss from the
50:50 (LE:GE %inol) polymers (Fig. 31). The rate of mass
loss fell with an increase in polymer mw due to the
decreased hydrolysis rate as the polymer mw increased.
Thus, the mass degradation half life t( 05 determined from
the mass versus time plots, increased from 3.2 to 6 weeks
when the inherent viscosity of the polymer increased from
0.307 to 0.728 (Table 10). The relationship between mass
degradation half-life and polymer inherent viscosity was
found to be linear (Fig. 32).
An increase in the particle size of the polymer powder,
sample 50(0.443) (Figs. (30) and (31) caused a significant
decrease in both the mw reduction rate and mass loss rate.
The mass degradation curve for the 50(0.443) polymer was
almost identical with that of the higher mw polymer,
50(0.643) and the mass degradation half-lives for those
polymers were essentially identical, i.e. 5.2 weeks for the
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latter and 5.3 weeks for the former (Table 10). The 50
(0.443) sample exhibited the lowest overall chain scission
rate amongst the 50:50 (LE:GE% mol) polymers investigated,
having an iv reduction half-life of 3.1 weeks, whereas
polymers of considerably higher mw, such as 50 (0.728) and
50 (0.643), had iv reduction half-lives of approximately 2
weeks (Table 10).
The increase in the particle size of the polymer powder
altered the shape of the iv versus time curve, which became
very similar to the mass versus time curve. Thus, the iv
versus time curve for the 50 (0.443) sample was the only
such curve to have a lag period. After that period, which
appeared to last approximately 2 weeks, the hydrolysis rate
abruptly increased to become comparable to that of the
other 50:50 polymers as indicated from the slopes of the
middle portions of the iv versus time plots (Fig. 30). The
decreased specific surface area of the sample would cause
a decrease in the contribution of surface reactions to the
overall hydrolysis and a possible delay in the saturation
of the matrix with water. Consequently, there would be a
delay in the establishment of the polymer's bulk
"equilibrium" hydrolysis rate. This may explain the
initial decrease in the hydrolysis rate observed when the
particle size of the sample increased. Once the particles
have been saturated an "equilibrium" hydrolysis rate is
established which depends on the chemical structure of the
polymer rather than on the physical form of the polymer
matrix. Under these circumstances a sharp increase in the
rate of hydrolysis is observed (Fig. 30). The reduced
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initial hydrolysis rate as well as the increased difficulty
and time required for the removal of soluble chain
fragments from the larger particles probably accounts for
the decrease in mass loss rate observed with the increase
in particle size of the polymer powder (Fig. 31).
Pitt et al. (1980) found that the chain scission rate was
the same for films and cylinders of poly(e-caprolactone),
despite a large surface-to-volume difference, and they
suggested that the hydrolysis occurs in the bulk of the
material. The results obtained here indicate that when the
polymer is in powder form the contribution of surface
reactions becomes significant, and that the degradation
rate increases with an increase in the specific surface
area of the polymer.
The complete mass degradation curves appeared to have
sigmoidal shape consisting of three distinctive regions:
an initial lag period, an apparent steady-state hydrolysis
region and finally a region where the mass loss rate
diminishes as the polymer mass is exhausted and the curve
levels off (Figs. 28 and 30). In the apparent steady-state
region, between approximately 20 and 80% mass loss, the
mass loss rate may be considered as constant, implying that
the rate of soluble degradation product formation becomes
almost constant once sufficient chain scission has taken
place to initiate mass loss from the polymer. This may be
considered a reasonable possibility for chain scission has
been reported to be a random process (Pitt et al., 1981ab•
Sigmoidal pH versus time curves, with an almost linear
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middle region, were previously obtained with
poly(glycolide) fibres in water. The decrease in the pH of
the solution was attributed to the liberation of glycolic
acid resulting from polymer degradation (Chu, 1985).
The effects of polymer molecular weight on poly(lactide-co-
glycolide) degradation were also investigated using 85:15
(LE:GE %mol) polymers which degrade at a lower rate than
the 50:50 polymers. Three 85:15 polymers were examined
having 1.160, 0.901, and 0.423 initial inherent viscosity
values. The chain scission rate decreased with an increase
in the mw of the polymer (Fig. 33), as with the 50:50
polymers (Fig. 30), but the effect was much more
pronounced, due probably to the lower hydrolysis rates of
the 85:15 polymers. This indicates that as the glycolide
content ofthefpolymer increases the influence of molecular
weight on the rate of polymer hydrolysis decreases.
The dependence of hydrolysis rate on polymer molecular
weight as found in this study (Figs. 30 and 33) implies
that the widespread practice of regarding poly(lactide-co-
glycolide) hydrolysis as occurring at a rate independent of
the mw of the polymers (Pitt et al., '981b' Visscher et al.,
1985) and thus assigning degradation rates to poly(lactide-
co-glycolide) compositions rather than to individual
polymers (Miller et al., 1977, Reed and Gilding, 1981) is
inaccurate.
The rate of mass loss from the 85:15 polymers was also
affected by the polymer molecular weight. 	 Thus, an
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increase in the inherent viscosity from 0.423 to 1.160
reduced the polymer mass degraded over a 12-week period
from -42% to -3.5%. However, there was no significant
difference in the percent mass loss between the 85 (1.160)
and the 85 (0.901) polymers over the same period. The lag
period prior to mass loss appeared to be a function of the
polymer molecular weight (Fig. 34).
Schindler et al. (1977) arbitrarily defined lag period as
the time required for 5% loss in the weight of the polymer
to occur. This definition appears to lack physical
significance because it does not take into consideration
the relationship between the lag period and the mechanism
of polymer degradation. Lag period would be better defined
as the time required for an apparent steady-state mass
degradation to be established and consequently correspond
to the time of the first inflection in the percent polymer
mass remaining versus time plot. The lag period could be
determined using the mass degradation plots, provided the
inflection in the plot is sufficiently sharp.
Alternatively, the lag period can be estimated by fitting
the data of the steady-state region of the polymer mass
versus time plot to zero order rate equations of the
general structure:
lOOM = 
a - KmotM0	 Equation 13
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Where M0 and M are the polymer mass at time zero and t
respectively, a is the intercept and Km4, the slope of the
least square straight line, corresponding to the steady-
state mass loss rate. The lag period can be calculated by
substituting 100 for 100 M/MQ in equation 15 and solving it






This method, unlike the method proposed by Schindler et al.
(1977), is based on the degradation mechanism and produces
lag period values using the actual degradation data of the
individual polymer. It can prove particularly useful when
the lag period cannot be determined directly from the mass
degradation plot, i.e. when the time of steady-state mass
loss commencement is not clear, such as in the case of
polymers having low molecular weight or high glycolide
content (Figs. 28 and 31).
The lag period for the 85:15 polymers could not be
determined with the above method because those polymers,
especially those having high molecular weight, underwent
little mass loss during the 12-week study period.
Nevertheless, the lag period appeared to increase with an
increase in polymer mw because the high mw 85(1.160)
polymer underwent neither significant (-3.5%) nor
consistent mass loss during the 12-week period, whilst the
low mw 85(0.423) polymer lost approximately 42% of its
original weight during the same period (Fig. 34). If the
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method of Schindler et al. (1977) was applied the lag
period values for the 85(1.160), 85(0.301), and 85(0.423)
polymers would be ^ 12 weeks, 6 weeks, and 2 weeks
respectively, i.e. the lag period is significantly
shortened as the polymer molecular wight falls. The
increase in the lag period with the polymer molecular
weight has also been observed with poly(lactide) polymers
(Pitt et al., 1981k Ogawa et al., 1988), and can be
attributed to the increased time required for a polymer
chain to be reduced to small soluble oligomers during
degradation as the polymer molecular weight increases.
The lag period values for all the polymers for which
sufficient data points in the steady-state region of the
mass degradation curve were available were estimated using
equations 13 and 14. The results obtained confirmed that
increasing the molecular weight, or the lactide content, of
poly(lactide-co-glycolide) polymers produced a longer lag
period. Mass loss during the lag period was, in all cases,
less than 10%, and did not appear to correlate with the
properties of the polymers (Table 11).
The 85:15 (0.423) polymer exhibited lower degradation rate
than the 75:25 (0.848) polymer despite its molecular weight
being less than half the molecular weight of the (0.848)
polymer (Figs. 28 and 29). The degradation rate of
poly(lactide-co-glycolide) polymers appears to be more
sensitive to changes in polymer composition than to changes
in polymer molecular weight. 	 This was further
substantiated when the effects of composition and molecular
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weight on degradation rate were quantitatively compared.
The mass degradation half lives, t(O5m) of polymers with
approximately the same molecular weight (iv-0.3-0.4) but
with different composition, i.e. the copolymers in Fig. 28,
were plotted against the percent change in lactide content
of those polymers, assigning the value zero to the polymer
with the lowest lactide content. Thus, the 50(0.343)
polymer was assigned the value 0%, so that the 75(0.307)
polymer corresponded to a 70% change in lactide content.
The slope of the least square - line for the t(OSM) versus %
increase in the lactide content was 0.129 (Fig. 35). The
t(OSM) value for the 85(0.923) polymer was 13.6 weeks as
determined by extrapolating the 6 to 12 weeks portion of
its mass degradation curve to the 50% mass loss value.
This appears to be a reasonable approximation because the
actual plot reached 42% mass loss, i.e. very close to 50%
value, and because the middle regions of the mass loss
curves could be considered to be linear (Fig. 28).
Following the previous procedure the t(os values obtained
with 50:50 (LE:GE %mol) polymers having different molecular
weights (Fig. 31) were plotted against the percent change
in the mw. The slope of the least square line for this
data was 0.016 (Fig.36), i.e. much lower than the slope of
t(051..4) versus percent increase in lactide content.
Although hydrolysis of water-soluble esters has been
studied widely, the problem as to how 0H or H 3O attacks the
ester bonds of highly polyinerized and water-insoluble
esters has not yet been solved. 	 It appears that
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poly (lactide-co-glycolide) degradation involves random
chain scission by hydrolytic cleavage of ester groups
(Schindler et al., 1977; Pitt et al., 1981a,b), although an
unzipping depolyinerization mechanism has also been proposed
to operate under certain conditions (Makino et al., 1985).
The activation energy values for the degradation of
poly(lactide) microcapsules were found to be comparable to
those for the hydrolysis of alkyl-acetates (Makino et al.,
1985) indicating that degradation of the polymer can be
ascribed to hydrolysis. Furthermore, hydrolysis of
poly(lactide) and of a 30:70 (LE:GE %mol) copolymer was
found to depend on the pH of the incubation medium,
accelerating in strongly acidic or strongly alkaline
buffered media (Reed and Gilding, 1981; Makino et al.,
1986b) in accordance with the features of acid-base
catalysis of ester hydrolysis. Pitt et al. (1981a) proposed
that degradation must occur in the bulk of the material
because, within limits, the rate of poly(E-caprolactone)
chain scission was found to be independent of geometry.
Nevertheless, they also reported that the rate of mass
degradation in vivo was much higher for poly(€-
caprolactone) powders than for poly(c-caprolactone)
capsules, which was attributed to the greater surf ace-to-
volume ratio of the powder samples. They were unable to
decide whether surface reactions involved a biological
mechanism or whether it was of the same nature as the
degradation in the bulk of the material. The increase in
degradation rate in vivo of poly(lactide-co-glycolide)
powders with an increase in the specific surface area of
the sample as found in this study (Figs 30 and 31), implies
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that increasing the specific surface area of the sample
could alone cause an increase in the degradation rate in
vivo, although enzymatic involvement would probably
supplement the effects of the increased specific surface
area.
Poly(lactide-co-glycolide) degradation involves hydrolysis
of the polymer chains resulting in a decrease in the
polymer molecular weight with time and dissolution of the
resulting small chain fragments, which in turn results in
time dependent mass loss from the polymer. Hydrolysis of
the polymers could be followed by measuring the decrease In
their molecular weight with time. However, the measured
rate of molecular weight reduction does not necessarily
reflects the actual rate of ester bonds cleavage. In some
cases the inherent viscosity appeared to level of f, or to
increase during certain periods of the degradation, which,
superficially interpreted, would mean that in those cases
the hydrolysis had been discontinued or chains were
reconnected causing an increase in polymer molecular
weight. A possible explanation for this phenomenon could
be that, during those periods, the rate of polymer
hydrolysis had become lower than the rate of small chain
fragments removal by diffusion into bulk solution and the
molecular weight of the residual polymer particle being an
overage, increased (Figs. 27, 29, and 30). It would
appear, therefore, that the rate of molecular weight
reduction would reliably reflect the rate of polymer
hydrolysis only before the onset of mass loss from the
polymer.
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Pitt et al. (1981 b) proposed that the hydrolysis of poly
(e-caprolactone) and related polyesters is autocatalyzed by
the generated carboxylic acid end groups. Evidence for
this was provided when the partial ethoxylation of the
initially present carboxylic acid end groups ("end
capping") caused a decrease in the rate of poly (c-
caprolactone) chain scission in deionized water. It was
assumed that the carboxylic acid groups would not be
dissociated in the hydrophobic polymer bulk, and that they
would function by hydrogen bonding to the ester links (Pitt
and Gu, 1987).
Neglecting the contribution of uncatalyzed hydrolysis the
rate of chain scission of an aliphatic polyester
autocatalyzed by the generated carboxylic acid end groups,
would be given by:
d[COOH] =K[coolil [ester] [H20]
Equation 15
where K is a rate constant and (COOH], [ester], and [H20]
are the concentrations of carboxylic acid end groups,
ester, and water molecules respectively.
For a small number of chain scissions, the ester as well as
the water concentration can be considered constant and












Substitution of the Mark-Houwink relationship (equation 19)
into equation 18 gives equation 20:
[n] =K"M
Equation 19
(n] = [n] ,
Equation 20




In the derivation of equation 21 it was assumed that the
carboxylic acid end groups participate in the transition
state of the hydrolysis reaction in their undissociated
from. However, the hydrolysis of ester bonds in neutral
and alkaline buffered media will more probably generate
carboxylic acid end groups in their dissociated form. The
pK of carboxylic acid end groups in poly(lactide-co-




approximate closely to that of lactoyllactic acid, which
has been reported to be - 3.0 (Schindler et al., 1977).
Application of the Henderson-Hasselbach equation (equation
22) for the dissociation of a weak acid with pK = 3.0 shows
that the concentration of the dissociated carboxylic acid
end groups in an aqueous environment of pH = 7.4, such as
the phosphate buffer used in this work, will be more than
25 X times greater than the concentration of the
undissociated carboxylic acid end groups (equation 25):
pH=pka - log _[c00H]
[COO-]
Equation 22
7.4 = 3.0 -log
[COO-]
Equation 23







If dissociation of carboxylic acid end groups is assumed
the hydrogen ion concentration will be proportional to the
square root of the acid concentration (Pitt et al., 1981a):
Where KD°5 is proportionally constant.
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The possibility that the generated hydrogen ions catalyze
the hydrolysis of ester bonds cannot be ruled out. The
hydrolysis rate of poly(ethylene terepthalate) by water
vapour at 150-220°C has been found to be proportional to










Integration of Equation 29 leads to:
2((COOH]° 5 - ( CooH] 5) = K1t
Equation 30
and rearrangement gives
[cooH]° 5 = [ COoH]g 5 + -	 t2
Equation 31
Provided (COOH] = !ç' equation 31 becomes:
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(M)° 5 = ( M (') -0.5 +
Equation 32
Substitution of the Mark-Houwink relationship (equation 19)
into equation 32 leads to:




When the polymer is in powder form the contribution of
reactions occurring on the surface of the particles to the
overall hydrolysis should be significant. These surface
reactions will be controlled by the properties of the
incubation liquid which will, exert great influence on the
degradation kinetics. In accordance with this Makino et
al. (1986gb) found that the degradation rate of
poly(lactide) microcapsules was significantly affected by
the pH and ionic strength of the bulk solution. In
buffered neutral to slightly alkaline solutions such as
phosphate buffer, pH = 7.4, and the physiological
environment the acidic degradation products will be
converted into neutral salts. In those media autocatalyzed
hydrolysis should be negligible. Chu (1982) observed
differed degradation kinetics of poly(glycolide) fibres in
acidic than in neutral buffer media and the difference was
attributed to the lack of autocatalyzed hydrolysis in the
neutral buffer media.
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If	 poly(lactide-co-glycolide)	 hydrolysis	 is	 not
autocatalytic chain cleavage will follow the rate law:
d[COOHJ =K3 [ester] [H20]
dt
Equation 34
Before any noticeable mass loss from the polymer takes
place the concentration terms in the right side of equation




where K4 = K3 (COOH] [H20]
Integration results in:
[COOH] - (COOH) 0
 - K4t	 Equation 36
and provided that (COOH] = M1 ' equation 36 becomes:
0% j -
- (Ma , -K4t
Equation 37
Substitution of the Mark-Houwink relationship (equation 19)
into equation 37 leads to:
[n] -1/a - [] -1/a = K5 t where K = K (K") 'a
Eq. 38
Equation 38 is equivalent to the following equation:
[n] -1/a = [n] -1/a + K t
Equation 39
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Using the Solomon-Ciuta approximate relationship (equation
7, paragraph 1.3.3.2) the inherent viscosity versus time
degradation data for the polymers which underwent
comparatively little mass loss over the 12 week period were
converted to intrinsic viscosity [n) versus time data. For
the 75 (0.848) polymer degradation data prior to the fourth
week of incubation were used because the polymer suffered
significant mass loss after that period (Fig.29). The
intrinsic viscosity versus time data so generated were
fitted to the kinetics equations 21, 33, and 39 using the
values 0.75 and 0.66 as the Mark-Houwink exponent a for
poly(lactide) and poly(lactide-co-glycolide) respectively
(Schindler and Harper, 1979; Pitt and Gu, 1987). Better
correlation coefficients were obtained by fitting the data
to equation 39 (Table 12) indicating that the hydrolysis of
poly(lactide-co-glycolide) spray dried powders was not
autocatalyzed by the generated carboxylic acid end groups.
This result justifies the reservations for the degradation
mechanism proposed by Pitt et al. (l98lIb) discussed
previously. It would appear that autocatalyzed bulk
hydrolysis might be the predominant degradation mechanism
for the degradation of comparatively highly hydrophobic
poly (€-caprolactone) in acidic or not buffered media, but
the degradation of the more hydrophillic poly(lactide-co-
glycolide) in neutral buffer media appears to follow non
autocatalyzed hydrolysis kinetics.
Examination of the hydrolysis rate constants in Table 12
confirms that the rate of poly(lactide-co-glycolide)
hydrolysis is a function of the polymer properties,
-151-
increasing with an increase in glycolide content or with a
decrease in the molecular weight of the polymer.
3.3.4
	
	 Compaction Behaviour of Spray Dried Poly(lactide-
co-glycolide) Polymers
Heckel (1961 a,b) considered the compaction of powders to
be a first order reaction, the pores being the reactant and




where D is the relative density of the compact (apparent
density of the tablet divided by the particle density), P
is the applied pressure and K, A constants.
Considerable deviations from this expression by the
experimental data occur at both low and high pressures, due
to particle rearrangement and strain hardening
respectively, or as compact density approaches the true
density of the powder at high pressures, but over the
middle pressure range a straight line relationship between
ln(1/1-D) and P exists, so that the constants K and A can
be determined from the slope and the intercept respectively
of the extrapolated linear region of in (i/1-D) versus P
plots. The reciprocal of constant K is numerically equal
to the yield pressure (Pr) of the material and the higher
the value of K the softer and more ductile a powder is.
The constant A represents the densification effected by
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filling the die and by individual particle movement and
rearrangement at low compaction pressures.
A typical Heckel plot for poly(lactide-co-glycolide) spray
dried powders is shown in Fig 37. The plot consisted of an
initial curved region, during which densification occurred
through particle slippage and rearrangement, followed by an
essentially linear region during which densification
through plastic deformation took place. The P.s. values of
the polymers, calculated from the slope of the 2.5 to 3.5
KN part of the Heckel plots (each KN of compaction force in
the abscissa of the plot corresponds to 11.44 MPa of
compaction pressure), were in the range of 28-33 MPa,
indicating a material of high plasticity. The loose and
porous texture of the spray dried polymer particles,
decreasing the resistance of the powder to deformation,
contribute to the low P. values observed (Table 13). The
P. values obtained are in the range of P. s. values reported
for other polymeric materials used as pharmaceutical
excipients (the P values for poly(vinyl chloride) and
poly(ethylene) have been found to be 69.8 and 15.5 MPa
respectively, and similar to the P value of maize starch,
a common direct tableting excipient, for which P = 40.3 MPa
(Roberts and Rowe, 1987).
Heckel plots have been used to elucidate the consolidation
mechanisms during the compaction of powders. The form of
the Heckel plots obtained with different particle size
fractions has been used to differentiate between materials
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consolidating by plastic deformation, or fragmentation.
Upon compaction, the former produce parallel lines which
represent the different densification obtained with
different particle size fractions, whilst the latter give
coincident straight lines above a certain compaction
pressure. However, the type of Heckel plots may vary
depending on the experimental compaction technique used and
different particle size fractions of the same material may
exhibit changes in the predominant consolidation mechanism
ranging from brittle to plastic deformation, so that
classification of a material using data for a range of
particle sizes would appear to be unreliable (Rue and
Rees, 1978). A more reliable way to elucidate the
consolidation mechanism could be to obtain Heckel plots of
a material using different compaction rates (Rue and Rees,
1978). Plastic deformation is time dependent and materials
consolidating through plastic deformation should exhibit a
significant increase in consolidation with decreasing
compaction rates. The P of spray dried poly(lactide-co-
glycolide) increased from 28.43 to 48.69 MPa when the
compaction rate increased from 0.5. to 1.5 KN.s 1 (Table 13),
indicating that plastic deformation is the predominant
consolidation mechanism.
It can be seen in Fig 37 that even at low compaction
pressures a compact of high density results. For example
at 5 KN (57.20 NPa) ln (1/l-D) equals 2.5 and consequently
n=0.918. This demonstrates the high ductility of the spray
dried polymers and implies that, even at low pressures,
strong tablets should be produced, because high density
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values mean more intimate contact between the particles and
strong interparticle bonding.
The characteristics of the polymers, such as composition
and molecular weight, did not appear to have any
significant effect on the yield pressure of the powders
over the range studied (Table 13).
3.3.5	 Wettability of Spray Dried Poly(lactide-co-
glycolide) Polymers
The contact angle values obtained with polymers of
different composition and mw were in the range of 72-78°
(Table 14), indicating a moderate polymer hydrophobicity.
The positive values of CosO (Table 14), imply that water
would penetrate into the heterogeneous poly(lactide-co-
glycolide) matrix since a positive capillary pressure
differential (P) would exist (as shown by equation 41) and
this would draw water into the matrix:
= ycos8/m
Equation 41
where y is the surface tension of the liquid, 0 is the
liquid-solid contact angle, and m is the ratio of the
cross-sectional area of the capillary to its perimeter
(Ganderton and Selkick, 1970).
The polymer mw did not appear to have any effect on
poly(lactide-co-glycolide) wettability in contrast to the
effect of composition (Table 14). Thus an increase in
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glycolide content tended to increase the polymer
wettability due to the decreased number of hydrophobic
lactic acid methyl side groups in the polymer chain as the
glycolide content increased. However, the contact angle
values obtained from polymers of different composition, but
similar mw, i.e. the polymers in Table 14 having IV 0.8,
were not found to differ significantly (0.05 level of
significance) when using the analysis of variance (ANOVA)
statistical method (Table 15). ANOVA was carried out using
the KWIKSTAT version 2.00 (Texasoft/Mission Technologies,
Texas, USA, 1989) statistical software.
3.3.6
	
	 Water Uptake from poly(lactide-co-glycolide)
Matrices
Water uptake from poly(lactide-co-glycolide) matrices
increased steadily with time and no equilibrium was reached
because degradation caused a continuous transformation
throughout the experiment causing the matrix to become more
hydrophillic (Figs. 38 and 39). Chain scission, which
starts immediately after the immersion of the polymers in
the liquid (paragraph 3.3.3) generates hydrophillic groups
(hydroxyl and carboxylic acid end groups), which cause this
increase in the matrix hydrophilicity. The oligomers also
produced when extensive chain scission has occurred would
create an osmotic pressure difference between the interior
of the tablet and the surrounding liquid, because the
oligomers formed in the interior diffuse out from the
matrix at lower rate than those formed at the tablet
surface. This would draw water into the matrix, the outer
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layers of the tablet functioning as a "semipermeable
membrane".
Advanced degradation, after prolonged periods of immersion
in an aqueous medium, turns the interior of the matrix into
a hydrogel (Fig.5.6) which is capable of absorbing large
qualities of water. Thus, the hydrolysis of the polymer
causes water to be drawn continuously into the matrix, and
the weight of the matrix increases with time, but
degradation is proceeding continuously and eventually when
mass loss due to this outweighs the gain from water uptake
the weight of the matrix begins to fall (Fig. 38).
An increase in glycolide content caused an increase in both
the percent water uptake and water uptake rate (Fig. 38).
This can be attributed to the increased polymer
hydrophilicity and to the decrease in the Tg of the
polymer, which will enhance the permeability of the polymer
in water and increase the amount of water that can be
accommodated by the polymer. A decrease in polymer mw
caused an increase in both the percent water uptake and
water uptake rate (Fig. 39) because of the increased
polymer hydrophilicity and the decreased Tg of the polymer.
The 85(0.308) and 50(0.343) polymers showed similar water
uptake profiles, characteristic of their low mw. After the
initial burst the water uptake rate assumed a fairly
constant lower value for the remainder of the process, only
increasing in the final stages (Figs. 38 and 39). The
constant water uptake rates, calculated by fitting the data
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between the initial burst and the final stages to zero
order rate equations, were 1.10 (r = 0.9978) and 1.70
mg.day 1
 (r = 0.9995) for the 85(0.308) and 50(0.343)
polymers respectively. The mechanism responsible for the
increase in water uptake during the concluding stages is
probably associated with the transformation of the central
portion of the 85(0.308) and 50(0.343) tablets into
hydrogels, due to advanced polymer hydrolysis (Fig. 56).
The water uptake experiments lasted 20 days for the 50
(0.343) and 25 days for the remaining polymers. When the
experiment was discontinued the 50(0.343) and 85(0.308)
tablets had become highly deformed and softened. They had
also filled with water, which would have been squeezed out
of the matrices under the lowest pressure. The 50(0.343)
polymer, which according to the degradation data obtained
here exhibits the highest degradation rate [the mass
degradation half-life of this polymer in powder form was
found to be approximately 26 days (Table 10)], was the only
matrix for which a weight reduction was observed during the
25 days of the water uptake experiment (Fig. 38). After 20
days immersion in, pH = 7.4, the interior of the 50(0.343)
tablets had been completely dissolved and after drying
tablets with an empty central portion and highly eroded
surface layers were obtained (Fig. 40). The big difference
in the extent of degradation between the 50(0.343) polymer
and the high mw 75(1.134) polymer is clearly demonstrated
in Figs. 40 and 41.
High mw polymers did not degrade significantly during the
25 day experimental period and the tablets retained their
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initial shape and strength (Fig. 41). The more hydrophobic
ones, i.e. the 100(1.178) and the 85(1.278), absorbed water
at relatively low rates, 0.082 (r = 0.9920) and 0.147
mg.day 1
 (r = 0.9846) respectively. These rates were
calculated from the slopes of the linear regression lines
of the% water uptake versus time data. The 75(1.134)
polymer, which is the most hydrophillic of the high mw
polymers studied here, showed a "mixed" water uptake
profile; the first part resembling the water uptake profile
of the high mw polymers, whereas the second that of the low
mw polymers (Fig. 38). An abrupt increase in water uptake
rate occurred in the middle of the 25 days period, the
water uptake rate being 0.483 mg.day' before the point of
inflection on day 13 and 1.109 mg.day 1
 afterwards, when
calculated by fitting the data before and after the point
of inflection to the zero order rate equation, r = 0.9651
and r = 0.9979 respectively. These results indicate that
the hydrophilicity of the matrix increased after 13 days
immersion probably due to polymer hydrolysis occurring
during the first 2 weeks. The observed 40% reduction in
the iv of a 75(0.848) polymer over the 2 week period would
support this contention (Fig. 29).
After the initial burst water uptake rate appears to
decrease with time as "saturation" of the matrix
approached. The "saturation" involves not only the filling
with water of capillaries and pores within the matrix, but
also the saturation of the polymer itself, as indicated by
the considerable swelling observed during the initial
stages of water uptake. Thus, the 100 (1.178), 75 (1.134)
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and 50 (0.343) matrices swelled by 12.71, 27.30 and 30.56%
respectively after 2 days immersion in buffer, pH = 7.4.
The decrease in water uptake rate is more evident with
polymers having a relatively low water uptake rate (Figs.
38 and 39). Accordingly, an "equilibrium point" can be
defined as that point of the initial water uptake versus
time curves where the rate of water uptake becomes minimum.
As no significant degradation, or at least no degradation
sufficient to bring about an increase in water uptake rate,
has occurred until this point the water uptake at
"equilibrium point" can be considered to reflect better the
inherent hydrophilicity of the original polymer than water
uptake values obtained after the initiation of polymer
degradation. Furthermore, the data up to "equilibrium
point" can be analyzed to elucidate the water uptake
kinetics before any significant degradation takes places
and to assign a water uptake rate value for each sample.
The water uptake rate became minimum after 5 days for the
100(1.178), 85(1.278), 75(1.134) and 85(0.727) polymers;
after 2 days for the 85(0.308) and after 3 days for the 50
(0.343) polymer. The time required for "saturation"
appeared to depend on the hydrophilicity of the polymer and
on the weight of the matrix (Table 16). These data up to
equilibrium were fitted to zero, first and Higuchi
kinetics.	 The regression equations describing Higuchi
kinetics had the form:
where M0, M are the matrix weight at time zero and t
respectively, and a, K constants. This equation provided
the best fit, as indicated by better correlation
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(M-M0) lOO/M0 = a +
Equation 42
coefficients, suggesting that the water uptake followed
Higuchi kinetics. The slopes of the regression lines
resulting from fitting the data to Higuchi's model
correspond to the water uptake rate constants. Both the
water uptake rate and the percent water uptake at
"equilibrium" increased with an increase in glycolide
content, or a decrease in the mw of the polymer (Figs. 38
and 39, Table 17).
The swelling (% increase in tablet thickness) of the
tablets after 25 days immersion in phosphate buffer, pH =
7.4, increased with an increase in glycolide content, or a
decrease in mw of the polymer (Table 18). The increased
polymer affinity for water, as hydrophilicity of the
polymer increases, accounts for the observed increase in
swelling. Unexpectedly, and in contrast to thickness the
diameter of all tablets appeared to decrease slightly (1-
2%) after 25 days of immersion. This can be attributed to
the tendency of the polymer chains to relieve internal
stresses by expanding during swelling in a direction
opposite to the direction of movement of the material
during compaction. Thus swelling of the polymer chains at
right angles to the circumference of the tablet, to cause
an increase in tablet thickness, will be accompanied by
tensioning in a radical direction which will cause a
diminution of the circumference.
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TABLE 9: Composition of the Polymers Synthesized for Spray
Drying
lactide (%mol) in











TABLE 10: Molecular Weight Degradation Half-Lives, t(oMv)
and Mass Degradation Half-Lives, t(OSm) for 50:50
(LE:GE % Mol) Polymers













TABLE ii: Lag Period and % Mass Loss during Lag Period
for Poly (lactide-co-glycolide) Polymers
LE (%mol)	 Inherent	 Lag Period	 % Mass Loss
Viscosity	 (weeks)
(dug)
50	 0.278	 0.46	 7
50	 0.343	 1.53	 4
50	 0.443	 2.37	 10
75	 0.307	 1.37	 4
75	 0.848	 5.00	 6
% mass loss is approximate value determined from the mass
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TABLE 13: Effect of Polymer Composition and Molecular
Weight on Yield Pressure,P
LE (%mol) iv (dug) rate (KN/s) 	 P (MPa) CV (%)
75	 1.134	 0.5	 31.61	 7.57
The particle size range of the powders was 63-150L
a Coefficient of variance
TABLE 14: Effect of Copolymer Composition (LE% mol) and
Molecular Weight (iv) on the Copolymer Contact
Angle (0) with Water
LE (% inol)	 iv (dug) CosO	 0(°)	 c.V. (%)
	100	 0.820	 0.216	 77.5	 3.96
	
85	 1.278	 0.261	 74.9	 1.34
	
85	 0.727	 0.250	 75.5	 1.37
	
85	 0.334	 0.245	 75.8	 0.89
	
75	 0.796	 0.312	 71.8	 4.57
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TABLE 18: Effect of Polymer Composition (LE %mol) and
Molecular Weight (iv) on the Swelling of
P0 lymers
LE (% Mol)	 iv (dl.g')	 Swelling'
	








75	 1.134	 32.05	 (27•30)d
	
50	 0.343	 34.8c (3056)d
a	 % vertical expansion of tablet after 25 days immersion
in phosphate buffer (mean of two replicates)
b	 approximate value
c	 approximate value after 20 days immersion in phosphate
buffer
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FiG. 27 MW reduction with time profiles for polymers with initial
lv 0.3-0.4 (Incubation medium: phosphate buffer, pH 7.4).
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Fig.28 Mass loss with time profiles for polymers of initial iv 0.3-0.4
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Fig.29 Mass loss and mw reduction with
time profiles for polymers with initial lv
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FIg.30 MW reduction with time profiles
for 50:50(LE:GE %mol) polymers having
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Fig. 31 Mass loss with time profiles for
50:50(LE:GE %mol) polymers having
different initial iv (incubation medium:
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FIg. 32 Effect of polymer mw,Iv on the mass
degradation hail-life ,t(0.5m) of 50:50
(LE:GE %mol) polymers C regression equation:
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Fig. 33 MW reduction with time profiles
for 85:15(LE:GE %mol) polymers having
different Initial mw (incubation medium:
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Fig. 34 Mass loss with time profiles for
85:15(LE:GE %mol) polymers having
different initial mw (Incubation medium:
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Fig. 36 Effect of %increase in mw on mass
degradation half-life, t(0.5m) of polymers (regression
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FIg. 37 Heckel plot of a 75(1.134) polymer (particle sIze






















Fig. 38 %water uptake with time for
polymers having different composition
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FIg. 39 %water uptake with time from
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Fig. 40 Scanning Electron Microscope of 50(0.343)
Matrices (prepared by compressing polymer powders
of 63-150M at 10 IN) Befor, and After 20 days
Incubation in Phosphate Buffer, pH=7.4.
1341, 1342: Mid cross-section cut of the matrix before
incubation
1048, 1049: Matrix appearance at the end of incubation
period.
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Fig. 41 scanning Electron Micrographs of 75(1.134)
Matrices (prepared by compressing polymer
powders of 63-150,L at 10 RN) After 25 Days
Incubation in Phosphate Buffer, pH=7.4
1355, 1356:	 Mid cross-section cut of the matrix after
incubation.
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One of the least complicated approaches to the manufacture
of sustained release dosage forms involves the direct
compression of blends of drug, polymer, and additives to
form a tablet in which drug is embedded in a matrix core of
polymer.
In this chapter, spray dried poly(lactide-co-glycolide)
powders were used to prepare phenobarbitone matrix tablets.
Short (48 hours) release experiments in vitro were carried
out to investigate the effects of technological factors,
such as compaction force, particle size and drug : polymer
ratio, on drug release and on the mechanical strength of
the tablets. The combination of formulation variables
giving satisfactory low initial drug release was then used
to prepare tablets for longer term investigation of the
effects of polymer characteristics on drug release. The
prospect of using poly(lactide-co-glycolide) matrix tablets
for the long term controlled delivery of bioactive agents
was considered.
4.2	 Materials and Methods
4.2.1	 Materials
Poly (lactide-co-glycolide) polymers, phenobarbitone (Sigma
minimum assay 99%), sodium phenobarbitone (Fluka, minimum
assay 99%), magnesium stearate (BDH, GPR) and chloroform
(FSA, analar) were used.
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4.2.2	 Methods
4.2.2.1 Preparation of Tablets
Drug and polymer powders of the same size particle fraction
were mixed in a tumbling blender (Pascall Engineering
England). A mixing time of 30 minutes was found to produce
homogenous drug-polymer mixtures. These were compressed in
the Dartec apparatus to obtain tablets of approximately 220
mg. A compaction force of 10 KN was normally applied, the
rate and dwell time being maintained at 1 KN.s' and 15s
respectively. Unless otherwise specified the drug polymer
mixtures consisted of 25% drug by weight.
4.2.2.2 Drug Release Properties of Tablets
Drug release from the polymer matrices was investigated
using a USP XXII (1990) automated dissolution apparatus.
The apparatus consisted of a water bath (Copley dissolution
bath), spectrophotometer (Philips Pye Unicam 8620
UV/VIS/NIR) and attached cell changer with an Opus PCIII
coupled to the spectrophotometer. The PU8260 TDS version
1.2 Philips Scientific, 1987 (England) software was used to
program the operation of the dissolution system and to
perform data capture and analysis.
1L of phosphate buffer, pH = 7.4, was used as dissolution
medium. The stirring rate was maintained at 50 rpm and the
temperature at 37°C. The dissolution medium was assayed,
both for phenobarbitone and sodium phenobarbitone, at 240
nm.
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Automated release experiments were conducted for 48 hours,
with manual sampling for longer experiments. All release
determinations were carried out at least in duplicate. A
Minolta SKT 101 (Japan) camera attached to a Nikon Labphot
(Japan) microscope was used to take pictures of tablets
after dissolution. SEN pictures of tablets before and
after dissolution were also taken.
4.2.2.3 Mechanical Properties of Tablets
The diametral breaking strength of tablets was measured
using a CT4O tester (Engineering System, Nottingham).
Their tensile strength (T) was determined from the formula




where P is the force causing fracture, d is the tablet
diameter and 1 is the tablet thickness.
4.3	 Factors Investigated Affecting Drug Release from
Poly(lactide-co-glycolide) Matrix Tablets
4.3.1	 Factors Related to Formulation
The effects of the following formulation variables were
investigated:
I. Compaction force: Five forces were used: 2.5, 5, 10,
20 and 30 KN. These corresponded to 28.60, 57.20,
111.44, 228.78 and 343.17 MPa compaction pressures
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respectively. The effect of compaction force was
examined at 43-63j. and 250-420j. particle size
fractions of the drug-polymer powder mixtures.
II. Particle size fraction: Four particle size fractions
were used: 45-63, 63-150, 150-250, and 250-420j.
III. Drug proportion in the matrix (% weight): three
proportions were examined: 12.5, 25 and 50%.
4.3.2	 Factors Related to the Polymer
The effects of changing the following polymer properties
were investigated:
I. Polymer molecular weight: three molecular weights of
a 85:15 (LE:GE %mol) polymer were studied. The
polymers had 1.278, 0.727 and 0.308 inherent
viscosities.
II. Polymer composition: four lactide: glycolide molar
ratios were examined: 100:0, 85:15, 75:25, and 50:50.
The tablets were prepared from 150-250& powders using
10 KN forces at 1 KN.s 1 rate.
4.4	 Results and Discussion
4.4.1	 Effect of Formulation Factors
The effects of compaction force were investigated using a
85(0.727) polymer. The rate of phenobarbitone release
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decreased with an increase in compaction force. The effect
was more pronounced with tablets prepared using powder
mixtures of large particle size, 25O-42Oj. (Figs. 42 and
43)
As negligible degradation takes place during the first 2









Where Q is the amount of drug released after time t per
unit exposed area, D = the diffusion coefficient of the
drug in the dissolution medium t and € are the tortuosity
and porosity of the matrix respectively, A is the amount of
drug per unit volume, and Cs the solubility of drug in the
dissolution medium.
Increasing the compaction pressure causes a decrease in the
porosity of the matrix (Table 19), and according to
Equation 44 a lower rate of drug release results. It was
shown (paragraph 3.3.4) that poly(lactide-co-glycolide) is
a soft and ductile material, which explains the low
porosity values obtained, even at low compression (Table
19). The porosity of the tablets prepared for the 45-63k
powders did not change significantly at compaction forces
higher than 5 KN (Table 19) which accounts for the small
differences in the rate of drug release between tablets
prepared using compaction forces higher than 5 KN (Fig.
43).
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When the same compaction pressure was applied the matrices
prepared from powders with a small particle size fraction
( 45-63M resulted in a lower porosity than those matrices
prepared from large particles, size fraction 25O-42O.i
(Table 19). This is probably because small particles are
capable of higher densification through interparticulate
slippage and rearrangement than large particles. Similar
results have been obtained during compaction studies
involving crystalline and spray dried lactose (Fell and
Newton, 1970). Because of their lower porosity, matrix
tablets prepared from the smaller particle size range
exhibited slower drug release rates than those prepared
from the larger particle size range using the same
compaction pressure (Figs. 42 and 43).
Sustained release matrix tablets should have adequate
mechanical strength to withstand shocks during handling,
shipping and dispensing. Nor should disintegration of the
matrix occur during drug delivery. Tablets with high
tensile strength values were obtained, even with low
compression pressures, due to the high plasticity of the
spray dried polymers. Soft, ductile materials, such as
poly(lactide-co-glycolide), deform extensively during
compaction causing a high interparticulate area of contact
and therefore strong interparticulate bonding, leading to
the formation of strong compacts. The tensile strength of
the tablets did not change significantly at compaction
forces higher than 20 KN (Table 20).
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The effect of the particle size fraction of the drug-
polymer powders on drug release was investigated using a
75(1.134) polymer. A compaction force of 10 KN was
employed. An increase in the particle size fraction caused
an increase in the rate of release (Fig. 44), probably
because, for a given compaction pressure, increasing the
particle size of the powder undergoing compression results
in compacts with higher porosity (Table 19). However, only
relatively small differences in drug release rates were
obtained by changing particle size, probably due to the
loose and porous texture of the spray dried polymer
particles. This decreases considerably the resistance of
the particles to deformation, reducing the significance of
particle size on the properties of these tablets.
An increase in phenobarbitone content (% weight) in the
matrix caused a significant increase in the amount of
phenobarbitone release. The amount of phenobarbitone
released in 48 hours increased from 10.39 to 36.49% when
the amount of phenobarbitone in the matrix increased from
12.5 to 50% (Fig. 45).
According to Higuchi's relationship (Equation 44) an
increase in the amount of the drug in the matrix (A) should
cause an increase in the rate of druq release. It should
also cause an increase in the porosity of the leached
portion of the matrix (E), which in turn would further
increase drug release rate. The porosity of the leached
portion of the matrix is given by (Higuchi, 1963):
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€ = € + V5A
Equation 45
Where c is the initial matrix porosity, V is the specific
volume of the drug, and A is the amount of drug per unit
matrix volume.
The results obtained (Figs. 42 to 45) show that the rate of
drug release is affected by the change in formulation
variables, and that the effects of changing any particular
variable (e.g. compaction force) could depend on the level
of the others (e.g. particle size). The rate of drug
release can be diminished by increasing the compaction
force, by decreasing the particle size of the drug-polymer
mixture, or decreasing the proportion of the drug in the
matrix. However, exceedingly high compaction forces, or
very small particle sizes, should be avoided since the
former increases the wear of tableting machines and the
latter the powder cohesiveness. It was observed that the
larger particle sizes (l5O-25Ojt and 250-420p) flowed into
the dye of the Dartec instrument more readily and packed
more uniformly than the smaller particle sizes. A
compaction force of 10 KN, combined with a particle size
fraction of 15O-25O, gave a satisfactory low initial drug
release so that formulations prepared under these
conditions were used to investigate the effects of polymer
characteristics.
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4.4.2	 Effect of Polymer Characteristics
The effect of changing the polymer composition and
molecular weight on the release of phenobarbitone from
poly(lactide-co-glycolide) matrix tablets in vitro was
investigated. Drug release followed for more than 30 days.
The release of phenobarbitone was significantly sustained
(Figs. 46, 48 and 50).
Drug release profiles consisted of three regions. An
initial region of relatively high release rate, probably
due to the rapid leaching of drug from surface layers of
the tablet (burst effect), followed by an extended region
of lower but essentially constant release rate (steady
state release region), which appeared to last approximately
until the time required for 80% of the drug to be released.
The steady state release region was followed by a final
region in which the rate of drug release fell of f as
exhaustion of drug in the matrix approached (Fig. 46,
release profile of 75(1.134) matrices and Fig. 48, release
profile of 85(0.727) matrix].
Plotting the rate of drug release against time (Figs 47, 49
and 50) showed that the rate remained essentially constant
between approximately 20 and 80% release, suggesting that
drug release did not follow the matrix release mechanism
suggested by Higuchi (1963). It was found that the
polymers swell upon immersion in an aqueous environment
(paragraph 3.3.6.). swelling of the polymer particles may
reduce the volume of water filled pores and channels
available for drug diffusion or may even create blind
-190-
aqueous domains inside the matrix (Fig. 51). (The pores in
the matrices are considered to fill with water very rapidly
as indicated by the rapid release of sodium phenobarbitone,
which is almost complete after 3 hours, Fig. 52).
Diffusion through the swollen polymer may then become the
predominant release mechanism.
The rate of diffusion in the swollen polymer is much lower
than that in water because polymer chains impose severe
restrictions in drug movement and this, together with the
decrease in drug diffusion rate via aqueous capillaries and
pores due to the decrease in pore volume caused by polymer
swelling, probably accounts for the significantly sustained
release of phenobarbitone from the matrix tablets.
Degradation and water uptake with time cause an increase in
drug release rate, the former generating aqueous channels
through which drug diffusion and release can occur, and the
latter because drug diffuses mainly through the aqueous
regions of a polymer membrane (Langer and Peppas, 1981).
The increase in drug release rate with time caused by
degradation and water uptake compensated for the decrease
in release rate caused by the increase in the distance with
time which the drug has to travel to be liberated, and so
an essentially constant rate of drug release resulted
(Figs. 47, 49 and 50).
An increase in the glycolide content of relatively high mw
polymers caused an increase in drug release rate (Fig. 46),
due to an increased water uptake and swelling, which
facilitates drug diffusion through the polymer. 	 A
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concomitant increase in the polymer degradation rate with
an increase of glycolide content will also contribute. SEM
pictures of mid-cross-section tablet cuts before and after
dissolution confirmed that the 75(1.134) polymer was more
degraded after dissolution than the 100(1.178) polymer
(Figs. 53 and 54). The 100(1.178) polymer did not appear
to undergo significant degradation over the 33 day period.
After dissolution this polymer appeared to retain a
continuous matrix having relatively few pores.
Phenobarbitone crystals embedded in the matrix could still
be observed (Fig. 54)
Comparison of the steady state drug release constants,
calculated by fitting the release data in the steady state
region of the curves to zero order rate equations, revealed
that the introduction of 25% mol glycolic acid units in the
polymer chains increased the rate of drug release by a
factor of approximately 3 (Table 21).
A decrease in polymer molecular weight was shown to
increase swelling, water uptake and degradation rate
(paragraphs 3.3.3 and 3.3.6), and it would therefore be
expected that by decreasing the molecular weight an
increased drug release rate would result. This was indeed
the case when the inherent viscosity of a 85:15 (LE:GE
%mol) polymer decreased from 1.278 to 0.727, but a further
decrease in the inherent viscosity to 0.308 brought about
the opposite effect, i.e. a decrease in the rate of drug
release (Figs. 48 and 49). This can be attributed to the
rapid hydrolysis of the low mw polymer, which gradually
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transformed the interior of the matrix to a hydrogel (Fig.
56). For release to occur the drug had to diffuse through
that gel so that only one release mechanism operated,
whilst in the case of high mw polymers drug release could
occur by both diffusion through aqueous channels and
diffusion through the swollen polymers (Fig. 51).
The transformation of the central portion of the tablet
into a hydrogel had already started after 10 days
dissolution. The gel area had cavities due to erosion of
the polymer. After 20 days the dimensions of the cavities
increased and a large number of tiny holes covered the gel
area. Significant degradation of the surface layers of the
matrix could also be observed. After 28 days immersion in
phosphate buffer gelation of the tablet centre was
complete; the interior of the tablet was then a soft, gummy
and sticky material (in the SEM pictures the gel formed
after 28 days appears to be "inflated" because of water
evaporation out from the gel during evacuation of the SEN
sample compartment) (Figs. 55 and 56). The gel became
thinner with time, and its rather loose texture after 31
days dissolution is shown in Fig. 57.
Similar phenomena to that observed with the 85(0.308)
polymer occurred with a low mw 50:50 (LE:GE %mol) polymer
(Figs. 58 and 59). However, gelation of the central
portion in the 50(0.343) matrices proceeded more slowly
than in the 85(0.308) matrices, as comparison of the gel
texture in Figs. 56 and 59 shows, possibly because the
50(0.343) polymer had a slightly higher initial mw than the
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85(0.308) polymer. The surface layers of the 50(0.343)
matrices appeared to be more degraded than the 85(0.308)
matrices after 28 days dissolution. (Comparison of
micrographs 1406, 1407 with micrographs 1417, 1418 in figs.
56 and 59). Both the higher mass loss rate, creating a
more porous structure in the surface layers of the tablets
and the smaller extent of central portion gelation,
resulting in an extension of the period during which drug
diffusion from the tablet interior through aqueous pores
occurs, probably account for the higher rate of drug
release observed with the 50(0.343) matrices. The steady
state release rate constants were 0.78 and 1.24% released
x day' for the 85(0.308) and the 50(0.343) tablets
respectively. These values were lower than the rate
obtained from polymers with much higher molecular weights.
The 85(0.308) polymer exhibited the lowest rate of drug
release from all polymers studied and only poly(lactide),
sample 100(1.178) had a lower drug release rate than
50(0.343) polymer over the 33 days study period (Table 21).
From the results obtained (Figs. 46, 48 and 50) it can be
deduced that drug release from poly(lactide-co-glycolide)
matrix tablets can be controlled by modifying the polymer
properties. However, this can be more easily accomplished
by modifying the composition of relatively high mw polymers
rather than by changing the molecular weight of the
polymer. Drug release appears to involve, besides
diffusion through the water filled pores, diffusion through
the swollen polymer where the size of the drug molecule may
be expected to exert a significant influence on the release
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rate, because diffusion in polymers is much more sensitive
to the molecular weight of the permeant molecules than is
diffusion in liquids.
In all cases the initial stage of release (burst stage)
lasted 2 days and the amount of drug released during that
period tended to increase with the hydrophilicity of the
matrix, i.e. with an increase in the glycolide content, or
a decrease in the polymer mw, ranging from 15 to 32% (Figs.
46, 48 and 50). Comparison of these results with the
results obtained in the study of technological factors
(paragraph 4.4.1) indicates that the amount of drug
released during the initial burst stage was primarily a
function of technological factors rather than function of
characteristics.
Drug release from many poly(lactide-co-glycolide) systems
has been reported as biphasic or discontinuous. Pitt et
al. (1979) reported that the release of progesterone from
films prepared from polymers with relatively high glycolide
content increased abruptly and significantly after
approximately 5% release had occurred (20 - 30 days), due
to film fragmentation and exposure of a larger surface
area. Beck et al. (1983 k) also found that the release of
norethisterone from poly (lactide-co-glycolide)
microcapsules was biphasic. Initially, the microcapsules
released the drug by diffusion but later degradation of the
polymer induced a second phase of release producing
increased norethisterone serum levels. The release levels
of LHRH analogues from poly(lactide-co-glycolide) depots
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was reported to be both biphasic and discontinuous. During
the initial phase the polypeptide was released by leaching
from the surface of the formulation, whilst during the
second phase the polypeptide release occurred by diffusion
through aqueous channels generated by polymer degradation.
The two phases were separated by a period of subeffective,
or no polypeptide release, unless very low mw polymers with
high g].ycolide content and high drug contents were used
(Hutchinson and Furr, 1985; Sanders et al., 1986). The
release of levonorgestrel from small cylinders prepared
using a 90:10 (1-LE:GE %ntol) high mw polymer was also
reported to be biphasic, but no explanation for this was
given (Wise et al., 1980).
With respect to the above reports the continuous and
essentially constant release rate obtained with the
poly(lactide-co-glyco].ide) matrix tablets would appear to
provide a significant improvement.
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TABLE 19: Effect of Compaction Force (F) on the Porosity
(e) of 85(0.727) - Phenobarbitone Matrix Tablets
Particle Size Range ()	 F(KN)	 (c)






20	 0 • 046




20	 0 • 031
	
30	 0.031
TABLE 20: Effect of Compaction Force (F) on the Tensile
Strength (T) of 85(0.727) - Phenobarbitone Matrix
Tablets.






Particle size range of drug-polymer mixtures, 45-63j.
T values are the mean of three replicates.
*CT4O tester indication.
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Each Kvalue is the mean of two determinations;
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hours
Fig. 42 Plots of phenobarbitone release
from 85(0.727) matrlces(250-42Oi)
prepared using different compaction forces
(dissolution medium: phosphate buffer
,pH=7.4, 37° C ; stirring rate: 50 rpm).
0
	 10	 20	 30	 40	 50
hours
FIg. 43 Plots of phenobarbitone release
from 85(0.727) matrices (45 -63w) prepared
using different compaction forces
(dissolution medium: phosphate buffer
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hours
FIg. 44 Phenobarbltone release from 75(1.134)
matrices prepared by compressing at 10 KN
drug-polymer mixtures of different particle size
( dissolution medium: phosphate buffer, pH=7.4, 370 C
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hours
Fig. 45 Drug release plots from 85(1.278)
matrices with different phenobarbitone
content (%wlw) (dissolution medium:
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days
Fig. 46 Plots of phenobarbitone release
from polymer matrices having different
composition (dissolution medium : phosphate






0	 10	 20	 30day
Fig. 47 Rate of phenobarbitone release
from polymer matrices having different
composition (dissolution medium: phosphate

































10	 20	 30	 40
days
Fig. 48 plots of phenobarbitone release
from 85:15(LE:GE % mol) matrices having
different mw (dissolution medium: phosphate
buffer, pH=7.4, 375 C ; stirring rate: 50 rpm).
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0	 10	 20	 30
day
Fig. 49 Rate of phenobarbitone release
from 85:15(LE:GE %mol) matrices having
differernt mw ( dissolution medium: phosphate
buffer, pH=7.4, 37°C ; stirring rate: 50 rpm).
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FIg. 50 Phenobarbltone release and rate
of release from a 50(0.343) matrIx
( dissolution medium: phosphate buffer,
pH=7.4, 37 C ; stirring rate: 50 rpm).
Fig. 51 Drug Release from a Swollen Matrix (A) and from
a Matrix with Gelatinized Central Portion (B)












0	 2	 4	 6	 8
hours
Fig. 52 Phenobarbitone and sodium phenobarbitone
release from 75(1.134) matrices prepared by
compressing drug-polymer mixtures of 150-25011 at 10 KN
( dissolution medium: phosphate buffer,
pH=7.4, 3f C ; stirring rate: 50 rpm).
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rig. 53 scanning Electron Micrographs of 75(1.134) -
Phenobarbitone Matrices Befor. and After 33 Days
Dissolution in Phosphate Buffer, pH=7.4
1352: Mid cross-section cut of a tablet before dissolution







Fig. 54 Scanning Electron Micrographs of 100(1.178) -
Phenobarbitone Matrices Before and After 33 Days
Dissolution in Phosphate Buffer, pH=7.4
1401: Mid cross-section cut of a tablet before dissolution
1053: Mid cross-section cut of a tablet after dissolution
1410: Detail of the mid cross-section cut shown in 1053.
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Fig. 55 Bcanning Electron Micrographs of 85(0.308) -
Phenobarbitone Matrices (prepared by compressing
drug-polymer mixtures of 150-250L at 10 ZN)
Before and After Dissolution in Phosphate Buffer,
pH=7.4
1346, 1347: Mid cross-section cut of a tablet before
dissolution
1411, 1412: Mid cross-section cut of a tablet after 10 days
dissolution
1413:	 Detail of the mid cross-section cut shown in
1411.
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Pig. 56 Scanning Electron Micrographs of 85(0.308) -
Phenobarbitone Matrices (prepared by compressing
drug-polymer mixtures of 15O-25OL at 10 RN)
After Days Dissolution in Phosphate Buffer,
pH=7.4
1414, 1415: Mid cross-section cut of a tablet after 20 days
dissolution.
	
1416:	 Detail of the mid cross-section shown in
1414. 1
417, 1418: Mid cross-section cut of a tablet after 28
days.
	
1419:	 Detail of the mid cross-section cut shown in
1417.
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rig. 57 Photograph of Mid Cross-Section Cut of a
85(0.308) - phenobarbitone Matrix (prepared by
compressing drug-polymer mixtures of 15O-25O at
10 RN) After 31 Days Dissolution in Phosphate
Buffer, pH=7.4 (Magnification X100).
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Fig. 58 scanning Electron Micrographs of 50(0.343) -
Phenobarbiton. Matrices (prepared by compressing
drug-polymer mixtures of 150-250M at 10 N)
B.fore and After Dissolution in Phosphate Buffer,
pR=7.4
1343, 1345: Mid cross-section cut of a tablet before
dissolution.
1420, 1402: Mid cross-section cut of a tablet after 10 days
dissolution.








Fig. 59	 scanning Electron Micrographs of 50(0.343) -
Phenobarbitone Mixtures (prepared by compressing
drug-polymer mixtures of 150-2501L at 10 KN)
After Dissolution in Phosphate Buffer, pH=7.4




	 Detail of the mid-cross-section cut shown in
1404









Biodegradable polymers have become increasingly important
in the development of controlled release drug delivery
systems. The use of biodegradable polymers makes the
surgical removal of the depleted device unnecessary, but
perhaps most importantly, the degradation of the carrier
can be utilized to control the rate of drug release. A
number of biodegradable polymers are currently being
evaluated as carriers for sustained drug delivery, but the
polymers receiving the most attention at this time are the
homo-and-copolymers of lactic and glycolic acid. This is
mainly because of their established biocompatability and
regulatory approval of their application as biodegradable
surgical sutures.
Low molecular weight poly(lactic-co-glycolic) polymers can
be prepared by the direct condensation of lactic and
glycolic acids in aqueous solutions. With this method poly
lactic acids of relatively high mw's were obtained by
removing the water with an entraining agent in the presence
of mineral acid catalyst. The polymers of moderate mw were
viscous oils, whereas those having molecular weights of
approximately 3,000 and above were
	 brittle glasslike
Sc
masses (Fillachione and FisJer, 1944). High mw polymers
(mw > 10,000) cannot be produced by this method because a
high degree of dehydration (>99%) would be required, which
is difficult to achieve because Henry's law considerations
make it difficult to distil the infinitesimal quantity of
water in equilibrium with a polymer of this mw.
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High mw (>10,000) poly(lactide-co-glycolide) polymers can
be prepared by the ring opening polymerization of the
cyclic "monomers" lactide and glycolide. This ring opening
polymerization proceeds through the pair addition of lactic
or glycolic acid units yielding polydimers. When protic or
Lewis acids are used the mechanism of polymerization is
cationic, whilst a co-ordinate mechanism has been proposed
when organometallic catalysts are used (Cherdron et al.,
1962; Dittrich and Schulz, 1971).
Although the importance of polymerization conditions on the
properties of the resulting polymers has been recognised
the effects of changing the polymerization conditions have
been studied in a rather empirical manner, leading
frequently to contradictory findings. In this work the
synthesis of poly(lactide-co-glycolide) by the ring opening
polymerization of lactide and glycolide has been thoroughly
investigated from a pharmaceutical viewpoint. The effects
of changing the polymerization conditions were discussed
with respect to the mechanism of polymerization. The
effects of preparative variables on the yield of
polymerization were also considered since a satisfactory
yield is required to make polymer synthesis cost effective.
Exclusion of moisture during lactide/glycolide preparation
and storage, as well as during polymerization, is essential
if high mw polymers are to be obtained. It was found that
small lactide/glycolide crystals having a higher specific
surface area absorbed moisture at a higher rate during
handling and storage and resulted in lower mw polymers than
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larger crystals. Moisture absorbed by the monomers caused
their hydrolysis to acidic products, which act as chain
transfer agents, terminating the polymerization. The a
form of glycolide, which is more stable hydrolytically, is
slowly converted to the f3 isomer on standing at ambient
temperature (Frazza and Schmitt, 1971). Therefore, the
monomers should preferably be used immediately after their
preparation or they should be effectively protected from
moisture during storage. Because moisture causes monomer
hydrolysis, but also functions as chain transfer agent
itself, the polymerization should be carried out in an
inert atmosphere or in highly evacuated vessels.
Two type of catalysts, which have been reported to be
particularly effective in the polymerization of
lactide/glycolide are Lewis acids and organometallic
compounds.	 The comparative effectiveness of these
catalysts was investigated by using antimony trifluoride as
representative of the first type and stannous octoate as
representative of the second.
	 Stannous octoate was
preferred over diethyl zinc or trialkyl aluminium, which
have also been used (Wise et al., 1979a), because the last
two compounds are pyrophoric, igniting on contact with air,
which makes their handling difficult.
	 Furthermore,
stannous octoate had been approved by the FDA (Food and
Drug Administration, USA) as a food stabilizer so that
possible residual catalyst in the polymers would not
represent a serious problem. Under both polymerization
conditions used, stannous octoate was far more effective,
resulting in polymers having 3 to 9 times greater inherent
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viscosity than polymers synthesized using antimony
trifluoride (Table 3). This indicates that organometallic
compounds are more effective catalysts than Lewis acids for
the polymerization of lactide/glycolide. Since stannous
octoate was found to be more effective, this catalyst was
selected for the remainder of the work.
The effect of catalyst level on the mw of the resulting
polymer and on the yield of polymerization was investigated
at two temperatures, one high (190°C) and one low (130°C).
At both temperatures the mw and the yield passed through a
maximum at fairly low catalyst levels, before falling at
higher catalyst concentrations. The amount of catalyst
required for polymers with high mw appeared to coincide
with that resulting in a high yield (Figs. 12 and 13, Table
4). From the reaction of catalyst with monomer active
species are formed (Species A in reaction shown in Fig. 11)
which initiate the polymerization. The rate of
polymerization increased with an increase in catalyst
concentration (Table 6) due to increased rate of initiating
species generation.	 Thus, increasing the catalyst
concentration resulted in an increase in both polymer mw
and yield of the polymerization. However, excessive
increase in catalyst levels caused a too high rate of
polymerization, resulting in a sudden mw build up followed
by a mw decline due to depolymerization reactions.
Depolymerization probably takes place through a "back
biting" mechanism in which an active centre in a polymer
molecule attacks a carbonyl group in the same molecule,
instead of a monomer carbonyl group, resulting in the
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cleavage of the polymer chain into two segments (Fig. 14).
The probability of these "back biting" reactions increases
with an increase in the catalyst to monomer ratio,
accounting for the mw decline when catalyst levels beyond
the optimum for a given set of polymerization conditions
were introduced in the polymerization mixture.
Polymers of higher mw were obtained at lower temperatures
(Figs. 12 and 13). This is attributable to the increased
probability of "back biting" depolymerization reactions
because rotational and folding mobility is enhanced at
higher temperatures.
The polymers exhibited similar polymerization behaviour,
with regard to the polymerization conditions, irrespective
of their composition. Thus, the mw of both 90:10 and 70:30
(LE:GE w/w in the starting polymerization mixture)
compositions followed the same pattern of change with
respect to catalyst level. The catalyst level resulting in
polymers with the highest mw (optimum catalyst level) was
the same for both compositions. However, the compositions
rich in glycolide appear to require more severe
polymerization conditions, since, at all catalyst levels,
polymers produced from the 90:10 starting composition had
a higher mw than those prepared from the 70:30 starting
composition. An increase in the amount of catalyst above
the optimum, for a given set of polymerization conditions,
did not result in higher mw polymers, indicating that the
polymerization of mixtures with high glycolide contents
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probably requires higher polymerization temperatures (Figs.
12 and 13).
When polymerization proceeds through chain reactions
polymer of high mw is normally formed at once and polymer
mw changes little throughout the polymerization. The mw of
the polymers synthesized here continued to increase
throughout the polymerization (up to 4 hours when optimum
catalyst levels were used), even at conversions higher than
90% (Fig. 18), indicating that poly(lactide-co-glycolide)
polymerization is not a chain reaction in the kinetic
sense. The effect of polymerization time appears to depend
on the amount of catalyst used. At optimum catalyst levels
the yield remained essentially constant, but the mw fell at
polymerization times longer than 4 hours (Figs. 16 and 17).
As the high yields obtained with a 4 hours polymerization
indicated, the polymerization had been essentially
completed within the 4 hours period, so that only "back
biting" reactions could occur after that period causing
depolymerization. Using a sub-optimum catalyst level,
lower mw and yield were obtained, which were still
increasing at periods longer than 4 hours (Figs. 16 and
17).
The time of polymerization was found to affect the
composition of the resulting polymers. Glycolide, being
more reactive, was preferentially polymerized in the
initial stages, so that polymers prepared using short
polymerization times were richer in glycolic acid units
than those prepared using longer polymerization times
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(Table 7). These results indicate that when optimum
amounts of catalyst for a given temperature are used, 4
hours polymerization should be carried out, since polymers
of lower molecular weights at a lower yield are produced
using shorter polymerization periods, whilst the polymer mw
falls at longer periods. Furthermore, the composition of
polymers appears to stabilize after 4 hours polymerization
(Table 7), so that polymers with consistent properties can
be prepared using a 4 hours polymerization period. When
sub-optimum catalyst levels are used longer polymerization
times are required, whilst with higher than the optimum
catalyst levels the reaction proceeds to rapidly and
shorter polymerization times have to be employed to obtain
the same degree of polymerization.
The polymerization of lactide/glycolide in the presence of
small amounts of alcohol, such as lauryl alcohol has been
proposed to be cationic (Frazza and Schmitt, 1971). It is
believed that in polymerizations proceeding through a
cationic mechanism the catalyst reacts with a co-catalyst
to form the initiating species. When lauryl alcohol was
included in the polymerization mixture as a co-catalyst,
increasing the lauryl alcohol concentration caused both a
decrease in the mw of the resulting polymers and in the
yield of polymerization (Table 5). This was attributed to
the interruption of the proton exchange between the polymer
chains and the monomers, which is responsible for chain
growth, by the lauryl alcohol molecules.
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Polymers synthesized in this work having an inherent
viscosity of approximately 0.2 or less were yellowish,
granular, brittle materials, whereas higher mw polymers
were tough fibrous materials which could not be powdered by
grinding. Therefore alternative methods of producing these
polymers in powdered form had to be developed. For this
purpose the spray drying technique was adopted.
The microstructure of biodegradable polymers can be
investigated by NNR spectroscopy or by degradation
experiments. In the first method the ' 3C - NMR spectrum of
the sample is recorded and its fine structure could provide
information for the monomer sequence in the polymer
molecules. In the second method the sample is allowed to
degrade in an aqueous environment and the ratio of lactic
to glycolic acid units is determined periodically. If
there is a large amount of block copolymer in the sample,
the ratio of lactic acid to glycolic acid units increases
with time, since the glycolic acid sequences are
preferentially hydrolyzed. In this work the first method,
which is more rapid and possibly more sensitive, was
adopted.
The structure of the '3C - NNR spectra indicated that block
copolymers were produced, irrespective of polymer
conditions, due probably to the higher reactivity of
glycolide monomer. The block nature of the polymers was
also indicated by the presence of insoluble material in
tetrahydrofuran or chloroform material from polymers rich
in glycolide, such as the 50:50 (LE:GE %mol) polymers. The
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insoluble material was probably polymer molecules having
large blocks of glycolic acid units, since poly(glycolide)
is insoluble in common organic solvents. A random monomer
sequence would be preferred because random copolymers would
exhibit more reproducible behaviour, such as solubility in
organic solvents and biodegradation rate, consistent with
their composition and molecular weight. Copolymers with a
narrow range of chain composition may possibly be made
using a monomer feed technique (Askill and Gilding, 1981).
However, the need for accurate metering of a high
temperature lactide and glycolide mixture, together with
the rapidity of polymerization, makes this prospect very
difficult experimentally.
Because racemic lactide was used to synthesize the polymers
all samples examined were amorphous, showing a Tg which
increased with increasing lactide content, or mw of the
polymer (Table 8). This might have a significant effect on
the polymer performance as a controlled drug release
excipient. The increase in the degradation rate of spray
dried polymer powders with an increase in glycolide
content, or a decrease in polymer mw (Figs. 27, 30 and 33),
was attributed, amongst other factors, to a reduction of
Tg. This caused an increase in both the water penetration
rate and the ease with which the transition state for ester
hydrolysis could be achieved.
The results obtained from the investigation of
poly(lactide-co-glycolide) synthesis show that the
polymerization conditions affect the mw and composition of
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the polymers formed and, consequently, all polymer
properties which depend on polymer mw and composition.
There is a significant interdependence between such
preparative variables as the amount of catalyst, time and
temperature so that the effect of changing any one of them
on the properties of the resulting polymer depends on the
level of the other two. It appears possible to control the
properties of the polymers formed by judicious adjustment
of the polymerization conditions. Thus, the mw of the
resulting polymers can be decreased by employing lower than
optimum catalyst concentrations, by decreasing the
polymerization time, by incorporating small amounts of
alcohol in the polymerization mixture, or by a combination
of those. The mw of the polymer can also be decreased by
fractionization, but the low yields obtained with this
method (less than 50% according to Kitchell and Wise
(1985)] make fractionization non cost-effective. In
general it is advantageous to prepare a polymer with the
desired properties in the first place rather than to modify
the properties of an already produced polymer.
Larger quantities of polymers, with different compositions
and mw's, were synthesized by modification of the
preparative procedure based on the data acquired in the
study of polymer synthesis. These polymers were spray
dried from chloroform solution using a mini spray dryer.
The main problem encountered was the production of threads,
instead of particles, when relatively high mw polymers were
sprayed, unless very dilute solutions were used. This was
attributed to the nature of poly(lactide-co-glycolide)
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molecules and the strong intermolecular interactions of
both physical and chemical nature. Very dilute (1-2% w/v)
solutions of the high mw polymers had to be used in order
for polymer particles to be obtained. There was also a
significant deposition of partially dried material on the
wall of the drying chamber, which was attributable to the
tacky nature of the polymers at the drying temperature and
to the characteristics, such as the size and atomizing
method, of the spray dryer used. It was, therefore,
necessary to recycle the deposited material twice in order
that acceptable spray drying yields (70 - 80%) be achieved.
The use of very dilute solutions and the need for deposit
recycling increased the time and cost of spray drying per
polymer batch. The use of larger spray driers, with more
efficient atomizing equipment, may improve the spray drying
characteristics of poly (lactide-co-glycolide) polymers.
The spray dried particles appeared to be porous,
approximately spherical agglomerates of tiny spheres
probably produced as droplets attached to each other during
spray drying. Because of their almost spherical shape and
their sufficiently high particle density (around 1.3 g.cm3)
significant problems with regard to powder flowability are
not expected, although the smaller particle sizes, 63-149,
and especially 45-63.i, showed a certain degree of
cohesiveness. The agglomerate and rather loose texture of
the particles probably increased powder compressibility.
Soft and ductile powders were obtained by spray drying the
polymers. The yield pressure values obtained were in the
range of 28-33 MPa, and depended on the compaction rate,
indicating a material consolidating through plastic
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deformation. The characteristics of the polymer, such as
mw and composition, did not appear to have any significant
effect on the yield pressure of the powders (Table 13).
Degradation of poly(lactide-co-glycolide) polymers involves
bulk hydrolysis of ester bonds, resulting in a reduction in
polymer mw with time and dissolution of the small chain
fragments formed, which in turn results in time dependent
mass loss from the polymer. The polymer hydrolysis is
usually followed by measuring the decrease in polymer mw,
however, it was shown that the rate of hydrolysis does not
always coincide with the rate of mw reduction. The
dissolution of small oligomers may cause an apparent
increase in the mw of the remaining polymer and create a
false picture of the polymer hydrolysis (Fig. 27). The
rate of mw reduction may be considered to safely reflect
the rate of polymer hydrolysis only before mass loss from
the polymer takes place.
Pitt et al. (198l1,b) proposed that the hydrolysis of
poly(€-caprolactone) and related polyesters is
autocatalyzed by the carboxylic acid end groups generated.
However, for polymers in powder form the surface hydrolysis
reactions will be significant. These surface reactions
will be controlled by the properties of the incubation
medium and in slightly alkaline solutions of pH = 7.4 the
acidic degradation products will be converted to neutral
salts. It would appear reasonable to expect that
autocatalyzed hydrolysis in such media would be negligible.
Rate equations were developed for autocatalyzed either by
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the dissociated or dissociated form of the carboxylic end
groups, and also non-autocatalyzed polymer hydrolysis. The
degradation data fitted best equations describing non-
autocatalyzed hydrolysis indicating that the hydrolysis of
poly(lactide-co-glycolide) in buffer, pH 7.4, followed
such a mechanism (Table 12).
The rate of polymer hydrolysis increased with respect to
the glycolide content, which was attributed to the greater
susceptibility of the glycolate ester bond to hydrolysis as
well as to the decrease in the Tg of the polymer with
increasing glycolide content (Figs. 27 and 29). A decrease
in polymer mw caused an increase in the polymer hydrolysis
rate because of the increase in density of the hydrophillic
chain end groups and the decrease in polymer Tg (Figs. 30
and 33). The rate of mass loss from the polymer also
increased with increased glycolide content, or a decrease
in polymer mw, because of the increased rate of polymer
hydrolysis.
The mass degradation profiles had sigmoidal shape
consisting of three distinctive regions: an initial lag
time corresponding to the time required for the production
of small soluble chain fragments through chain scission, an
apparent steady-state mass loss region, during which the
mass loss rate appears to be constant, and finally a late
region where the mass loss rate diminishes as the polymer
rate is exhausted (Figs. 29 and 31).
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Based on the characteristics of mass degradation profiles
the lag period was determined as the time required for an
apparent steady-state mass loss to be established.
Accordingly, the lag period can be determined graphically
as the time of the first inflection in the percent polymer
mass remaining versus time plots. If the point of
inflection in the curve is not clear, as in the case of
polymers having low mw or high glycolide content (Figs. 28
and 31), the lag period can be determined by fitting the
data of the steady-state mass loss region to the zero order
rate law and calculating the time for which the percent
remaining polymer mass becomes equal to 100 in the
resulting regression equations (Equations 13 and 14).
Unlike the method proposed by Schindler et al. (1977), in
which the lag period is defined as the time required for 5%
mass loss to occur, the method proposed in this work has
physical significance, because the lag period is recognised
as the period required for a composite phenomenon to reach
"equilibrium". Furthermore, lag period values determined
according to this method are based on the actual
degradation data of the individual polymer. The lag period
was found to increase with an increase in lactide content,
because polymer hydrolysis rate falls with increasing
lactide content, or with an increase in polymer MW, because
polymer hydrolysis rate falls with increasing polymer MW,
but also because longer times are required for a polymer
molecule to be reduced to small soluble oligomers as the
polymer mw increases (Figs. 29 and 34, Table 11).
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An increase in the particle size of the polymer powder,
sample 50(0.443), caused a significant decrease in both the
hydrolysis rate and the mass loss rate (Table 10). The
decrease in hydrolysis rate was attributed to the decreased
contribution of the surface hydrolysis, because of the
lower specific surface area, and to the delay in the
establishment of the polymer bulk "equilibrium" hydrolysis
rate. The latter was considered to be responsible for the
lag period observed in the iv versus time profile of the
50(0.443) sample, which was the only case lag period was
observed in the iv versus time profile (Fig. 30). The
decrease in mass loss rate was attributed to the decreased
initial hydrolysis rate and to the increased difficulty and
time required for the removal of soluble chain fragments
from the larger particles. These results indicate that the
degradation rate of poly(lactide-co-glycolide) is affected
by the specific surface area of the polymer form.
When the effects of composition and mw on polymer
degradation rate were quantitatively compared it was found
that composition is a more dominant factor than mw in
poly(lactide-co-glycolide) degradation (Figs. 35 and 36).
The results obtained in this study would indicate that the
composition of the polymer determines an average value
around which the degradation time fluctuates as a result of
modifications in polymer mw. The degradation times of
polymers with small differences in composition can overlap
as a result of differences in mw, but the degradation times
cannot overlap when big differences in composition are
involved, irrespective of the mw of the polymers.
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Drug release from heterogeneous matrices occurring by drug
diffusion through liquid filled capillaries and pores will
depend on the ability of the dissolution medium to wet the
polymer surface. The wettability of spray dried
poly(lactide-co-glycolide) powders was assessed by
conducting contact angle measurements. The h-€ method was
used to determine the contact angle between a polymer
compact and water (Lek et al., 1976). The contact angle
values obtained were in the range 72° - 78° (Table 14),
indicating a moderate polymer hydrophobicity. They also
indicated that the water will penetrate into the
capillaries and pores of matrices prepared by compressing
poly(lactide-co-glycolide) polymers. The mw of the polymer
did not appear to have any effect on the contact angle
values, whereas an increase in glycolide content tended to
lower the contact angle, reflecting the increased polymer
hydrophilicity as its content in hydrophobic lactic acid
units is reduced. However, the decrease in contact angle
with polymer content in glycolide was not statistically
significant (Table 15).
The polymer hydrophilicity can also be assessed by
measuring the water uptake by the polymer. This will
determine the volume of the aqueous regions in the polymer
through which drug diffusion can take place which in turn
affects the rate of drug release. Furthermore, it will
affect the degradation rate of the biodegradable polymers,
because hydrolysis rate depends on water availability.
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Water uptake by poly(lactide-co-glycolide) matrices
increased steadily as matrix hydrophilicity increased with
time due to polymer degradation. The increase in
hydrophilicity was due to the generation of hydrophillic
hydroxyl and carboxylic acid end groups through ester bond
hydrolysis. Water can also be drawn into the matrix
through an osmotic mechanism. The oligomers produced in
the tablet interior diffuse out from the matrix at a lower
rate than those produced in the surface region of the
tablet and cause an osmotic pressure difference between the
bulk solution and the solution within the tablet to be
established. Advanced degradation transformed the interior
of the tablet into a hydrogel (Figs. 56 and 57). This had
a significant effect on the rate of drug release from
matrix tablets as drug in the central portion of the
tablets had to diffuse through this gel to be liberated.
Thus, water was drawn continuously into the matrix,
increasing the matrix weight with time, but when mass loss
due to degradation outweighed the gain from water
absorption the weight loss of the matrix began to fall.
(Fig. 38)
An increase in glycolide content or a decrease in polymer
mw caused an increase in both the percent water uptake and
water uptake rate due to the increased rate of polymer
hydrolysis and decreased Tg values (Figs. 38 and 39).
An "equilibrium water uptake" was defined which represented
the percent water uptake at the point of the initial part






The existence of a long steady-state release region, which
represented a high proportion of the overall release
profile extending approximately from the time required for
20% to the time required for 80% drug release to take
place, indicated that the release did not follow the
Higuchi matrix release kinetics (Higuchi, 1963). A
composite mechanism of drug release was proposed involving
diffusion of the drug through water filled capillaries and
pores of the matrix and drug diffusion through the swollen
polymer (Fig. 51). The significant delay in drug
liberation was attributed to the decreased drug diffusion
rate through the swollen polymer as compared to that
through water and to the decreased drug diffusion rate via
water filled pores due to the pore volume reduction caused
by polymer swelling. The constant drug release rate over
the steady-state stage of release is complex and may be
attributed to a number of factors including polymer
degradation and water uptake. These could cause a
progressive increase in drug release rate which would
compensate for and balance the decrease in release rate
caused by the increasing drug diffusion path with time.
The rate of drug release increased with an increase in the
glycolide content of relatively high mw polymers. This was
attributed to the increase in water uptake and swelling,
which enhanced drug diffusion through the polymer. This
was further aided by the increase in polymer degradation
rate which resulted in an increased rate of aqueous channel
generation within the polymer through which diffusion and
drug release could take place. The steady state release
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from a 75:25 poly(lactide-co-glycolide) was found to be 3
times greater than that from a poly(lactide) polymer
(Table 21).
The effect of polymer mw on the rate of drug release was
not as straight forward as with polymer composition.
Decreasing the ntw initially caused and increase in the drug
release rate due to the increased swelling, water uptake,
and degradation rate, but further decrease in mw caused the
opposite effect (Figs. 48 and 49). This was attributed to
the rapid hydrolysis of the low mw polymer which caused the
gradual but rapid transformation of the central portion of
the tablet to a hydrogel. This allowed diffusion through
the gel as the only release pathway for drug in the tablet
interior, eliminating release by diffusion through aqueous
channels. Thus, the rate of drug release from a low mw
polymer, sample 85(0.0308), was lower than that from
polymers having both much higher mw and lactide content
(Table 21).
The duration of the burst stage of release appeared to be
approximately 2 days. The amount of drug released during
that period, although tending to increase with the
hydrophilicity of the matrix and ranging from 15.78 for the
most hydrophobic 100(1.178) to 32% for the most
hydrophillic 50(0.343) polymer (Figs. 46, 48 and 50),
appeared primarily to be a function of formulation factors.
The most influential formulation factor was the drug to
polymer ratio (Fig. 45).
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Sustained drug delivery using poly(lactide-co-glycolide)
polymers has been pursued either by microencapsulation of
the drug with the polymer or by melt extrusion of drug-
polymer mixtures to produce implantable articles (e.g.
small cylinders). In this work the use of poly(lactide-co-
glycolide) heterogeneous matrix tablets as sustained
release dosage forms was investigated. The manufacture of
matrix tablets is a relatively simple and well known
procedure which does not involve heating, as in melt
extrusion, or solution of drug and polymer, as in
microencapsulation. Consequently limitations arising from
these processes such as polymer degradation, drug
decomposition, protein denaturation by heat or problems
associated with the solubility of polymer or drug in
aqueous or organic solvents are avoided.
Drug release from microencapsulated products is relatively
rapid due to their high specific surface area so that they
are not normally suitable for long-term drug release
applications. Biphasic drug release patterns have been
reported with poly (lactide-co-glycolide) microcapsules
(Beck et al., 1983a). By contrast periods during which no
drug or sub-effective amounts have been released may be
observed with poly(lactide-co-glycolide) implants
(Hutchinson and Furr, 1985; Sanders et al., 1986). These
periods were reduced, or eliminated, by employing rapidly
degraded polymers, but this caused a decrease in the
overall duration of the release. Consequently, the
continuous release, occurring for the bulk of the process
at an essentially constant rate, from poly(lactide-co-
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glycolide) matrix tablets irrespective of the polymer used
can be considered a significant improvement.
The rate of drug release from poly(lactide-co-glycolide)
matrix tablets can be controlled by changing polymer
characteristics such as the composition and mw, or by
formulation factors such as the drug to polymer ratio,
compaction pressure, and particle size. However, further
research is required to investigate the significance of
compaction pressure and particle size in conjunction with
the polymer properties, on the long-term drug release
Each drug-polymer combination should be regarded as unique
and the development of a sustained release dosage form
based on poly(lactide-co-glycolide) polymers requires
research involving the specific drug, the polymer and
formulation parameters in order to find the optimum
combination for the specific application. The choice of a
particular poly(lactide-co-glycolide) polymer is
particularly dictated by the intended lifetime of the
preparation and, as a rule of thumb, the longer the
intended lifetime the higher the lactide content and/or the
mw of the polymer. The major problems that can be
encountered in the preparation of matrix tablets using
poly(lactide-co-glycolide) polymers are those associated
with the flowability of polymer particles and the
separation of the constituents of the drug-polymer mixture
due to differences in particle density caused by the
vibration of tableting machines. In such cases dry or wet
granulation of the drug-polymer mixture might be useful.
In wet granulation, using alcohol free water as granulating
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liquid the polymer itself would function as binder due to
its tacky nature. The investigation of the preparation and
properties of poly(lactide-co-glycolide) tablets prepared
by compacting granules might prove to be an interesting
research field concerning the application of these polymers
in controlled drug delivery.
The development of biotechnology and genetic engineering in
recent years has generated increasing numbers of
polypeptide and protein drugs and the controlled delivery
of these heat and solution labile macromolecules using
poly(lactide-co-glycolide) matrix tablets may be a useful
alternative to their parenteral administration.
In conclusion, the feasibility of using spray dried
poly(].actide-co-glycolide) polymers in the preparation of
controlled release matrix tablets intended for subcutaneous
or subdermal implantation has been demonstrated. Further
research is required to fully elucidate the drug release
mechanism from these matrix tablets. The investigation of
release using drugs of similar aqueous solubility, but of
different size, may be particularly useful in that respect
as the diffusion through swollen polymers is very sensitive
to the size of the diffusing molecules. Research involving
specific types of drug where this formulation can be
useful, such as contraceptive steroids, narcotic
antagonists, antimalarial drugs, disulfiram, polypeptides,
proteinic hormones and vaccines, and in vivo tests of the
formulations produced, will also be required to establish
the usefulness of this approach in the derivation of
-238-
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